LOKIASV2_1503_ESMFold_hypothetical_protein	3w0m-assembly1.cif.gz_A	3w0m-assembly1.cif.gz_A Crystal structure of a thermostable mutant of aminoglycoside phosphotransferase APH(4)-Ia, apo form	7.307E-13	1.000	379	14	324	326	1	289	293	326	0.954	0.986
LOKIASV2_1503_ESMFold_hypothetical_protein	5iqg-assembly1.cif.gz_A	5iqg-assembly1.cif.gz_A Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GDP, Magnesium, and Gentamicin C1	6.541E-12	1.000	330	10	325	326	2	288	292	330	0.969	0.983
LOKIASV2_1503_ESMFold_hypothetical_protein	6ch4-assembly3.cif.gz_C	6ch4-assembly3.cif.gz_C Aminoglycoside Phosphotransferase (2'')-Ia S376N mutant in complex with GMPPNP and Magnesium	8.545E-12	1.000	330	10	325	326	2	293	297	330	0.969	0.983
LOKIASV2_1503_ESMFold_hypothetical_protein	4n57-assembly1.cif.gz_A	4n57-assembly1.cif.gz_A Crystal structure of aminoglycoside phosphotransferase APH(2'')-IVa ADP complex	1.458E-11	1.000	329	12	319	326	2	296	296	331	0.945	0.997
LOKIASV2_1503_ESMFold_hypothetical_protein	5iqc-assembly3.cif.gz_C	5iqc-assembly3.cif.gz_C Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Gentamicin C1	1.116E-11	1.000	325	10	317	326	2	290	297	322	0.945	0.973
LOKIASV2_1503_ESMFold_hypothetical_protein	6c5u-assembly1.cif.gz_A	6c5u-assembly1.cif.gz_A Aminoglycoside Phosphotransferase (2'')-Ia in complex with GMPPNP, Magnesium, and Ribostamycin, Alternate form	1.178E-11	1.000	319	9	325	326	3	289	293	331	0.972	0.980
LOKIASV2_1503_ESMFold_hypothetical_protein	6cgd-assembly2.cif.gz_B	6cgd-assembly2.cif.gz_B Aminoglycoside Phosphotransferase (2'')-Ia in complex with GMPPNP, Magnesium, and Amikacin	1.242E-11	1.000	319	9	325	326	5	293	297	330	0.972	0.973
LOKIASV2_1503_ESMFold_hypothetical_protein	5iqf-assembly2.cif.gz_B	5iqf-assembly2.cif.gz_B Aminoglycoside Phosphotransferase (2'')-Ia (CTD of APH(6')-Ie/APH(2'')-Ia) in complex with GDP and Magnesium	2.010E-11	1.000	317	9	317	326	5	290	296	321	0.948	0.966
LOKIASV2_1503_ESMFold_hypothetical_protein	6ch4-assembly2.cif.gz_B	6ch4-assembly2.cif.gz_B Aminoglycoside Phosphotransferase (2'')-Ia S376N mutant in complex with GMPPNP and Magnesium	2.770E-11	1.000	316	9	317	326	5	290	297	322	0.948	0.963
LOKIASV2_1503_ESMFold_hypothetical_protein	4ork-assembly4.cif.gz_D	4ork-assembly4.cif.gz_D Crystal Structure of the Phosphotransferase Domain of the Bifunctional Aminoglycoside Resistance Enzyme AAC(6')-Ie-APH(2'')-Ia	3.619E-11	1.000	315	10	325	326	2	291	295	331	0.969	0.983
LOKIASV2_1503_ESMFold_hypothetical_protein	4dfb-assembly2.cif.gz_B	4dfb-assembly2.cif.gz_B Crystal structure of aminoglycoside phosphotransferase aph(2")-id/aph(2")-iva in complex with kanamycin	3.817E-11	1.000	315	12	322	326	3	300	301	332	0.954	0.990
LOKIASV2_1503_ESMFold_hypothetical_protein	5iqh-assembly1.cif.gz_A	5iqh-assembly1.cif.gz_A Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) S214A mutant in complex with GMPPNP and Magnesium	1.806E-11	1.000	314	9	325	326	2	291	294	331	0.972	0.986
LOKIASV2_1503_ESMFold_hypothetical_protein	3n4v-assembly2.cif.gz_B	3n4v-assembly2.cif.gz_B apo APH(2")-IVa form III	3.619E-11	1.000	313	12	320	326	3	298	298	335	0.948	0.993
LOKIASV2_1503_ESMFold_hypothetical_protein	5iqc-assembly2.cif.gz_B	5iqc-assembly2.cif.gz_B Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Gentamicin C1	3.817E-11	1.000	313	9	317	326	9	293	299	321	0.948	0.953
LOKIASV2_1503_ESMFold_hypothetical_protein	5iqd-assembly2.cif.gz_B	5iqd-assembly2.cif.gz_B Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Ribostamycin	1.905E-11	1.000	313	9	317	326	5	292	299	325	0.948	0.963
LOKIASV2_1503_ESMFold_hypothetical_protein	6cey-assembly1.cif.gz_A	6cey-assembly1.cif.gz_A Aminoglycoside Phosphotransferase (2'')-Ia in complex with GMPPNP, Magnesium, and Lividomycin moieties	2.922E-11	1.000	309	18	325	326	9	285	288	322	0.945	0.962
LOKIASV2_1503_ESMFold_hypothetical_protein	5iqe-assembly3.cif.gz_C	5iqe-assembly3.cif.gz_C Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Neomycin B	2.120E-11	1.000	307	10	325	326	2	288	292	327	0.969	0.983
LOKIASV2_1503_ESMFold_hypothetical_protein	3tdw-assembly1.cif.gz_A	3tdw-assembly1.cif.gz_A The GDP complex of the aminoglycoside 2'-phosphotransfere-IIIa F108L mutant	8.069E-11	1.000	306	9	324	326	3	295	302	333	0.969	0.970
LOKIASV2_1503_ESMFold_hypothetical_protein	5iqh-assembly4.cif.gz_D	5iqh-assembly4.cif.gz_D Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) S214A mutant in complex with GMPPNP and Magnesium	4.027E-11	1.000	305	10	325	326	2	289	291	332	0.969	0.990
LOKIASV2_1503_ESMFold_hypothetical_protein	5iqb-assembly1.cif.gz_A	5iqb-assembly1.cif.gz_A Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Kanamycin A	3.082E-11	1.000	305	15	325	326	6	289	292	324	0.954	0.973
LOKIASV2_1503_ESMFold_hypothetical_protein	5iqi-assembly3.cif.gz_C	5iqi-assembly3.cif.gz_C Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) Y237F mutant in complex with GMPPNP and Magnesium	6.873E-11	1.000	304	10	325	326	2	293	297	331	0.969	0.983
LOKIASV2_1503_ESMFold_hypothetical_protein	6ctz-assembly1.cif.gz_A	6ctz-assembly1.cif.gz_A Structure of the GDP and kanamycin complex of APH(2")-IIia	3.070E-10	1.000	302	18	324	326	8	294	297	325	0.942	0.966
LOKIASV2_1503_ESMFold_hypothetical_protein	4dta-assembly1.cif.gz_A	4dta-assembly1.cif.gz_A Crystal Structure of F95M Aminoglycoside-2''-Phosphotransferase Type IVa in Complex with Adenosine	4.987E-11	1.000	302	12	324	326	3	297	298	338	0.960	0.990
LOKIASV2_1503_ESMFold_hypothetical_protein	6cav-assembly2.cif.gz_B	6cav-assembly2.cif.gz_B Aminoglycoside Phosphotransferase (2'')-Ia in complex with GMPPNP, Magnesium, and Dibekacin	7.250E-11	1.000	300	10	325	326	2	290	292	329	0.969	0.990
LOKIASV2_1503_ESMFold_hypothetical_protein	4dfb-assembly1.cif.gz_A	4dfb-assembly1.cif.gz_A Crystal structure of aminoglycoside phosphotransferase aph(2")-id/aph(2")-iva in complex with kanamycin	5.261E-11	1.000	300	12	319	326	3	295	297	333	0.945	0.987
LOKIASV2_1503_ESMFold_hypothetical_protein	6cav-assembly3.cif.gz_C	6cav-assembly3.cif.gz_C Aminoglycoside Phosphotransferase (2'')-Ia in complex with GMPPNP, Magnesium, and Dibekacin	9.472E-11	1.000	298	12	325	326	1	283	285	325	0.963	0.993
LOKIASV2_1503_ESMFold_hypothetical_protein	4ork-assembly3.cif.gz_C	4ork-assembly3.cif.gz_C Crystal Structure of the Phosphotransferase Domain of the Bifunctional Aminoglycoside Resistance Enzyme AAC(6')-Ie-APH(2'')-Ia	6.900E-12	1.000	296	10	315	326	2	289	293	330	0.939	0.983
LOKIASV2_1503_ESMFold_hypothetical_protein	6cgg-assembly1.cif.gz_A	6cgg-assembly1.cif.gz_A Aminoglycoside Phosphotransferase (2'')-Ia in complex with GMPPNP, Magnesium, and Arbekacin	9.472E-11	1.000	296	9	325	326	2	292	296	331	0.972	0.983
LOKIASV2_1503_ESMFold_hypothetical_protein	4ork-assembly2.cif.gz_B	4ork-assembly2.cif.gz_B Crystal Structure of the Phosphotransferase Domain of the Bifunctional Aminoglycoside Resistance Enzyme AAC(6')-Ie-APH(2'')-Ia	1.705E-10	1.000	296	9	317	326	4	290	296	323	0.948	0.970
LOKIASV2_1503_ESMFold_hypothetical_protein	5iqc-assembly4.cif.gz_D	5iqc-assembly4.cif.gz_D Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Gentamicin C1	2.112E-10	1.000	295	9	315	326	5	287	290	322	0.942	0.976
LOKIASV2_1503_ESMFold_hypothetical_protein	5iqi-assembly2.cif.gz_B	5iqi-assembly2.cif.gz_B Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) Y237F mutant in complex with GMPPNP and Magnesium	8.512E-11	1.000	295	9	325	326	5	291	294	329	0.972	0.976
LOKIASV2_1503_ESMFold_hypothetical_protein	4dtb-assembly2.cif.gz_B	4dtb-assembly2.cif.gz_B Crystal Structure of F95Y Aminoglycoside-2''-Phosphotransferase Type IVa in Complex with Guanosine	1.305E-10	1.000	292	12	319	326	3	297	297	333	0.945	0.993
LOKIASV2_1503_ESMFold_hypothetical_protein	5iqe-assembly4.cif.gz_D	5iqe-assembly4.cif.gz_D Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Neomycin B	1.705E-10	1.000	290	9	325	326	5	289	292	328	0.972	0.976
LOKIASV2_1503_ESMFold_hypothetical_protein	5iqg-assembly2.cif.gz_B	5iqg-assembly2.cif.gz_B Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GDP, Magnesium, and Gentamicin C1	2.479E-10	1.000	286	9	325	326	4	287	290	329	0.972	0.979
LOKIASV2_1503_ESMFold_hypothetical_protein	3ham-assembly1.cif.gz_A	3ham-assembly1.cif.gz_A Structure of the gentamicin-APH(2")-IIa complex	5.528E-10	1.000	286	15	326	326	9	298	299	323	0.957	0.970
LOKIASV2_1503_ESMFold_hypothetical_protein	3tdv-assembly2.cif.gz_B	3tdv-assembly2.cif.gz_B Structure of the GDP complex of wild-type aminoglycoside 2'-phosphotransferase-IIIa	7.619E-10	1.000	281	15	326	326	5	299	299	336	0.957	0.987
LOKIASV2_1503_ESMFold_hypothetical_protein	5iqh-assembly3.cif.gz_C	5iqh-assembly3.cif.gz_C Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) S214A mutant in complex with GMPPNP and Magnesium	3.605E-10	1.000	278	18	325	326	11	285	288	318	0.945	0.955
LOKIASV2_1503_ESMFold_hypothetical_protein	5iqi-assembly4.cif.gz_D	5iqi-assembly4.cif.gz_D Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) Y237F mutant in complex with GMPPNP and Magnesium	5.241E-10	1.000	277	9	325	326	5	288	291	328	0.972	0.976
LOKIASV2_1503_ESMFold_hypothetical_protein	6cgg-assembly4.cif.gz_D	6cgg-assembly4.cif.gz_D Aminoglycoside Phosphotransferase (2'')-Ia in complex with GMPPNP, Magnesium, and Arbekacin	2.911E-10	1.000	275	26	326	326	24	289	289	308	0.923	0.920
LOKIASV2_1503_ESMFold_hypothetical_protein	6cav-assembly4.cif.gz_D	6cav-assembly4.cif.gz_D Aminoglycoside Phosphotransferase (2'')-Ia in complex with GMPPNP, Magnesium, and Dibekacin	5.528E-10	1.000	271	10	326	326	2	284	284	330	0.972	0.996
LOKIASV2_1503_ESMFold_hypothetical_protein	5iqb-assembly4.cif.gz_D	5iqb-assembly4.cif.gz_D Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Kanamycin A	9.435E-10	1.000	270	9	326	326	4	289	289	330	0.975	0.990
LOKIASV2_1503_ESMFold_hypothetical_protein	3hav-assembly1.cif.gz_A	3hav-assembly1.cif.gz_A Structure of the streptomycin-ATP-APH(2")-IIa ternary complex	2.104E-09	1.000	265	15	315	326	9	288	296	319	0.923	0.946
LOKIASV2_1503_ESMFold_hypothetical_protein	6ch4-assembly4.cif.gz_D	6ch4-assembly4.cif.gz_D Aminoglycoside Phosphotransferase (2'')-Ia S376N mutant in complex with GMPPNP and Magnesium	6.490E-10	1.000	263	10	326	326	2	282	282	333	0.972	0.996
LOKIASV2_1503_ESMFold_hypothetical_protein	7w1a-assembly1.cif.gz_B	7w1a-assembly1.cif.gz_B Crystal Structure of MPH-E in complex with GMP and Azithromycin	1.610E-09	1.000	259	15	309	326	6	283	287	322	0.905	0.969
LOKIASV2_1503_ESMFold_hypothetical_protein	4fex-assembly3.cif.gz_C	4fex-assembly3.cif.gz_C Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor tyrphostin AG1478	3.996E-09	1.000	256	26	291	326	18	258	261	278	0.816	0.923
LOKIASV2_1503_ESMFold_hypothetical_protein	4feu-assembly6.cif.gz_F	4feu-assembly6.cif.gz_F Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor anthrapyrazolone SP600125	5.507E-09	1.000	248	27	291	326	6	244	245	280	0.813	0.976
LOKIASV2_1503_ESMFold_hypothetical_protein	3hav-assembly3.cif.gz_C	3hav-assembly3.cif.gz_C Structure of the streptomycin-ATP-APH(2")-IIa ternary complex	1.228E-08	1.000	247	15	310	326	9	282	284	308	0.908	0.965
LOKIASV2_1503_ESMFold_hypothetical_protein	4fev-assembly1.cif.gz_A	4fev-assembly1.cif.gz_A Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP1	3.788E-09	1.000	246	12	291	326	8	262	263	302	0.859	0.970
LOKIASV2_1503_ESMFold_hypothetical_protein	1l8t-assembly1.cif.gz_A	1l8t-assembly1.cif.gz_A Crystal Structure Of 3',5"-Aminoglycoside Phosphotransferase Type IIIa ADP Kanamycin A Complex	1.295E-08	1.000	244	12	291	326	6	260	263	298	0.859	0.970
LOKIASV2_1503_ESMFold_hypothetical_protein	5ih0-assembly1.cif.gz_A	5ih0-assembly1.cif.gz_A Macrolide 2'-phosphotransferase type II Y92M mutant - complex with GDP and erythromycin	3.047E-08	1.000	243	14	319	326	1	299	299	332	0.939	1.000
LOKIASV2_1503_ESMFold_hypothetical_protein	4fex-assembly2.cif.gz_B	4fex-assembly2.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor tyrphostin AG1478	8.006E-09	1.000	242	27	291	326	19	260	261	277	0.813	0.927
LOKIASV2_1503_ESMFold_hypothetical_protein	5igw-assembly1.cif.gz_A	5igw-assembly1.cif.gz_A Macrolide 2'-phosphotransferase type II - complex with GDP and clarithromycin	2.096E-08	1.000	242	17	318	326	9	294	296	320	0.926	0.966
LOKIASV2_1503_ESMFold_hypothetical_protein	4fev-assembly9.cif.gz_F	4fev-assembly9.cif.gz_F Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP1	1.441E-08	1.000	241	27	291	326	11	251	252	279	0.813	0.956
LOKIASV2_1503_ESMFold_hypothetical_protein	4gkh-assembly2.cif.gz_B	4gkh-assembly2.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor 1-NA-PP1	8.446E-09	1.000	240	12	291	326	16	267	268	292	0.859	0.940
LOKIASV2_1503_ESMFold_hypothetical_protein	5igh-assembly1.cif.gz_A	5igh-assembly1.cif.gz_A Macrolide 2'-phosphotransferase type I	6.465E-09	1.000	240	27	320	326	27	300	301	311	0.902	0.910
LOKIASV2_1503_ESMFold_hypothetical_protein	4gkh-assembly17.cif.gz_I	4gkh-assembly17.cif.gz_I Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor 1-NA-PP1	7.194E-09	1.000	239	27	291	326	23	265	266	283	0.813	0.914
LOKIASV2_1503_ESMFold_hypothetical_protein	4gkh-assembly18.cif.gz_K	4gkh-assembly18.cif.gz_K Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor 1-NA-PP1	9.399E-09	1.000	239	12	291	326	15	268	269	296	0.859	0.944
LOKIASV2_1503_ESMFold_hypothetical_protein	4dca-assembly1.cif.gz_A	4dca-assembly1.cif.gz_A Crystal structure of aminoglycoside phosphotransferase APH(2'')-Ib, ADP-bound	1.233E-09	1.000	239	15	314	326	6	287	296	319	0.920	0.953
LOKIASV2_1503_ESMFold_hypothetical_protein	4few-assembly8.cif.gz_D	4few-assembly8.cif.gz_D Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP2	1.295E-08	1.000	237	27	291	326	21	265	266	279	0.813	0.921
LOKIASV2_1503_ESMFold_hypothetical_protein	4h05-assembly1.cif.gz_A	4h05-assembly1.cif.gz_A Crystal structure of aminoglycoside-3'-phosphotransferase of type VIII	1.366E-08	1.000	237	17	291	326	6	267	270	300	0.844	0.970
LOKIASV2_1503_ESMFold_hypothetical_protein	4gki-assembly6.cif.gz_F	4gki-assembly6.cif.gz_F Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor 1-NM-PP1	1.366E-08	1.000	235	27	291	326	20	260	261	279	0.813	0.923
LOKIASV2_1503_ESMFold_hypothetical_protein	4fev-assembly7.cif.gz_B	4fev-assembly7.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP1	2.738E-08	1.000	232	27	291	326	13	253	254	280	0.813	0.949
LOKIASV2_1503_ESMFold_hypothetical_protein	2bkk-assembly2.cif.gz_C	2bkk-assembly2.cif.gz_C Crystal structure of Aminoglycoside Phosphotransferase APH(3')-IIIa in complex with the inhibitor AR_3a	1.785E-08	1.000	232	12	291	326	5	259	262	297	0.859	0.973
LOKIASV2_1503_ESMFold_hypothetical_protein	4ej7-assembly2.cif.gz_B	4ej7-assembly2.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, ATP-bound	4.199E-08	1.000	229	12	291	326	11	264	265	303	0.859	0.958
LOKIASV2_1503_ESMFold_hypothetical_protein	3jr1-assembly2.cif.gz_B	3jr1-assembly2.cif.gz_B Crystal structure of Putative fructosamine-3-kinase (YP_719053.1) from HAEMOPHILUS SOMNUS 129PT at 2.32 A resolution	6.820E-09	1.000	229	18	319	326	15	295	295	327	0.926	0.953
LOKIASV2_1503_ESMFold_hypothetical_protein	4feu-assembly2.cif.gz_B	4feu-assembly2.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor anthrapyrazolone SP600125	4.199E-08	1.000	226	27	291	326	20	262	263	280	0.813	0.924
LOKIASV2_1503_ESMFold_hypothetical_protein	7w1a-assembly2.cif.gz_A	7w1a-assembly2.cif.gz_A Crystal Structure of MPH-E in complex with GMP and Azithromycin	5.485E-08	1.000	225	25	308	326	19	284	287	303	0.871	0.927
LOKIASV2_1503_ESMFold_hypothetical_protein	4few-assembly7.cif.gz_B	4few-assembly7.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP2	7.975E-08	1.000	220	27	291	326	15	255	256	284	0.813	0.941
LOKIASV2_1503_ESMFold_hypothetical_protein	3hav-assembly2.cif.gz_B	3hav-assembly2.cif.gz_B Structure of the streptomycin-ATP-APH(2")-IIa ternary complex	4.929E-08	1.000	218	15	312	326	9	295	297	328	0.914	0.966
LOKIASV2_1503_ESMFold_hypothetical_protein	4feu-assembly3.cif.gz_C	4feu-assembly3.cif.gz_C Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor anthrapyrazolone SP600125	2.096E-08	1.000	213	31	291	326	26	261	262	284	0.801	0.901
LOKIASV2_1503_ESMFold_hypothetical_protein	2bkk-assembly1.cif.gz_A	2bkk-assembly1.cif.gz_A Crystal structure of Aminoglycoside Phosphotransferase APH(3')-IIIa in complex with the inhibitor AR_3a	1.042E-07	1.000	212	12	291	326	6	244	247	290	0.859	0.968
LOKIASV2_1503_ESMFold_hypothetical_protein	7w19-assembly2.cif.gz_B	7w19-assembly2.cif.gz_B Crystal Structure of Acinetobacter baumannii MPH-E	7.560E-08	1.000	212	14	317	326	1	290	291	334	0.933	0.997
LOKIASV2_1503_ESMFold_hypothetical_protein	2qg7-assembly1.cif.gz_A	2qg7-assembly1.cif.gz_A Plasmodium vivax ethanolamine kinase Pv091845	3.214E-08	1.000	210	15	326	326	50	368	368	352	0.957	0.867
LOKIASV2_1503_ESMFold_hypothetical_protein	5igu-assembly1.cif.gz_A	5igu-assembly1.cif.gz_A Macrolide 2'-phosphotransferase type II	1.876E-07	1.000	209	26	319	326	3	264	264	310	0.902	0.992
LOKIASV2_1503_ESMFold_hypothetical_protein	6fux-assembly1.cif.gz_A	6fux-assembly1.cif.gz_A Structure of aminoglycoside phosphotransferase APH(3'')-Id from Streptomyces rimosus ATCC10970 in complex with ADP and streptomycin	1.598E-07	1.000	209	18	294	326	9	265	267	296	0.850	0.963
LOKIASV2_1503_ESMFold_hypothetical_protein	6iy9-assembly2.cif.gz_B	6iy9-assembly2.cif.gz_B Crystal structure of aminoglycoside 7"-phoshotransferase-Ia (APH(7")-Ia/HYG) from Streptomyces hygroscopicus complexed with hygromycin B	1.515E-07	1.000	208	16	313	326	30	321	324	321	0.914	0.901
LOKIASV2_1503_ESMFold_hypothetical_protein	6fuc-assembly1.cif.gz_A	6fuc-assembly1.cif.gz_A Structure of aminoglycoside phosphotransferase APH(3'')-Id from Streptomyces rimosus ATCC10970	4.199E-08	1.000	200	15	294	326	11	268	270	309	0.859	0.956
LOKIASV2_1503_ESMFold_hypothetical_protein	3att-assembly1.cif.gz_A	3att-assembly1.cif.gz_A Crystal structure of Rv3168 with ATP	8.413E-08	1.000	195	36	326	326	41	338	352	331	0.893	0.847
LOKIASV2_1503_ESMFold_hypothetical_protein	2hw6-assembly2.cif.gz_B	2hw6-assembly2.cif.gz_B Crystal structure of Mnk1 catalytic domain	2.844E-04	1.000	109	26	311	326	10	233	233	316	0.877	0.961
LOKIASV2_1503_ESMFold_hypothetical_protein	6oyw-assembly2.cif.gz_B	6oyw-assembly2.cif.gz_B ASK1 kinase domain in complex with Compound 11	1.086E-04	1.000	107	26	310	326	12	254	256	320	0.874	0.949
LOKIASV2_1503_ESMFold_hypothetical_protein	6v6a-assembly2.cif.gz_C	6v6a-assembly2.cif.gz_C Inhibitory scaffolding of the ancient MAPK, ERK7	4.619E-05	1.000	106	16	322	326	3	289	299	378	0.942	0.960
LOKIASV2_1503_ESMFold_hypothetical_protein	6oyt-assembly2.cif.gz_D	6oyt-assembly2.cif.gz_D ASK1 kinase domain in complex with GS-4997	2.296E-04	1.000	105	26	312	326	17	252	253	321	0.880	0.933
LOKIASV2_1503_ESMFold_hypothetical_protein	6oyt-assembly1.cif.gz_C	6oyt-assembly1.cif.gz_C ASK1 kinase domain in complex with GS-4997	1.497E-04	1.000	104	25	305	326	11	231	236	305	0.862	0.936
LOKIASV2_1503_ESMFold_hypothetical_protein	5h2u-assembly4.cif.gz_D	5h2u-assembly4.cif.gz_D Crystal structure of PTK6 Kinase Domain complexed with Dasatinib	4.853E-04	1.000	102	28	326	326	11	263	263	340	0.917	0.962
LOKIASV2_1503_ESMFold_hypothetical_protein	4eqm-assembly3.cif.gz_C	4eqm-assembly3.cif.gz_C Structural analysis of Staphylococcus aureus serine/threonine kinase PknB	1.497E-04	1.000	102	28	326	326	14	266	269	340	0.917	0.941
LOKIASV2_1503_ESMFold_hypothetical_protein	2yaa-assembly1.cif.gz_B	2yaa-assembly1.cif.gz_B Crystal structure of the autoinhibited form of mouse DAPK2 in complex with ATP	1.497E-04	1.000	102	26	325	326	12	283	299	357	0.920	0.910
LOKIASV2_1503_ESMFold_hypothetical_protein	6qau-assembly2.cif.gz_B	6qau-assembly2.cif.gz_B Crystal structure of ULK2 in complexed with MRT67307	2.422E-04	1.000	100	28	311	326	14	263	265	340	0.871	0.943
LOKIASV2_1503_ESMFold_hypothetical_protein	7up8-assembly1.cif.gz_A	7up8-assembly1.cif.gz_A Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 27 (co-crystal)	4.134E-04	1.000	100	26	311	326	10	238	273	310	0.877	0.839
LOKIASV2_1503_ESMFold_hypothetical_protein	3orx-assembly5.cif.gz_E	3orx-assembly5.cif.gz_E PDK1 mutant bound to allosteric disulfide fragment inhibitor 1F8	1.854E-04	1.000	100	24	324	326	3	226	274	330	0.923	0.818
LOKIASV2_1503_ESMFold_hypothetical_protein	3q4t-assembly1.cif.gz_A	3q4t-assembly1.cif.gz_A Crystal structure of Activin receptor type-IIA (ACVR2A) kinase domain in complex with dorsomorphin	2.696E-04	1.000	100	27	319	326	13	305	305	364	0.899	0.961
LOKIASV2_1503_ESMFold_hypothetical_protein	6qau-assembly1.cif.gz_A	6qau-assembly1.cif.gz_A Crystal structure of ULK2 in complexed with MRT67307	1.666E-04	0.999	98	29	311	326	15	273	276	348	0.868	0.938
LOKIASV2_1503_ESMFold_hypothetical_protein	3h0z-assembly1.cif.gz_A	3h0z-assembly1.cif.gz_A Aurora A in complex with a bisanilinopyrimidine	1.142E-03	0.999	97	26	313	326	7	246	248	326	0.883	0.968
LOKIASV2_1503_ESMFold_hypothetical_protein	3h9o-assembly1.cif.gz_A	3h9o-assembly1.cif.gz_A Phosphoinositide-dependent protein kinase 1 (PDK-1) in complex with compound 9	2.696E-04	0.999	97	24	324	326	4	228	276	330	0.923	0.815
LOKIASV2_1503_ESMFold_hypothetical_protein	1zrz-assembly1.cif.gz_A	1zrz-assembly1.cif.gz_A Crystal Structure of the Catalytic Domain of Atypical Protein Kinase C-iota	1.419E-04	0.999	97	28	311	326	10	266	312	336	0.871	0.824
LOKIASV2_1503_ESMFold_hypothetical_protein	6bab-assembly3.cif.gz_C	6bab-assembly3.cif.gz_C The structure of human CamKII with bound inhibitor	2.177E-04	0.999	96	26	326	326	1	284	284	365	0.923	1.000
LOKIASV2_1503_ESMFold_hypothetical_protein	6bab-assembly1.cif.gz_A	6bab-assembly1.cif.gz_A The structure of human CamKII with bound inhibitor	1.146E-04	0.999	96	26	326	326	5	290	290	366	0.923	0.986
LOKIASV2_1503_ESMFold_hypothetical_protein	4yga-assembly3.cif.gz_E	4yga-assembly3.cif.gz_E CDPK1, from Toxoplasma gondii, bound to inhibitory VHH-1B7	4.150E-05	0.999	96	28	325	326	11	264	442	347	0.914	0.575
LOKIASV2_1503_ESMFold_hypothetical_protein	4yga-assembly1.cif.gz_A	4yga-assembly1.cif.gz_A CDPK1, from Toxoplasma gondii, bound to inhibitory VHH-1B7	1.086E-04	0.999	96	28	317	326	11	271	448	338	0.890	0.583
LOKIASV2_1503_ESMFold_hypothetical_protein	5uox-assembly2.cif.gz_B	5uox-assembly2.cif.gz_B Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failure	5.401E-04	0.998	95	25	310	326	12	251	252	323	0.877	0.952
LOKIASV2_1503_ESMFold_hypothetical_protein	3ggf-assembly3.cif.gz_A	3ggf-assembly3.cif.gz_A Crystal structure of human Serine/threonine-protein kinase MST4 in complex with an quinazolin	2.063E-04	0.998	95	27	325	326	11	265	275	341	0.917	0.927
LOKIASV2_1503_ESMFold_hypothetical_protein	4cqg-assembly1.cif.gz_A	4cqg-assembly1.cif.gz_A The crystal structure of MPK38 in complex with OTSSP167, an orally- administrative MELK selective inhibitor	2.422E-04	0.998	95	15	311	326	3	246	313	332	0.911	0.780
LOKIASV2_1503_ESMFold_hypothetical_protein	7qwk-assembly6.cif.gz_F	7qwk-assembly6.cif.gz_F GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	6.689E-04	0.998	94	27	310	326	10	250	254	321	0.871	0.949
LOKIASV2_1503_ESMFold_hypothetical_protein	6b2q-assembly2.cif.gz_C	6b2q-assembly2.cif.gz_C Dual Inhibition of the Essential Protein Kinases A and B in Mycobacterium tuberculosis	6.689E-04	0.998	94	28	324	326	15	257	265	340	0.911	0.917
LOKIASV2_1503_ESMFold_hypothetical_protein	3ma6-assembly2.cif.gz_B	3ma6-assembly2.cif.gz_B Crystal structure of kinase domain of TgCDPK1 in presence of 3BrB-PP1	1.209E-04	0.998	94	28	313	326	10	265	266	342	0.877	0.962
LOKIASV2_1503_ESMFold_hypothetical_protein	5dew-assembly1.cif.gz_A	5dew-assembly1.cif.gz_A Crystal structure of PAK1 in complex with an inhibitor compound 5	2.844E-04	0.998	94	27	326	326	24	261	295	329	0.920	0.807
LOKIASV2_1503_ESMFold_hypothetical_protein	7p1l-assembly1.cif.gz_A	7p1l-assembly1.cif.gz_A The MARK3 Kinase Domain Bound To AA-CS-1-008	2.844E-04	0.998	94	26	315	326	6	248	301	328	0.890	0.807
LOKIASV2_1503_ESMFold_hypothetical_protein	5w9e-assembly1.cif.gz_A	5w9e-assembly1.cif.gz_A Toxoplasma Gondii CDPK1 in complex with inhibitor GXJ-186	9.254E-05	0.998	94	28	325	326	12	282	451	351	0.914	0.601
LOKIASV2_1503_ESMFold_hypothetical_protein	5uor-assembly1.cif.gz_A	5uor-assembly1.cif.gz_A Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failure	3.715E-04	0.998	93	26	310	326	12	248	249	324	0.874	0.952
LOKIASV2_1503_ESMFold_hypothetical_protein	4bic-assembly2.cif.gz_B	4bic-assembly2.cif.gz_B Crystal Structures of Ask1-inhibitor Complexes	5.120E-04	0.998	93	26	311	326	13	257	259	327	0.877	0.946
LOKIASV2_1503_ESMFold_hypothetical_protein	6yid-assembly2.cif.gz_C	6yid-assembly2.cif.gz_C Crystal structure of ULK2 in complex with SBI-0206965	4.134E-04	0.998	93	29	310	326	17	258	259	330	0.865	0.934
LOKIASV2_1503_ESMFold_hypothetical_protein	4mvf-assembly1.cif.gz_A	4mvf-assembly1.cif.gz_A Crystal Structure of Plasmodium falciparum CDPK2 complexed with inhibitor staurosporine	4.134E-04	0.998	93	28	314	326	17	232	408	306	0.880	0.529
LOKIASV2_1503_ESMFold_hypothetical_protein	3aln-assembly1.cif.gz_A	3aln-assembly1.cif.gz_A Crystal Structure of human non-phosphorylated MKK4 kinase domain complexed with AMP-PNP	5.401E-04	0.997	92	26	313	326	19	251	270	329	0.883	0.863
LOKIASV2_1503_ESMFold_hypothetical_protein	7b8w-assembly3.cif.gz_C	7b8w-assembly3.cif.gz_C Structure of LIMK1 Kinase domain with allosteric inhibitor TH-470	5.120E-04	0.997	92	21	325	326	3	268	276	352	0.936	0.964
LOKIASV2_1503_ESMFold_hypothetical_protein	7b8w-assembly1.cif.gz_A	7b8w-assembly1.cif.gz_A Structure of LIMK1 Kinase domain with allosteric inhibitor TH-470	4.601E-04	0.997	92	21	325	326	3	270	279	356	0.936	0.961
LOKIASV2_1503_ESMFold_hypothetical_protein	4jdk-assembly1.cif.gz_A	4jdk-assembly1.cif.gz_A Crystal structure of Serine/threonine-protein kinase PAK 4 F461V mutant in complex with Paktide S peptide substrate	8.283E-04	0.997	92	26	318	326	24	286	290	345	0.899	0.907
LOKIASV2_1503_ESMFold_hypothetical_protein	5xvf-assembly1.cif.gz_A	5xvf-assembly1.cif.gz_A Crystal Structure of PAK4 in complex with inhibitor CZH062	9.724E-04	0.997	92	26	311	326	25	275	290	331	0.877	0.866
LOKIASV2_1503_ESMFold_hypothetical_protein	7p1l-assembly2.cif.gz_B	7p1l-assembly2.cif.gz_B The MARK3 Kinase Domain Bound To AA-CS-1-008	1.579E-04	0.997	92	27	318	326	10	250	300	329	0.896	0.803
LOKIASV2_1503_ESMFold_hypothetical_protein	4uv0-assembly1.cif.gz_A	4uv0-assembly1.cif.gz_A Structure of a semisynthetic phosphorylated DAPK	6.689E-04	0.997	92	26	325	326	12	283	300	354	0.920	0.907
LOKIASV2_1503_ESMFold_hypothetical_protein	6oyt-assembly2.cif.gz_B	6oyt-assembly2.cif.gz_B ASK1 kinase domain in complex with GS-4997	7.056E-04	0.997	91	25	287	326	12	218	238	286	0.807	0.870
LOKIASV2_1503_ESMFold_hypothetical_protein	6n3o-assembly1.cif.gz_A	6n3o-assembly1.cif.gz_A Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agents	1.204E-03	0.997	91	27	319	326	7	250	252	327	0.899	0.968
LOKIASV2_1503_ESMFold_hypothetical_protein	6yid-assembly1.cif.gz_A	6yid-assembly1.cif.gz_A Crystal structure of ULK2 in complex with SBI-0206965	5.697E-04	0.997	91	29	310	326	15	256	259	333	0.865	0.934
LOKIASV2_1503_ESMFold_hypothetical_protein	2clq-assembly1.cif.gz_A-2	2clq-assembly1.cif.gz_A-2 Structure of mitogen-activated protein kinase kinase kinase 5	4.583E-03	0.997	91	26	235	326	13	153	263	222	0.644	0.536
LOKIASV2_1503_ESMFold_hypothetical_protein	7mu7-assembly1.cif.gz_A	7mu7-assembly1.cif.gz_A Ask1 bound to compound 3	7.056E-04	0.997	91	26	310	326	12	261	263	329	0.874	0.951
LOKIASV2_1503_ESMFold_hypothetical_protein	1v0p-assembly1.cif.gz_A	1v0p-assembly1.cif.gz_A Structure of P. falciparum PfPK5-Purvalanol B ligand complex	1.414E-03	0.997	91	26	235	326	6	146	277	224	0.644	0.509
LOKIASV2_1503_ESMFold_hypothetical_protein	4zy6-assembly2.cif.gz_B	4zy6-assembly2.cif.gz_B Crystal structure of P21-activated kinase 1 in complex with an inhibitor compound 29	4.134E-04	0.997	91	9	323	326	3	247	280	341	0.966	0.875
LOKIASV2_1503_ESMFold_hypothetical_protein	2wnt-assembly1.cif.gz_B	2wnt-assembly1.cif.gz_B Crystal Structure of the Human Ribosomal protein S6 kinase	5.120E-04	0.997	91	28	313	326	8	254	285	332	0.877	0.867
LOKIASV2_1503_ESMFold_hypothetical_protein	5vlo-assembly1.cif.gz_A	5vlo-assembly1.cif.gz_A The structure of human CamKII with bound inhibitor	1.419E-04	0.997	91	27	326	326	7	290	290	362	0.920	0.979
LOKIASV2_1503_ESMFold_hypothetical_protein	3hmm-assembly1.cif.gz_A	3hmm-assembly1.cif.gz_A Structure of Alk5 + GW855857	7.443E-04	0.997	91	28	318	326	9	291	293	351	0.893	0.966
LOKIASV2_1503_ESMFold_hypothetical_protein	4f9b-assembly1.cif.gz_A	4f9b-assembly1.cif.gz_A Human CDC7 kinase in complex with DBF4 and PHA767491	1.026E-03	0.997	91	15	298	326	6	298	318	373	0.871	0.921
LOKIASV2_1503_ESMFold_hypothetical_protein	4azs-assembly1.cif.gz_A	4azs-assembly1.cif.gz_A High resolution (2.2 A) crystal structure of WbdD.	6.010E-04	0.997	91	28	289	326	221	441	442	300	0.804	0.500
LOKIASV2_1503_ESMFold_hypothetical_protein	4yjn-assembly1.cif.gz_A	4yjn-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1) in complex with inhibitor UW1639	1.030E-04	0.997	91	28	325	326	13	283	460	358	0.914	0.589
LOKIASV2_1503_ESMFold_hypothetical_protein	7qwk-assembly7.cif.gz_G	7qwk-assembly7.cif.gz_G GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	1.082E-03	0.996	90	27	310	326	10	251	257	321	0.871	0.942
LOKIASV2_1503_ESMFold_hypothetical_protein	3ggf-assembly3.cif.gz_B	3ggf-assembly3.cif.gz_B Crystal structure of human Serine/threonine-protein kinase MST4 in complex with an quinazolin	3.715E-04	0.996	90	27	325	326	10	263	270	344	0.917	0.941
LOKIASV2_1503_ESMFold_hypothetical_protein	7jij-assembly1.cif.gz_A	7jij-assembly1.cif.gz_A ATP-bound AMP-activated protein kinase	2.844E-04	0.996	90	27	311	326	8	259	407	335	0.874	0.619
LOKIASV2_1503_ESMFold_hypothetical_protein	5v19-assembly1.cif.gz_A	5v19-assembly1.cif.gz_A Structure-based drug design of novel ASK1 inhibitors using a fully integrated lead optimization strategy	5.401E-04	0.996	89	26	310	326	12	249	250	323	0.874	0.952
LOKIASV2_1503_ESMFold_hypothetical_protein	2in6-assembly1.cif.gz_A	2in6-assembly1.cif.gz_A Wee1 kinase complex with inhibitor PD311839	2.177E-04	0.996	89	12	309	326	1	255	256	343	0.914	0.996
LOKIASV2_1503_ESMFold_hypothetical_protein	2wtw-assembly1.cif.gz_A	2wtw-assembly1.cif.gz_A Aurora-A Inhibitor Structure (2nd crystal form)	5.401E-04	0.996	89	28	313	326	10	253	256	326	0.877	0.953
LOKIASV2_1503_ESMFold_hypothetical_protein	2clq-assembly2.cif.gz_B	2clq-assembly2.cif.gz_B Structure of mitogen-activated protein kinase kinase kinase 5	1.660E-03	0.996	89	25	310	326	12	257	259	329	0.877	0.950
LOKIASV2_1503_ESMFold_hypothetical_protein	6qat-assembly1.cif.gz_A	6qat-assembly1.cif.gz_A Crystal structure of ULK2 in complexed with hesperadin	1.573E-03	0.996	89	28	311	326	13	257	259	328	0.871	0.946
LOKIASV2_1503_ESMFold_hypothetical_protein	4bic-assembly1.cif.gz_A	4bic-assembly1.cif.gz_A Crystal Structures of Ask1-inhibitor Complexes	1.082E-03	0.996	89	28	326	326	15	247	260	321	0.917	0.896
LOKIASV2_1503_ESMFold_hypothetical_protein	4ow8-assembly1.cif.gz_A-2	4ow8-assembly1.cif.gz_A-2 Crystal structure of kinase domain of PknA from Mtb	1.204E-03	0.996	89	28	324	326	15	269	276	357	0.911	0.924
LOKIASV2_1503_ESMFold_hypothetical_protein	3qc4-assembly2.cif.gz_B	3qc4-assembly2.cif.gz_B PDK1 in complex with DFG-OUT inhibitor xxx	2.844E-04	0.996	89	9	319	326	3	276	279	365	0.954	0.982
LOKIASV2_1503_ESMFold_hypothetical_protein	8ho6-assembly1.cif.gz_A	8ho6-assembly1.cif.gz_A ScRIPK WT	3.325E-03	0.996	89	17	317	326	8	276	281	358	0.923	0.957
LOKIASV2_1503_ESMFold_hypothetical_protein	1oky-assembly1.cif.gz_A	1oky-assembly1.cif.gz_A Structure of human PDK1 kinase domain in complex with staurosporine	3.715E-04	0.996	89	26	311	326	10	266	282	343	0.877	0.911
LOKIASV2_1503_ESMFold_hypothetical_protein	6bab-assembly2.cif.gz_B	6bab-assembly2.cif.gz_B The structure of human CamKII with bound inhibitor	1.340E-03	0.996	89	26	312	326	1	258	285	333	0.880	0.905
LOKIASV2_1503_ESMFold_hypothetical_protein	5e91-assembly1.cif.gz_A	5e91-assembly1.cif.gz_A TGF-BETA RECEPTOR TYPE 2 KINASE DOMAIN (E431A,R433A,E485A,K488A,R493A,R495A) IN COMPLEX WITH 3-AMINO-6-[4-(2- HYDROXYETHYL)PHENYL]-N-[4-(MORPHOLIN-4-YL)PYRIDIN-3-YL] PYRAZINE-2-CARBOXAMIDE	6.689E-04	0.996	89	29	326	326	10	283	297	361	0.914	0.923
LOKIASV2_1503_ESMFold_hypothetical_protein	4d2t-assembly3.cif.gz_B	4d2t-assembly3.cif.gz_B Structure of MELK in complex with inhibitors	3.164E-04	0.996	89	12	315	326	2	258	323	346	0.933	0.796
LOKIASV2_1503_ESMFold_hypothetical_protein	5up3-assembly2.cif.gz_B	5up3-assembly2.cif.gz_B Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failure	7.852E-04	0.995	88	25	310	326	11	242	243	315	0.877	0.955
LOKIASV2_1503_ESMFold_hypothetical_protein	2wmv-assembly1.cif.gz_A	2wmv-assembly1.cif.gz_A Crystal structure of checkpoint kinase 1 (Chk1) in complex with inhibitors	1.340E-03	0.995	88	26	310	326	2	246	251	337	0.874	0.976
LOKIASV2_1503_ESMFold_hypothetical_protein	5m53-assembly1.cif.gz_A	5m53-assembly1.cif.gz_A Nek2 bound to arylaminopurine inhibitor 11	1.414E-03	0.995	88	26	310	326	1	253	255	335	0.874	0.992
LOKIASV2_1503_ESMFold_hypothetical_protein	2j90-assembly1.cif.gz_B	2j90-assembly1.cif.gz_B Crystal structure of human ZIP kinase in complex with a tetracyclic pyridone inhibitor (Pyridone 6)	2.287E-03	0.995	88	28	311	326	6	260	264	335	0.871	0.966
LOKIASV2_1503_ESMFold_hypothetical_protein	7b8w-assembly4.cif.gz_D	7b8w-assembly4.cif.gz_D Structure of LIMK1 Kinase domain with allosteric inhibitor TH-470	4.361E-04	0.995	88	26	326	326	8	236	273	332	0.923	0.839
LOKIASV2_1503_ESMFold_hypothetical_protein	4agu-assembly3.cif.gz_C	4agu-assembly3.cif.gz_C CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	7.056E-04	0.995	88	28	326	326	7	263	278	344	0.917	0.924
LOKIASV2_1503_ESMFold_hypothetical_protein	3orz-assembly4.cif.gz_D	3orz-assembly4.cif.gz_D PDK1 mutant bound to allosteric disulfide fragment activator 2A2	7.852E-04	0.995	88	24	326	326	6	245	279	342	0.929	0.860
LOKIASV2_1503_ESMFold_hypothetical_protein	5dey-assembly2.cif.gz_B	5dey-assembly2.cif.gz_B Crystal structure of PAK1 in complex with an inhibitor compound G-5555	6.689E-04	0.995	88	9	326	326	3	249	281	344	0.975	0.879
LOKIASV2_1503_ESMFold_hypothetical_protein	6ruu-assembly1.cif.gz_B	6ruu-assembly1.cif.gz_B Pseudokinase domain of human IRAK3	1.956E-04	0.995	88	12	317	326	1	284	286	361	0.939	0.993
LOKIASV2_1503_ESMFold_hypothetical_protein	3d5u-assembly1.cif.gz_A	3d5u-assembly1.cif.gz_A Crystal structure of a wildtype Polo-like kinase 1 (Plk1) catalytic domain.	8.738E-04	0.995	88	27	311	326	19	270	288	338	0.874	0.875
LOKIASV2_1503_ESMFold_hypothetical_protein	5s7i-assembly2.cif.gz_B	5s7i-assembly2.cif.gz_B XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010928a	7.443E-04	0.995	88	26	301	326	3	216	294	308	0.847	0.728
LOKIASV2_1503_ESMFold_hypothetical_protein	4ax8-assembly1.cif.gz_A	4ax8-assembly1.cif.gz_A Medium resolution structure of the bifunctional kinase- methyltransferase WbdD	1.142E-03	0.995	88	35	289	326	237	449	450	290	0.782	0.473
LOKIASV2_1503_ESMFold_hypothetical_protein	6oyt-assembly1.cif.gz_A	6oyt-assembly1.cif.gz_A ASK1 kinase domain in complex with GS-4997	2.833E-03	0.994	87	26	310	326	17	221	222	307	0.874	0.923
LOKIASV2_1503_ESMFold_hypothetical_protein	6qav-assembly2.cif.gz_D	6qav-assembly2.cif.gz_D Crystal structure of ULK2 in complexed with MRT68921	4.601E-04	0.994	87	29	326	326	14	242	254	331	0.914	0.902
LOKIASV2_1503_ESMFold_hypothetical_protein	2h6d-assembly1.cif.gz_A	2h6d-assembly1.cif.gz_A Protein Kinase Domain of the Human 5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK alpha-2 chain)	1.026E-03	0.994	87	27	322	326	9	254	256	339	0.908	0.961
LOKIASV2_1503_ESMFold_hypothetical_protein	4bie-assembly2.cif.gz_B	4bie-assembly2.cif.gz_B Crystal Structures of Ask1-inhibitor Complexes	6.340E-04	0.994	87	26	311	326	13	255	257	326	0.877	0.946
LOKIASV2_1503_ESMFold_hypothetical_protein	6oyw-assembly1.cif.gz_C	6oyw-assembly1.cif.gz_C ASK1 kinase domain in complex with Compound 11	8.283E-04	0.994	87	26	310	326	12	259	260	328	0.874	0.954
LOKIASV2_1503_ESMFold_hypothetical_protein	6yid-assembly1.cif.gz_B	6yid-assembly1.cif.gz_B Crystal structure of ULK2 in complex with SBI-0206965	1.026E-03	0.994	87	29	311	326	18	263	264	331	0.868	0.932
LOKIASV2_1503_ESMFold_hypothetical_protein	5h9b-assembly1.cif.gz_A	5h9b-assembly1.cif.gz_A Drosophila CaMKII-wt in complex with a fragment of the Eag potassium channel and Mg2+/AMPPN	9.724E-04	0.994	87	26	312	326	9	268	269	340	0.880	0.967
LOKIASV2_1503_ESMFold_hypothetical_protein	7du9-assembly1.cif.gz_B	7du9-assembly1.cif.gz_B Crystal structure of human Proto-oncogene tyrosine-protein kinase receptor Ret in complex with Pralsetinib	1.660E-03	0.994	87	27	315	326	23	272	273	327	0.887	0.916
LOKIASV2_1503_ESMFold_hypothetical_protein	3qd0-assembly1.cif.gz_A	3qd0-assembly1.cif.gz_A Phosphoinositide-Dependent Kinase-1 (PDK1) kinase domain with (2R,5S)-1-[2-Amino-6-(3-amino-1H-indazol-6-yl)-4-pyrimidinyl]-6-methyl-N-phenyl-3-piperidinecarboxamide	1.026E-03	0.994	87	26	324	326	9	227	274	325	0.917	0.799
LOKIASV2_1503_ESMFold_hypothetical_protein	4j95-assembly6.cif.gz_C	4j95-assembly6.cif.gz_C Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome in Space Group C2.	1.142E-03	0.994	87	27	317	326	16	274	281	347	0.893	0.922
LOKIASV2_1503_ESMFold_hypothetical_protein	1uu7-assembly1.cif.gz_A	1uu7-assembly1.cif.gz_A Structure of human PDK1 kinase domain in complex with BIM-2	5.401E-04	0.994	87	26	311	326	9	266	281	339	0.877	0.918
LOKIASV2_1503_ESMFold_hypothetical_protein	7xdw-assembly2.cif.gz_B	7xdw-assembly2.cif.gz_B Crystal structure of a receptor like kinase from Arabidopsis	2.685E-03	0.994	87	14	319	326	4	281	281	356	0.939	0.989
LOKIASV2_1503_ESMFold_hypothetical_protein	1v0b-assembly1.cif.gz_A	1v0b-assembly1.cif.gz_A Crystal structure of the t198a mutant of pfpk5	5.401E-04	0.994	87	27	311	326	7	285	286	369	0.874	0.976
LOKIASV2_1503_ESMFold_hypothetical_protein	6tsz-assembly1.cif.gz_U	6tsz-assembly1.cif.gz_U The ULK4 Pseudokinase Domain Bound To ATPgammaS	9.218E-04	0.994	87	27	326	326	10	271	287	351	0.920	0.913
LOKIASV2_1503_ESMFold_hypothetical_protein	6unq-assembly1.cif.gz_A	6unq-assembly1.cif.gz_A Kinase domain of ALK2-K493A with AMPPNP	1.026E-03	0.994	87	27	301	326	6	214	289	300	0.844	0.723
LOKIASV2_1503_ESMFold_hypothetical_protein	4nw6-assembly1.cif.gz_A	4nw6-assembly1.cif.gz_A Rsk2 N-terminal kinase in complex with 2-amino-7-substituted benzoxazole compound 27	3.522E-04	0.994	87	27	326	326	18	290	302	356	0.920	0.904
LOKIASV2_1503_ESMFold_hypothetical_protein	4f9c-assembly1.cif.gz_A	4f9c-assembly1.cif.gz_A Human CDC7 kinase in complex with DBF4 and XL413	8.283E-04	0.994	87	15	311	326	4	304	306	379	0.911	0.984
LOKIASV2_1503_ESMFold_hypothetical_protein	5t6a-assembly1.cif.gz_A	5t6a-assembly1.cif.gz_A Crystal Structure of TgCDPK1 from toxoplasma gondii complexed with 5GA	3.535E-05	0.994	87	28	325	326	11	278	431	345	0.914	0.622
LOKIASV2_1503_ESMFold_hypothetical_protein	1zyc-assembly1.cif.gz_A	1zyc-assembly1.cif.gz_A Crystal Structure of eIF2alpha Protein Kinase GCN2: Wild-Type in Apo Form.	1.204E-03	0.993	86	28	310	326	12	253	261	323	0.868	0.927
LOKIASV2_1503_ESMFold_hypothetical_protein	4j95-assembly6.cif.gz_D	4j95-assembly6.cif.gz_D Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome in Space Group C2.	1.142E-03	0.993	86	27	317	326	17	264	271	342	0.893	0.915
LOKIASV2_1503_ESMFold_hypothetical_protein	6qg4-assembly1.cif.gz_A	6qg4-assembly1.cif.gz_A Structure of the mitogen activated kinase kinase 7 in complex with pyrazolopyrimidine inhibitor 1h	1.497E-04	0.993	86	26	324	326	17	263	272	334	0.917	0.908
LOKIASV2_1503_ESMFold_hypothetical_protein	8a5j-assembly1.cif.gz_A	8a5j-assembly1.cif.gz_A Crystal structure of Human STE20-like kinase 1, MST1 in complex with compound XMU-MP-1	1.142E-03	0.993	86	27	325	326	3	275	279	360	0.917	0.978
LOKIASV2_1503_ESMFold_hypothetical_protein	3sc1-assembly1.cif.gz_A	3sc1-assembly1.cif.gz_A Novel Isoquinolone PDK1 Inhibitors Discovered through Fragment-Based Lead Discovery	1.026E-03	0.993	86	24	324	326	6	231	279	331	0.923	0.810
LOKIASV2_1503_ESMFold_hypothetical_protein	6b16-assembly2.cif.gz_B	6b16-assembly2.cif.gz_B P21-activated kinase 1 in complex with a 4-azaindole inhibitor	9.218E-04	0.993	86	9	326	326	3	249	281	346	0.975	0.879
LOKIASV2_1503_ESMFold_hypothetical_protein	5o1s-assembly1.cif.gz_A	5o1s-assembly1.cif.gz_A Dimethyl fumarate is an allosteric covalent inhibitor of the p90 ribosomal S6 kinases	1.082E-03	0.993	86	25	313	326	6	260	290	343	0.887	0.879
LOKIASV2_1503_ESMFold_hypothetical_protein	2vz6-assembly2.cif.gz_B	2vz6-assembly2.cif.gz_B Structure of human calcium calmodulin dependent protein kinase type II alpha (CAMK2A) in complex with Indirubin E804	7.443E-04	0.993	86	26	325	326	8	292	294	362	0.920	0.969
LOKIASV2_1503_ESMFold_hypothetical_protein	5qin-assembly1.cif.gz_A	5qin-assembly1.cif.gz_A TGF-BETA RECEPTOR TYPE 2 KINASE DOMAIN IN COMPLEX WITH N- {4-[3-(6-METHOXYPYRIDIN-3-YL)-1H-PYRROLO[3,2-B]PYRIDIN-2- YL]PYRIDIN-2-YL}ACETAMIDE	7.056E-04	0.993	86	29	326	326	10	283	295	359	0.914	0.929
LOKIASV2_1503_ESMFold_hypothetical_protein	3g2f-assembly1.cif.gz_A	3g2f-assembly1.cif.gz_A Crystal structure of the kinase domain of bone morphogenetic protein receptor type II (BMPR2) at 2.35 A resolution	1.948E-03	0.993	86	27	317	326	10	296	302	361	0.893	0.950
LOKIASV2_1503_ESMFold_hypothetical_protein	1z9x-assembly1.cif.gz_A	1z9x-assembly1.cif.gz_A Human DRP-1 kinase, W305S S308A D40 mutant, crystal form with 3 monomers in the asymmetric unit	1.204E-03	0.993	86	26	325	326	13	298	303	366	0.920	0.944
LOKIASV2_1503_ESMFold_hypothetical_protein	4y5q-assembly1.cif.gz_A	4y5q-assembly1.cif.gz_A Activated Calcium-Dependent Protein Kinase 1 from Cryptosporidium parvum (CpCDPK1) in complex with AMP	3.000E-04	0.993	86	26	313	326	12	267	449	338	0.883	0.570
LOKIASV2_1503_ESMFold_hypothetical_protein	7qwk-assembly4.cif.gz_D	7qwk-assembly4.cif.gz_D GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	2.055E-03	0.992	85	27	310	326	11	252	254	321	0.871	0.953
LOKIASV2_1503_ESMFold_hypothetical_protein	6vre-assembly2.cif.gz_B	6vre-assembly2.cif.gz_B Structure of ASK1 bound to BIO-1772961	2.168E-03	0.992	85	26	310	326	14	258	260	332	0.874	0.942
LOKIASV2_1503_ESMFold_hypothetical_protein	5d7v-assembly4.cif.gz_D	5d7v-assembly4.cif.gz_D Crystal structure of PTK6 kinase domain	2.685E-03	0.992	85	28	326	326	11	264	264	341	0.917	0.962
LOKIASV2_1503_ESMFold_hypothetical_protein	5vja-assembly1.cif.gz_B	5vja-assembly1.cif.gz_B Crystal Structure of human zipper-interacting protein kinase (ZIPK, alias DAPK3) in complex with a pyrazolo[3,4-d]pyrimidinone ligand (HS38)	2.988E-03	0.992	85	26	312	326	8	265	266	345	0.880	0.970
LOKIASV2_1503_ESMFold_hypothetical_protein	1uu9-assembly1.cif.gz_A	1uu9-assembly1.cif.gz_A Structure of human PDK1 kinase domain in complex with BIM-3	9.724E-04	0.992	85	24	324	326	7	231	277	331	0.923	0.812
LOKIASV2_1503_ESMFold_hypothetical_protein	6vpj-assembly1.cif.gz_A-2	6vpj-assembly1.cif.gz_A-2 TPX2 residues 7-20 fused to Aurora A residues 116-389 C247V + C319V double mutant dephosphorylated, and in complex with AMP-PNP	8.738E-04	0.992	85	26	326	326	27	262	279	335	0.923	0.846
LOKIASV2_1503_ESMFold_hypothetical_protein	7up8-assembly2.cif.gz_B	7up8-assembly2.cif.gz_B Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 27 (co-crystal)	1.270E-03	0.992	85	29	324	326	17	274	280	346	0.908	0.921
LOKIASV2_1503_ESMFold_hypothetical_protein	3orx-assembly2.cif.gz_B	3orx-assembly2.cif.gz_B PDK1 mutant bound to allosteric disulfide fragment inhibitor 1F8	8.738E-04	0.992	85	26	311	326	5	265	281	343	0.877	0.929
LOKIASV2_1503_ESMFold_hypothetical_protein	5ig1-assembly1.cif.gz_A	5ig1-assembly1.cif.gz_A Crystal structure of S. rosetta CaMKII kinase domain	4.361E-04	0.992	85	29	326	326	21	300	300	360	0.914	0.933
LOKIASV2_1503_ESMFold_hypothetical_protein	5qtz-assembly1.cif.gz_A	5qtz-assembly1.cif.gz_A TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH 6-[1-(2,2-DIFLUOROETHYL)-4-(6-METHYLPYRIDIN-2-YL)-1H-IMIDAZOL-5-YL]IMIDAZO[1,2-A]PYRIDINE	1.751E-03	0.992	85	28	315	326	13	302	303	356	0.883	0.957
LOKIASV2_1503_ESMFold_hypothetical_protein	3i79-assembly1.cif.gz_A	3i79-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1)	7.083E-05	0.992	85	28	314	326	11	268	455	341	0.880	0.567
LOKIASV2_1503_ESMFold_hypothetical_protein	7qwk-assembly3.cif.gz_C	7qwk-assembly3.cif.gz_C GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	2.055E-03	0.991	84	27	310	326	11	246	249	316	0.871	0.948
LOKIASV2_1503_ESMFold_hypothetical_protein	6oyw-assembly1.cif.gz_A-2	6oyw-assembly1.cif.gz_A-2 ASK1 kinase domain in complex with Compound 11	1.847E-03	0.991	84	26	310	326	12	260	261	331	0.874	0.954
LOKIASV2_1503_ESMFold_hypothetical_protein	5uor-assembly2.cif.gz_B	5uor-assembly2.cif.gz_B Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failure	2.413E-03	0.991	84	26	321	326	13	221	262	313	0.908	0.798
LOKIASV2_1503_ESMFold_hypothetical_protein	5hu3-assembly1.cif.gz_A	5hu3-assembly1.cif.gz_A Drosophila CaMKII-D136N in complex with a phosphorylated fragment of the Eag potassium channel and Mg2+/ADP	1.948E-03	0.991	84	26	316	326	9	263	266	341	0.893	0.959
LOKIASV2_1503_ESMFold_hypothetical_protein	5uhn-assembly2.cif.gz_B	5uhn-assembly2.cif.gz_B Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring a N549H/E565A Double Gain-of-Function Mutation	2.168E-03	0.991	84	27	324	326	15	268	269	344	0.914	0.944
LOKIASV2_1503_ESMFold_hypothetical_protein	5ugl-assembly2.cif.gz_B	5ugl-assembly2.cif.gz_B Crystal Structure of FGF Receptor 2 Tyrosine Kinase Domain Harboring the D650V Activating Mutation	1.660E-03	0.991	84	27	315	326	17	269	271	338	0.887	0.934
LOKIASV2_1503_ESMFold_hypothetical_protein	3tt0-assembly2.cif.gz_B	3tt0-assembly2.cif.gz_B Co-structure of Fibroblast Growth Factor Receptor 1 kinase domain with 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (BGJ398)	5.120E-04	0.991	84	27	324	326	22	269	272	341	0.914	0.912
LOKIASV2_1503_ESMFold_hypothetical_protein	8wsw-assembly4.cif.gz_D	8wsw-assembly4.cif.gz_D The Crystal Structure of LIMK2a from Biortus	7.056E-04	0.991	84	26	326	326	1	241	281	345	0.923	0.858
LOKIASV2_1503_ESMFold_hypothetical_protein	4a07-assembly1.cif.gz_A	4a07-assembly1.cif.gz_A Human PDK1 Kinase Domain in Complex with Allosteric Activator PS171 Bound to the PIF-Pocket	2.545E-03	0.991	84	26	311	326	6	267	283	340	0.877	0.926
LOKIASV2_1503_ESMFold_hypothetical_protein	7atu-assembly2.cif.gz_B	7atu-assembly2.cif.gz_B The LIMK1 Kinase Domain Bound To LIJTF500025	1.204E-03	0.991	84	26	325	326	10	275	287	350	0.920	0.927
LOKIASV2_1503_ESMFold_hypothetical_protein	6srh-assembly1.cif.gz_A	6srh-assembly1.cif.gz_A Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2117	1.340E-03	0.991	84	26	317	326	7	287	288	358	0.896	0.976
LOKIASV2_1503_ESMFold_hypothetical_protein	4ump-assembly1.cif.gz_A	4ump-assembly1.cif.gz_A Structure of MELK in complex with inhibitors	3.715E-04	0.991	84	12	319	326	1	252	313	347	0.945	0.805
LOKIASV2_1503_ESMFold_hypothetical_protein	4f9a-assembly1.cif.gz_A	4f9a-assembly1.cif.gz_A Human CDC7 kinase in complex with DBF4 and nucleotide	2.055E-03	0.991	84	15	298	326	6	295	315	370	0.871	0.921
LOKIASV2_1503_ESMFold_hypothetical_protein	2hak-assembly5.cif.gz_E	2hak-assembly5.cif.gz_E Catalytic and ubiqutin-associated domains of MARK1/PAR-1	5.697E-04	0.991	84	28	315	326	11	263	318	334	0.883	0.796
LOKIASV2_1503_ESMFold_hypothetical_protein	7qwk-assembly1.cif.gz_A	7qwk-assembly1.cif.gz_A GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	2.833E-03	0.990	83	27	307	326	11	245	245	323	0.862	0.959
LOKIASV2_1503_ESMFold_hypothetical_protein	5v19-assembly2.cif.gz_B	5v19-assembly2.cif.gz_B Structure-based drug design of novel ASK1 inhibitors using a fully integrated lead optimization strategy	1.573E-03	0.990	83	28	310	326	15	258	260	334	0.868	0.938
LOKIASV2_1503_ESMFold_hypothetical_protein	4agu-assembly2.cif.gz_B	4agu-assembly2.cif.gz_B CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	1.491E-03	0.990	83	28	326	326	6	260	276	344	0.917	0.924
LOKIASV2_1503_ESMFold_hypothetical_protein	4agu-assembly1.cif.gz_A	4agu-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	1.491E-03	0.990	83	28	326	326	7	262	277	347	0.917	0.924
LOKIASV2_1503_ESMFold_hypothetical_protein	2wei-assembly1.cif.gz_A	2wei-assembly1.cif.gz_A Crystal structure of the kinase domain of Cryptosporidium parvum calcium dependent protein kinase in complex with 3-MB-PP1	6.010E-04	0.990	83	28	313	326	20	275	278	335	0.877	0.921
LOKIASV2_1503_ESMFold_hypothetical_protein	3orx-assembly4.cif.gz_D	3orx-assembly4.cif.gz_D PDK1 mutant bound to allosteric disulfide fragment inhibitor 1F8	1.082E-03	0.990	83	26	326	326	6	249	283	343	0.923	0.862
LOKIASV2_1503_ESMFold_hypothetical_protein	7qhg-assembly2.cif.gz_B	7qhg-assembly2.cif.gz_B LIM domain kinase 2 (LIMK2) in complex with TH-470	4.601E-04	0.990	83	26	326	326	3	243	283	342	0.923	0.852
LOKIASV2_1503_ESMFold_hypothetical_protein	2v7o-assembly1.cif.gz_A	2v7o-assembly1.cif.gz_A Crystal structure of human calcium-calmodulin-dependent protein kinase II gamma	4.601E-04	0.990	83	14	325	326	1	303	306	381	0.957	0.990
LOKIASV2_1503_ESMFold_hypothetical_protein	6ilz-assembly4.cif.gz_G	6ilz-assembly4.cif.gz_G Crystal structure of PKCiota in complex with inhibitor	1.948E-03	0.990	83	26	311	326	2	256	315	339	0.877	0.810
LOKIASV2_1503_ESMFold_hypothetical_protein	4nif-assembly1.cif.gz_E	4nif-assembly1.cif.gz_E Heterodimeric structure of ERK2 and RSK1	5.120E-04	0.990	83	26	321	326	18	308	348	375	0.908	0.836
LOKIASV2_1503_ESMFold_hypothetical_protein	7m74-assembly1.cif.gz_A	7m74-assembly1.cif.gz_A ATP-bound AMP-activated protein kinase	7.443E-04	0.990	83	27	306	326	8	214	380	301	0.859	0.545
LOKIASV2_1503_ESMFold_hypothetical_protein	3ncg-assembly1.cif.gz_A	3ncg-assembly1.cif.gz_A Activated Calcium-Dependent Protein Kinase 1 from Cryptosporidium parvum (CpCDPK1) in complex with bumped kinase inhibitor NM-PP1	1.142E-03	0.990	83	28	313	326	15	265	426	334	0.877	0.589
LOKIASV2_1503_ESMFold_hypothetical_protein	5u6y-assembly1.cif.gz_B	5u6y-assembly1.cif.gz_B Pseudo-atomic model of the CaMKIIa holoenzyme.	7.443E-04	0.990	83	26	325	326	3	287	459	362	0.920	0.621
LOKIASV2_1503_ESMFold_hypothetical_protein	7kx6-assembly1.cif.gz_A	7kx6-assembly1.cif.gz_A Crystal structure of DCLK1-KD in complex with XMD8-85	1.082E-03	0.988	82	16	326	326	4	246	258	344	0.954	0.942
LOKIASV2_1503_ESMFold_hypothetical_protein	2hak-assembly8.cif.gz_H	2hak-assembly8.cif.gz_H Catalytic and ubiqutin-associated domains of MARK1/PAR-1	9.218E-04	0.988	82	26	284	326	6	211	277	295	0.794	0.744
LOKIASV2_1503_ESMFold_hypothetical_protein	5lvp-assembly4.cif.gz_D	5lvp-assembly4.cif.gz_D Human PDK1 Kinase Domain in Complex with an HM-Peptide Bound to the PIF-Pocket	9.218E-04	0.988	82	26	326	326	8	243	277	338	0.923	0.852
LOKIASV2_1503_ESMFold_hypothetical_protein	4ct2-assembly1.cif.gz_A	4ct2-assembly1.cif.gz_A Human PDK1-PKCzeta Kinase Chimera	5.380E-03	0.988	82	26	311	326	6	262	278	338	0.877	0.924
LOKIASV2_1503_ESMFold_hypothetical_protein	4j95-assembly5.cif.gz_B	4j95-assembly5.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome in Space Group C2.	1.660E-03	0.988	82	27	317	326	16	275	282	353	0.893	0.922
LOKIASV2_1503_ESMFold_hypothetical_protein	5hvj-assembly1.cif.gz_A	5hvj-assembly1.cif.gz_A Crystal structure of LIMK1 D460N mutant in complex with AMP-PNP	5.401E-04	0.988	82	28	326	326	15	245	283	333	0.917	0.816
LOKIASV2_1503_ESMFold_hypothetical_protein	7xdv-assembly2.cif.gz_B	7xdv-assembly2.cif.gz_B Crystal structure of a receptor like kinase from Arabidopsis	2.287E-03	0.988	82	14	319	326	4	283	283	363	0.939	0.989
LOKIASV2_1503_ESMFold_hypothetical_protein	5mrd-assembly1.cif.gz_A	5mrd-assembly1.cif.gz_A Human PDK1-PKCiota Kinase Chimera in Complex with Allosteric Compound PS267 Bound to the PIF-Pocket	1.660E-03	0.988	82	26	311	326	6	268	284	344	0.877	0.926
LOKIASV2_1503_ESMFold_hypothetical_protein	5s78-assembly1.cif.gz_A	5s78-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010934a	9.724E-04	0.988	82	27	317	326	10	284	285	350	0.893	0.965
LOKIASV2_1503_ESMFold_hypothetical_protein	4ytc-assembly1.cif.gz_A	4ytc-assembly1.cif.gz_A Discovery of VX-509 (Decernotinib): A Potent and Selective Janus kinase (JAK) 3 Inhibitor for the Treatment of Autoimmune Disease	2.685E-03	0.988	82	27	319	326	8	284	286	354	0.899	0.969
LOKIASV2_1503_ESMFold_hypothetical_protein	2hak-assembly4.cif.gz_D	2hak-assembly4.cif.gz_D Catalytic and ubiqutin-associated domains of MARK1/PAR-1	4.853E-04	0.988	82	26	312	326	6	251	309	334	0.880	0.796
LOKIASV2_1503_ESMFold_hypothetical_protein	4ynz-assembly1.cif.gz_A	4ynz-assembly1.cif.gz_A Structure of the N-terminal domain of SAD	9.218E-04	0.988	82	27	326	326	14	241	313	335	0.920	0.728
LOKIASV2_1503_ESMFold_hypothetical_protein	6ilz-assembly2.cif.gz_C	6ilz-assembly2.cif.gz_C Crystal structure of PKCiota in complex with inhibitor	2.168E-03	0.988	82	26	311	326	2	255	317	329	0.877	0.801
LOKIASV2_1503_ESMFold_hypothetical_protein	2i0e-assembly1.cif.gz_A	2i0e-assembly1.cif.gz_A Structure of catalytic domain of human protein kinase C beta II complexed with a bisindolylmaleimide inhibitor	8.283E-04	0.988	82	26	326	326	3	275	329	364	0.923	0.830
LOKIASV2_1503_ESMFold_hypothetical_protein	3zxt-assembly1.cif.gz_B	3zxt-assembly1.cif.gz_B Dimeric structure of DAPK-1 catalytic domain in complex with AMPPCP- Mg	4.344E-03	0.986	81	26	306	326	8	248	253	328	0.862	0.953
LOKIASV2_1503_ESMFold_hypothetical_protein	6oyw-assembly2.cif.gz_D-3	6oyw-assembly2.cif.gz_D-3 ASK1 kinase domain in complex with Compound 11	2.413E-03	0.986	81	28	310	326	14	259	260	326	0.868	0.946
LOKIASV2_1503_ESMFold_hypothetical_protein	6c19-assembly2.cif.gz_B	6c19-assembly2.cif.gz_B FGFR1 kinase complex with inhibitor SN36985	1.660E-03	0.986	81	24	324	326	12	262	264	338	0.923	0.951
LOKIASV2_1503_ESMFold_hypothetical_protein	5vja-assembly1.cif.gz_C	5vja-assembly1.cif.gz_C Crystal Structure of human zipper-interacting protein kinase (ZIPK, alias DAPK3) in complex with a pyrazolo[3,4-d]pyrimidinone ligand (HS38)	8.704E-03	0.986	81	26	326	326	8	251	265	336	0.923	0.921
LOKIASV2_1503_ESMFold_hypothetical_protein	4nks-assembly2.cif.gz_B	4nks-assembly2.cif.gz_B Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazolaminopyrimidine 3	9.724E-04	0.986	81	27	324	326	20	270	271	345	0.914	0.926
LOKIASV2_1503_ESMFold_hypothetical_protein	8xfm-assembly1.cif.gz_A	8xfm-assembly1.cif.gz_A The Crystal Structure of MNK2 from Biortus.	9.724E-04	0.986	81	27	313	326	11	275	276	348	0.880	0.960
LOKIASV2_1503_ESMFold_hypothetical_protein	4j99-assembly5.cif.gz_A	4j99-assembly5.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659T Mutation.	2.685E-03	0.986	81	27	324	326	18	279	280	350	0.914	0.936
LOKIASV2_1503_ESMFold_hypothetical_protein	4j99-assembly6.cif.gz_D	4j99-assembly6.cif.gz_D Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659T Mutation.	2.833E-03	0.986	81	27	324	326	19	280	281	347	0.914	0.932
LOKIASV2_1503_ESMFold_hypothetical_protein	3gxl-assembly1.cif.gz_A	3gxl-assembly1.cif.gz_A ALK-5 kinase complex with GW857175	1.573E-03	0.986	81	28	313	326	9	283	285	345	0.877	0.965
LOKIASV2_1503_ESMFold_hypothetical_protein	6hvd-assembly1.cif.gz_A	6hvd-assembly1.cif.gz_A Human SLK bound to a maleimide inhibitor	3.152E-03	0.986	81	28	317	326	21	280	286	345	0.890	0.909
LOKIASV2_1503_ESMFold_hypothetical_protein	1f3m-assembly1.cif.gz_C	1f3m-assembly1.cif.gz_C CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE KINASE PAK1	5.401E-04	0.986	81	14	326	326	1	255	287	355	0.960	0.889
LOKIASV2_1503_ESMFold_hypothetical_protein	5lqf-assembly1.cif.gz_A	5lqf-assembly1.cif.gz_A CDK1/CyclinB1/CKS2 in complex with NU6102	1.948E-03	0.986	81	28	310	326	11	285	287	355	0.868	0.958
LOKIASV2_1503_ESMFold_hypothetical_protein	2ivu-assembly1.cif.gz_A-2	2ivu-assembly1.cif.gz_A-2 Crystal structure of phosphorylated RET tyrosine kinase domain complexed with the inhibitor ZD6474	2.287E-03	0.986	81	27	315	326	26	288	289	341	0.887	0.910
LOKIASV2_1503_ESMFold_hypothetical_protein	2hak-assembly7.cif.gz_G	2hak-assembly7.cif.gz_G Catalytic and ubiqutin-associated domains of MARK1/PAR-1	1.026E-03	0.986	81	26	310	326	5	237	297	318	0.874	0.785
LOKIASV2_1503_ESMFold_hypothetical_protein	4bky-assembly1.cif.gz_A	4bky-assembly1.cif.gz_A Crystal structure of unphosphorylated Maternal Embryonic Leucine zipper Kinase (MELK) in complex with pyrrolopyrazole inhibitor	4.853E-04	0.986	81	14	319	326	1	250	311	342	0.939	0.804
LOKIASV2_1503_ESMFold_hypothetical_protein	6ilz-assembly3.cif.gz_E	6ilz-assembly3.cif.gz_E Crystal structure of PKCiota in complex with inhibitor	2.685E-03	0.986	81	26	311	326	1	254	316	333	0.877	0.804
LOKIASV2_1503_ESMFold_hypothetical_protein	6gvx-assembly2.cif.gz_B	6gvx-assembly2.cif.gz_B Crystal structure of Maternal Embryonic Leucine Zipper Kinase (MELK) in complex with dorsomorphin (Compound C)	4.853E-04	0.986	81	9	319	326	2	256	319	345	0.954	0.799
LOKIASV2_1503_ESMFold_hypothetical_protein	4ian-assembly1.cif.gz_B	4ian-assembly1.cif.gz_B Crystal Structure of apo Human PRPF4B kinase domain	8.738E-04	0.986	81	28	311	326	16	319	320	384	0.871	0.950
LOKIASV2_1503_ESMFold_hypothetical_protein	6qau-assembly2.cif.gz_C	6qau-assembly2.cif.gz_C Crystal structure of ULK2 in complexed with MRT67307	8.283E-04	0.984	80	28	322	326	15	235	250	332	0.905	0.884
LOKIASV2_1503_ESMFold_hypothetical_protein	4bid-assembly2.cif.gz_B	4bid-assembly2.cif.gz_B Crystal Structures of Ask1-inhibitor Complexes	3.152E-03	0.984	80	28	326	326	15	245	258	319	0.917	0.895
LOKIASV2_1503_ESMFold_hypothetical_protein	1mry-assembly1.cif.gz_A	1mry-assembly1.cif.gz_A crystal structure of an inactive akt2 kinase domain	1.026E-03	0.984	80	27	315	326	10	249	270	333	0.887	0.889
LOKIASV2_1503_ESMFold_hypothetical_protein	3nax-assembly1.cif.gz_A	3nax-assembly1.cif.gz_A PDK1 in complex with inhibitor MP7	2.413E-03	0.984	80	26	319	326	6	270	278	344	0.902	0.953
LOKIASV2_1503_ESMFold_hypothetical_protein	5d9k-assembly2.cif.gz_B	5d9k-assembly2.cif.gz_B Rsk2 N-terminal Kinase in Complex with BI-D1870	2.055E-03	0.984	80	27	318	326	10	264	280	333	0.896	0.911
LOKIASV2_1503_ESMFold_hypothetical_protein	5s7k-assembly1.cif.gz_A	5s7k-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010936a	3.904E-03	0.984	80	26	301	326	6	207	285	291	0.847	0.709
LOKIASV2_1503_ESMFold_hypothetical_protein	2biy-assembly1.cif.gz_A	2biy-assembly1.cif.gz_A Structure of PDK1-S241A mutant kinase domain	1.491E-03	0.984	80	26	311	326	10	272	287	344	0.877	0.916
LOKIASV2_1503_ESMFold_hypothetical_protein	2psq-assembly1.cif.gz_A	2psq-assembly1.cif.gz_A Crystal Structure of Unphosphorylated Unactivated Wild Type FGF Receptor 2 (FGFR2) Kinase Domain	3.152E-03	0.984	80	27	326	326	16	287	287	362	0.920	0.948
LOKIASV2_1503_ESMFold_hypothetical_protein	5e90-assembly1.cif.gz_A	5e90-assembly1.cif.gz_A TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D,I211V,Y249F, S280T,Y282F,S287N,A350C,L352F) IN COMPLEX WITH 3-AMINO-6- [4-(2-HYDROXYETHYL)PHENYL]-N-[4-(MORPHOLIN-4-YL)PYRIDIN-3-YL]PYRAZINE-2-CARBOXAMIDE	1.340E-03	0.984	80	28	315	326	13	302	303	361	0.883	0.957
LOKIASV2_1503_ESMFold_hypothetical_protein	5dvr-assembly1.cif.gz_A	5dvr-assembly1.cif.gz_A Crystal Structure of TgCDPK1 From Toxoplasma Gondii complexed with GW780159X	1.204E-03	0.984	80	28	311	326	12	263	386	332	0.871	0.653
LOKIASV2_1503_ESMFold_hypothetical_protein	3coh-assembly2.cif.gz_B	3coh-assembly2.cif.gz_B Crystal structure of Aurora-A in complex with a pentacyclic inhibitor	4.118E-03	0.981	79	26	326	326	7	231	247	336	0.923	0.911
LOKIASV2_1503_ESMFold_hypothetical_protein	5jt2-assembly2.cif.gz_C	5jt2-assembly2.cif.gz_C BRAFV600E Kinase Domain In Complex with Chemically Linked Vemurafenib Inhibitor VEM-BISAMIDE	5.380E-03	0.981	79	28	319	326	18	251	251	323	0.896	0.932
LOKIASV2_1503_ESMFold_hypothetical_protein	6c2t-assembly1.cif.gz_A-2	6c2t-assembly1.cif.gz_A-2 Aurora A ligand complex	3.152E-03	0.981	79	26	313	326	7	251	253	338	0.883	0.968
LOKIASV2_1503_ESMFold_hypothetical_protein	2x9f-assembly1.cif.gz_A	2x9f-assembly1.cif.gz_A ephB4 kinase domain inhibitor complex	2.988E-03	0.981	79	28	324	326	12	257	265	334	0.911	0.928
LOKIASV2_1503_ESMFold_hypothetical_protein	5a6n-assembly1.cif.gz_A	5a6n-assembly1.cif.gz_A Crystal structure of human death associated protein kinase 3 (DAPK3) in complex with compound 2	1.751E-03	0.981	79	26	326	326	7	257	271	346	0.923	0.926
LOKIASV2_1503_ESMFold_hypothetical_protein	8a66-assembly1.cif.gz_A	8a66-assembly1.cif.gz_A Crystal structure of MST2 in complex with XMU-MP-1	4.344E-03	0.981	79	27	325	326	4	272	275	356	0.917	0.978
LOKIASV2_1503_ESMFold_hypothetical_protein	3ckx-assembly1.cif.gz_A	3ckx-assembly1.cif.gz_A Crystal structure of sterile 20-like kinase 3 (MST3, STK24) in complex with staurosporine	2.685E-03	0.981	79	27	325	326	8	264	277	343	0.917	0.928
LOKIASV2_1503_ESMFold_hypothetical_protein	3otu-assembly1.cif.gz_A	3otu-assembly1.cif.gz_A PDK1 mutant bound to allosteric disulfide fragment activator JS30	2.833E-03	0.981	79	26	312	326	5	262	277	342	0.880	0.931
LOKIASV2_1503_ESMFold_hypothetical_protein	5s7g-assembly2.cif.gz_B	5s7g-assembly2.cif.gz_B XChem group deposition -- Crystal Structure of human ACVR1 in complex with XS035844b	4.834E-03	0.981	79	27	301	326	5	203	281	292	0.844	0.708
LOKIASV2_1503_ESMFold_hypothetical_protein	6gu6-assembly1.cif.gz_A	6gu6-assembly1.cif.gz_A CDK1/Cks2 in complex with Dinaciclib	7.443E-04	0.981	79	28	316	326	8	215	288	310	0.887	0.722
LOKIASV2_1503_ESMFold_hypothetical_protein	5s87-assembly2.cif.gz_B	5s87-assembly2.cif.gz_B XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010953a	2.685E-03	0.981	79	26	301	326	3	212	290	308	0.847	0.724
LOKIASV2_1503_ESMFold_hypothetical_protein	4krc-assembly1.cif.gz_A	4krc-assembly1.cif.gz_A Crystal Structure of Pho85-Pcl10-ATP-gamma-S Complex	1.026E-03	0.981	79	27	316	326	9	289	297	369	0.890	0.946
LOKIASV2_1503_ESMFold_hypothetical_protein	2wel-assembly1.cif.gz_A	2wel-assembly1.cif.gz_A Crystal structure of SU6656-bound calcium/calmodulin-dependent protein kinase II delta in complex with calmodulin	1.660E-03	0.981	79	26	310	326	7	264	304	341	0.874	0.849
LOKIASV2_1503_ESMFold_hypothetical_protein	5eak-assembly1.cif.gz_A	5eak-assembly1.cif.gz_A Optimization of Microtubule Affinity Regulating Kinase (MARK) Inhibitors with Improved Physical Properties	8.738E-04	0.981	79	25	319	326	8	254	305	334	0.905	0.810
LOKIASV2_1503_ESMFold_hypothetical_protein	4ekk-assembly1.cif.gz_A	4ekk-assembly1.cif.gz_A Akt1 with AMP-PNP	7.443E-04	0.981	79	27	318	326	10	274	319	351	0.896	0.831
LOKIASV2_1503_ESMFold_hypothetical_protein	6lnm-assembly3.cif.gz_E	6lnm-assembly3.cif.gz_E Crystal structure of CASK-CaMK in complex with Mint1-CID	7.852E-04	0.981	79	26	324	326	8	297	322	367	0.917	0.901
LOKIASV2_1503_ESMFold_hypothetical_protein	3a8x-assembly3.cif.gz_B	3a8x-assembly3.cif.gz_B Crystal Structure of PKCiota kinase domain	2.545E-03	0.981	79	26	326	326	11	278	331	351	0.923	0.810
LOKIASV2_1503_ESMFold_hypothetical_protein	6c9f-assembly1.cif.gz_A	6c9f-assembly1.cif.gz_A AMP-activated protein kinase bound to pharmacological activator R734	1.204E-03	0.981	79	27	311	326	8	261	373	342	0.874	0.681
LOKIASV2_1503_ESMFold_hypothetical_protein	6b2e-assembly1.cif.gz_A	6b2e-assembly1.cif.gz_A Structure of full length human AMPK (a2b2g1) in complex with a small molecule activator SC4.	3.508E-03	0.981	79	27	322	326	10	268	443	349	0.908	0.585
LOKIASV2_1503_ESMFold_hypothetical_protein	4ysm-assembly2.cif.gz_B	4ysm-assembly2.cif.gz_B Calcium-Dependent Protein Kinase from Eimeria tenella	8.283E-04	0.981	79	28	320	326	26	284	475	351	0.899	0.545
LOKIASV2_1503_ESMFold_hypothetical_protein	3zfm-assembly1.cif.gz_A	3zfm-assembly1.cif.gz_A Crystal structure of EphB2	1.414E-03	0.978	78	27	323	326	19	240	248	325	0.911	0.895
LOKIASV2_1503_ESMFold_hypothetical_protein	4bid-assembly1.cif.gz_A	4bid-assembly1.cif.gz_A Crystal Structures of Ask1-inhibitor Complexes	7.822E-03	0.978	78	28	233	326	15	146	254	213	0.632	0.520
LOKIASV2_1503_ESMFold_hypothetical_protein	6nzp-assembly3.cif.gz_B	6nzp-assembly3.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH COMPOUND-11 AKA 6-CYCLOPROPANEAMIDO-4-{[2-METHOXY-3-(1-METHYL-1H-1,2,4-TRI AZOL-3-YL)PHENYL]AMINO}-N-(?H?)METHYLPYRIDAZINE-3-CARBOXAMIDE	3.325E-03	0.978	78	27	315	326	13	221	260	310	0.887	0.804
LOKIASV2_1503_ESMFold_hypothetical_protein	7ovi-assembly1.cif.gz_A	7ovi-assembly1.cif.gz_A Protein kinase MKK7 in complex with phenethyltriazole-substituted pyrazolopyrimidine	8.738E-04	0.978	78	26	324	326	18	252	262	326	0.917	0.897
LOKIASV2_1503_ESMFold_hypothetical_protein	5vja-assembly1.cif.gz_A	5vja-assembly1.cif.gz_A Crystal Structure of human zipper-interacting protein kinase (ZIPK, alias DAPK3) in complex with a pyrazolo[3,4-d]pyrimidinone ligand (HS38)	5.987E-03	0.978	78	26	326	326	8	253	266	343	0.923	0.925
LOKIASV2_1503_ESMFold_hypothetical_protein	4iti-assembly2.cif.gz_B	4iti-assembly2.cif.gz_B Crystal structure of RIP1 kinase in complex with necrostatin-3 analog	2.168E-03	0.978	78	29	317	326	11	269	270	338	0.887	0.959
LOKIASV2_1503_ESMFold_hypothetical_protein	1zyd-assembly1.cif.gz_A	1zyd-assembly1.cif.gz_A Crystal Structure of eIF2alpha Protein Kinase GCN2: Wild-Type Complexed with ATP.	2.685E-03	0.978	78	28	325	326	12	262	270	335	0.914	0.930
LOKIASV2_1503_ESMFold_hypothetical_protein	4l00-assembly3.cif.gz_B	4l00-assembly3.cif.gz_B Crystal structure of the apo Jak1 pseudokinase domain	5.380E-03	0.978	78	28	319	326	23	278	278	341	0.896	0.921
LOKIASV2_1503_ESMFold_hypothetical_protein	2vu3-assembly1.cif.gz_A	2vu3-assembly1.cif.gz_A Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design.	2.833E-03	0.978	78	28	316	326	8	204	285	305	0.887	0.691
LOKIASV2_1503_ESMFold_hypothetical_protein	2pwl-assembly1.cif.gz_B	2pwl-assembly1.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic N549H Mutation Responsible for Crouzon Syndrome.	4.344E-03	0.978	78	26	326	326	15	286	286	357	0.923	0.951
LOKIASV2_1503_ESMFold_hypothetical_protein	3we4-assembly1.cif.gz_A	3we4-assembly1.cif.gz_A Crystal structure of S6K1 kinase domain in complex with a pyrimidine derivative PF-4708671 2-{[4-(5-ethylpyrimidin-4-yl)piperazin-1-yl]methyl}-5-(trifluoromethyl)-1H-benzimidazole	1.948E-03	0.978	78	27	318	326	10	274	287	345	0.896	0.923
LOKIASV2_1503_ESMFold_hypothetical_protein	3kxx-assembly4.cif.gz_D	3kxx-assembly4.cif.gz_D Structure of the mutant Fibroblast Growth Factor receptor 1	4.118E-03	0.978	78	24	313	326	20	284	288	346	0.890	0.920
LOKIASV2_1503_ESMFold_hypothetical_protein	6cth-assembly1.cif.gz_A	6cth-assembly1.cif.gz_A Crystal Structure of Pathogenesis-related Protein 1G (PR-1G) Kinase Domain from Cacao	7.028E-03	0.978	78	17	318	326	8	281	295	364	0.926	0.929
LOKIASV2_1503_ESMFold_hypothetical_protein	2i0e-assembly2.cif.gz_B	2i0e-assembly2.cif.gz_B Structure of catalytic domain of human protein kinase C beta II complexed with a bisindolylmaleimide inhibitor	2.413E-03	0.978	78	26	312	326	3	264	302	344	0.880	0.868
LOKIASV2_1503_ESMFold_hypothetical_protein	2qnj-assembly1.cif.gz_A	2qnj-assembly1.cif.gz_A Kinase and Ubiquitin-associated domains of MARK3/Par-1	2.055E-03	0.978	78	27	318	326	15	267	318	341	0.896	0.796
LOKIASV2_1503_ESMFold_hypothetical_protein	6ilz-assembly1.cif.gz_A	6ilz-assembly1.cif.gz_A Crystal structure of PKCiota in complex with inhibitor	3.508E-03	0.978	78	26	326	326	2	268	320	359	0.923	0.834
LOKIASV2_1503_ESMFold_hypothetical_protein	5n3f-assembly1.cif.gz_A	5n3f-assembly1.cif.gz_A cAMP-dependent Protein Kinase A from Cricetulus griseus in complex with fragment like molecule N-[3-(aminomethyl)phenyl]acetamide	1.142E-03	0.978	78	28	318	326	38	294	321	340	0.893	0.801
LOKIASV2_1503_ESMFold_hypothetical_protein	6ya8-assembly1.cif.gz_A	6ya8-assembly1.cif.gz_A Cdc7-Dbf4 bound to ADP-BeF3	3.325E-03	0.978	78	15	311	326	7	338	340	410	0.911	0.976
LOKIASV2_1503_ESMFold_hypothetical_protein	3mwu-assembly1.cif.gz_A	3mwu-assembly1.cif.gz_A Activated Calcium-Dependent Protein Kinase 1 from Cryptosporidium parvum (CpCDPK1) in complex with bumped kinase inhibitor RM-1-95	5.697E-04	0.978	78	26	313	326	12	266	447	332	0.883	0.570
LOKIASV2_1503_ESMFold_hypothetical_protein	8sap-assembly1.cif.gz_A	8sap-assembly1.cif.gz_A Crystal structure of class III lanthipeptide synthetase ThurKC	1.419E-04	0.978	78	10	287	326	178	443	833	342	0.853	0.319
LOKIASV2_1503_ESMFold_hypothetical_protein	2h34-assembly2.cif.gz_B	2h34-assembly2.cif.gz_B Apoenzyme crystal structure of the tuberculosis serine/threonine kinase, PknE	2.685E-03	0.975	77	27	315	326	3	239	243	328	0.887	0.975
LOKIASV2_1503_ESMFold_hypothetical_protein	5v24-assembly1.cif.gz_A	5v24-assembly1.cif.gz_A Structure-based drug design of novel ASK1 inhibitors using a fully integrated lead optimization strategy	3.508E-03	0.975	77	26	310	326	12	248	249	321	0.874	0.952
LOKIASV2_1503_ESMFold_hypothetical_protein	4bf2-assembly2.cif.gz_B	4bf2-assembly2.cif.gz_B Crystal Structures of Ask1-inhibitor Complexes	4.583E-03	0.975	77	25	318	326	11	207	252	309	0.902	0.782
LOKIASV2_1503_ESMFold_hypothetical_protein	6e2n-assembly1.cif.gz_A	6e2n-assembly1.cif.gz_A ASK1 kinase domain complex with inhibitor	4.118E-03	0.975	77	28	310	326	15	263	264	330	0.868	0.943
LOKIASV2_1503_ESMFold_hypothetical_protein	8ex2-assembly1.cif.gz_A	8ex2-assembly1.cif.gz_A Crystal structure of JAK2 JH2 (pseudokinase domain) in complex with HTSA3	3.152E-03	0.975	77	26	326	326	9	261	273	347	0.923	0.927
LOKIASV2_1503_ESMFold_hypothetical_protein	1zxe-assembly2.cif.gz_C	1zxe-assembly2.cif.gz_C Crystal Structure of eIF2alpha Protein Kinase GCN2: D835N Inactivating Mutant in Apo Form	2.685E-03	0.975	77	26	326	326	7	249	275	334	0.923	0.884
LOKIASV2_1503_ESMFold_hypothetical_protein	6qft-assembly1.cif.gz_A	6qft-assembly1.cif.gz_A Structure of the mitogen activated kinase kinase 7 in complex with pyrazolopyrimidin 1b	6.340E-04	0.975	77	28	324	326	22	268	276	330	0.911	0.895
LOKIASV2_1503_ESMFold_hypothetical_protein	6v6q-assembly2.cif.gz_D	6v6q-assembly2.cif.gz_D Crystal Structure of Monophosphorylated FGF Receptor 2 isoform IIIb with PTR657	7.028E-03	0.975	77	27	324	326	17	274	276	342	0.914	0.935
LOKIASV2_1503_ESMFold_hypothetical_protein	3qc4-assembly1.cif.gz_A	3qc4-assembly1.cif.gz_A PDK1 in complex with DFG-OUT inhibitor xxx	1.660E-03	0.975	77	26	312	326	6	262	277	341	0.880	0.928
LOKIASV2_1503_ESMFold_hypothetical_protein	4j95-assembly5.cif.gz_A	4j95-assembly5.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome in Space Group C2.	5.987E-03	0.975	77	27	317	326	17	272	279	342	0.893	0.918
LOKIASV2_1503_ESMFold_hypothetical_protein	5ime-assembly2.cif.gz_B	5ime-assembly2.cif.gz_B Crystal structure of P21-activated kinase 1 (PAK1) in complex with compound 9	2.545E-03	0.975	77	9	326	326	8	249	280	341	0.975	0.864
LOKIASV2_1503_ESMFold_hypothetical_protein	5a14-assembly1.cif.gz_A	5a14-assembly1.cif.gz_A Human CDK2 with type II inhibitor	1.270E-03	0.975	77	26	316	326	6	271	284	361	0.893	0.937
LOKIASV2_1503_ESMFold_hypothetical_protein	5hvj-assembly2.cif.gz_B	5hvj-assembly2.cif.gz_B Crystal structure of LIMK1 D460N mutant in complex with AMP-PNP	1.142E-03	0.975	77	27	326	326	12	242	284	338	0.920	0.813
LOKIASV2_1503_ESMFold_hypothetical_protein	3kk8-assembly1.cif.gz_A	3kk8-assembly1.cif.gz_A CaMKII Substrate Complex A	2.413E-03	0.975	77	26	310	326	9	265	284	335	0.874	0.905
LOKIASV2_1503_ESMFold_hypothetical_protein	5s7w-assembly1.cif.gz_A	5s7w-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with HM000007h	2.413E-03	0.975	77	26	317	326	6	283	284	358	0.896	0.979
LOKIASV2_1503_ESMFold_hypothetical_protein	5s8b-assembly1.cif.gz_A	5s8b-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010960a	3.508E-03	0.975	77	26	317	326	7	283	284	354	0.896	0.975
LOKIASV2_1503_ESMFold_hypothetical_protein	6nfy-assembly1.cif.gz_B	6nfy-assembly1.cif.gz_B Crystal structure of nonphosphorylated, HPK1 kinase domain in complex with sunitinib in the inactive state.	2.287E-03	0.975	77	26	326	326	11	256	285	334	0.923	0.863
LOKIASV2_1503_ESMFold_hypothetical_protein	5kbq-assembly1.cif.gz_A	5kbq-assembly1.cif.gz_A Pak1 in complex with bis-anilino pyrimidine inhibitor	5.675E-03	0.975	77	26	326	326	19	257	289	329	0.923	0.827
LOKIASV2_1503_ESMFold_hypothetical_protein	5s7v-assembly2.cif.gz_B	5s7v-assembly2.cif.gz_B XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010942a	3.152E-03	0.975	77	26	301	326	3	213	291	308	0.847	0.725
LOKIASV2_1503_ESMFold_hypothetical_protein	5s7k-assembly1.cif.gz_B-2	5s7k-assembly1.cif.gz_B-2 XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010936a	1.270E-03	0.975	77	26	317	326	3	292	293	367	0.896	0.990
LOKIASV2_1503_ESMFold_hypothetical_protein	4krd-assembly1.cif.gz_A	4krd-assembly1.cif.gz_A Crystal Structure of Pho85-Pcl10 Complex	1.847E-03	0.975	77	27	326	326	9	279	294	361	0.920	0.922
LOKIASV2_1503_ESMFold_hypothetical_protein	5twy-assembly1.cif.gz_A	5twy-assembly1.cif.gz_A Structure of Maternal Embryonic Leucine Zipper Kinase	3.522E-04	0.975	77	12	312	326	2	245	313	340	0.923	0.780
LOKIASV2_1503_ESMFold_hypothetical_protein	3ocb-assembly2.cif.gz_B	3ocb-assembly2.cif.gz_B Akt1 kinase domain with pyrrolopyrimidine inhibitor	1.340E-03	0.975	77	27	318	326	10	274	320	349	0.896	0.828
LOKIASV2_1503_ESMFold_hypothetical_protein	4ump-assembly1.cif.gz_D	4ump-assembly1.cif.gz_D Structure of MELK in complex with inhibitors	6.340E-04	0.975	77	15	319	326	3	264	321	351	0.936	0.816
LOKIASV2_1503_ESMFold_hypothetical_protein	6buu-assembly1.cif.gz_A	6buu-assembly1.cif.gz_A Crystal structure of AKT1 (aa 144-480) with a bisubstrate	2.287E-03	0.975	77	27	318	326	10	274	323	345	0.896	0.820
LOKIASV2_1503_ESMFold_hypothetical_protein	5li1-assembly1.cif.gz_A	5li1-assembly1.cif.gz_A Structure of a Par3-inhibitory peptide bound to PKCiota core kinase domain	2.545E-03	0.975	77	26	326	326	10	280	334	353	0.923	0.811
LOKIASV2_1503_ESMFold_hypothetical_protein	7myj-assembly2.cif.gz_C	7myj-assembly2.cif.gz_C Structure of full length human AMPK (a2b1g1) in complex with a small molecule activator MSG011	1.948E-03	0.975	77	27	326	326	11	280	465	357	0.920	0.581
LOKIASV2_1503_ESMFold_hypothetical_protein	5tkd-assembly3.cif.gz_B	5tkd-assembly3.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH 6-[(3,5-DIMETHYLPHE NYL)AMINO]-8- (METHYLAMINO)IMIDAZO[1,2-B]PYRIDAZINE-3-CARBO XAMIDE	8.251E-03	0.971	76	27	326	326	12	237	247	323	0.920	0.915
LOKIASV2_1503_ESMFold_hypothetical_protein	2z7q-assembly1.cif.gz_A	2z7q-assembly1.cif.gz_A Crystal structure of the N-terminal kinase domain of human RSK-1 bound to AMP-PCP	1.751E-03	0.971	76	27	326	326	10	249	255	345	0.920	0.941
LOKIASV2_1503_ESMFold_hypothetical_protein	3fdn-assembly1.cif.gz_A	3fdn-assembly1.cif.gz_A Structure-based drug design of novel Aurora kinase A inhibitors: Structure basis for potency and specificity	3.701E-03	0.971	76	26	304	326	9	260	261	335	0.856	0.966
LOKIASV2_1503_ESMFold_hypothetical_protein	2y4i-assembly1.cif.gz_B	2y4i-assembly1.cif.gz_B KSR2-MEK1 heterodimer	6.316E-03	0.971	76	28	319	326	18	264	265	338	0.896	0.932
LOKIASV2_1503_ESMFold_hypothetical_protein	2iw9-assembly1.cif.gz_C	2iw9-assembly1.cif.gz_C STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR	3.152E-03	0.971	76	28	311	326	9	260	269	340	0.871	0.937
LOKIASV2_1503_ESMFold_hypothetical_protein	5o2b-assembly1.cif.gz_A	5o2b-assembly1.cif.gz_A Crystal structure of WNK3 kinase domain in a diphosphorylated state and in a complex with the inhibitor PP-121	9.686E-03	0.971	76	28	310	326	21	260	269	315	0.868	0.892
LOKIASV2_1503_ESMFold_hypothetical_protein	4qqc-assembly1.cif.gz_A	4qqc-assembly1.cif.gz_A Crystal Structure of FGF Receptor (FGFR) 4 Kinase Domain in Complex with FIIN-2, an Irreversible Tyrosine Kinase Inhibitor Capable of Overcoming FGFR Kinase Gate-Keeper Mutations	2.685E-03	0.971	76	27	324	326	27	272	273	326	0.914	0.901
LOKIASV2_1503_ESMFold_hypothetical_protein	2r7b-assembly1.cif.gz_A	2r7b-assembly1.cif.gz_A Crystal Structure of the Phosphoinositide-dependent Kinase-1 (PDK-1)Catalytic Domain bound to a dibenzonaphthyridine inhibitor	5.120E-04	0.971	76	26	312	326	7	259	274	331	0.880	0.923
LOKIASV2_1503_ESMFold_hypothetical_protein	7umb-assembly1.cif.gz_B	7umb-assembly1.cif.gz_B NanoBRET tracer Tram-bo bound to a KSR2-MEK1 complex	6.663E-03	0.971	76	26	317	326	14	273	277	347	0.896	0.939
LOKIASV2_1503_ESMFold_hypothetical_protein	6i2y-assembly1.cif.gz_A	6i2y-assembly1.cif.gz_A Human STK10 bound to Foretinib	1.414E-03	0.971	76	28	325	326	17	275	279	352	0.914	0.928
LOKIASV2_1503_ESMFold_hypothetical_protein	4czt-assembly1.cif.gz_C	4czt-assembly1.cif.gz_C Crystal structure of the kinase domain of CIPK23	9.218E-04	0.971	76	26	312	326	5	261	286	340	0.880	0.899
LOKIASV2_1503_ESMFold_hypothetical_protein	2vz6-assembly1.cif.gz_A	2vz6-assembly1.cif.gz_A Structure of human calcium calmodulin dependent protein kinase type II alpha (CAMK2A) in complex with Indirubin E804	2.413E-03	0.971	76	27	326	326	7	291	291	361	0.920	0.979
LOKIASV2_1503_ESMFold_hypothetical_protein	3q53-assembly1.cif.gz_A	3q53-assembly1.cif.gz_A Structure of phosphorylated PAK1 kinase domain in complex with ATP	4.834E-03	0.971	76	9	325	326	8	287	292	367	0.972	0.959
LOKIASV2_1503_ESMFold_hypothetical_protein	5eak-assembly2.cif.gz_B	5eak-assembly2.cif.gz_B Optimization of Microtubule Affinity Regulating Kinase (MARK) Inhibitors with Improved Physical Properties	6.010E-04	0.971	76	26	324	326	2	216	300	320	0.917	0.717
LOKIASV2_1503_ESMFold_hypothetical_protein	4nus-assembly1.cif.gz_A	4nus-assembly1.cif.gz_A Rsk2 N-terminal kinase in complex with LJH685	1.270E-03	0.971	76	27	318	326	19	284	301	353	0.896	0.884
LOKIASV2_1503_ESMFold_hypothetical_protein	7b57-assembly1.cif.gz_B	7b57-assembly1.cif.gz_B Crystal structure of CaMKII-actinin complex bound to ADP	4.601E-04	0.971	76	26	325	326	10	294	303	364	0.920	0.941
LOKIASV2_1503_ESMFold_hypothetical_protein	2jdo-assembly1.cif.gz_A	2jdo-assembly1.cif.gz_A STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY) ETHYLAMINO)ETHYL)AMIDE	5.675E-03	0.971	76	27	318	326	10	273	315	343	0.896	0.838
LOKIASV2_1503_ESMFold_hypothetical_protein	4b0g-assembly1.cif.gz_A	4b0g-assembly1.cif.gz_A Complex of Aurora-A bound to an Imidazopyridine-based inhibitor	9.182E-03	0.967	75	26	313	326	9	242	247	325	0.883	0.947
LOKIASV2_1503_ESMFold_hypothetical_protein	6nzf-assembly1.cif.gz_B	6nzf-assembly1.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound_5 AKA 4-[(2-CARBAMOYLPHEN YL)AMINO]-6-[(5-FLUOROPYRIDIN-2-YL)AMINO]-N-METHYLPYRIDINE -3-CARBOXAMIDE	7.414E-03	0.967	75	26	326	326	9	238	248	331	0.923	0.927
LOKIASV2_1503_ESMFold_hypothetical_protein	8s98-assembly1.cif.gz_A	8s98-assembly1.cif.gz_A Crystal structure of the TYK2 pseudokinase domain in complex with compound 8	6.663E-03	0.967	75	27	326	326	15	246	256	334	0.920	0.906
LOKIASV2_1503_ESMFold_hypothetical_protein	2z7s-assembly1.cif.gz_A	2z7s-assembly1.cif.gz_A Crystal Structure of the N-terminal Kinase Domain of Human RSK1 bound to Purvalnol A	1.948E-03	0.967	75	27	326	326	10	250	256	342	0.920	0.941
LOKIASV2_1503_ESMFold_hypothetical_protein	8s9a-assembly3.cif.gz_C	8s9a-assembly3.cif.gz_C Crystal structure of the TYK2 pseudokinase domain in complex with TAK-279	7.028E-03	0.967	75	27	317	326	15	260	261	338	0.893	0.943
LOKIASV2_1503_ESMFold_hypothetical_protein	8tb6-assembly1.cif.gz_A	8tb6-assembly1.cif.gz_A TYK2 JH2 bound to Compound14	5.987E-03	0.967	75	27	317	326	19	260	263	339	0.893	0.920
LOKIASV2_1503_ESMFold_hypothetical_protein	6e2o-assembly1.cif.gz_A	6e2o-assembly1.cif.gz_A ASK1 kinase domain complex with inhibitor	2.988E-03	0.967	75	28	310	326	15	263	264	329	0.868	0.943
LOKIASV2_1503_ESMFold_hypothetical_protein	1zy5-assembly1.cif.gz_A	1zy5-assembly1.cif.gz_A Crystal Structure of eIF2alpha Protein Kinase GCN2: R794G Hyperactivating Mutant Complexed with AMPPNP.	3.508E-03	0.967	75	28	325	326	12	244	271	334	0.914	0.860
LOKIASV2_1503_ESMFold_hypothetical_protein	6nvg-assembly1.cif.gz_A	6nvg-assembly1.cif.gz_A FGFR4 complex with N-(3,5-dichloro-2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)phenyl)acrylamide	8.738E-04	0.967	75	27	324	326	17	270	272	333	0.914	0.934
LOKIASV2_1503_ESMFold_hypothetical_protein	8b8n-assembly1.cif.gz_A	8b8n-assembly1.cif.gz_A Crystal structure of JAK2 JH2-V617F in complex with Cdk2 inhibitor IV	2.168E-03	0.967	75	21	326	326	4	261	274	350	0.939	0.942
LOKIASV2_1503_ESMFold_hypothetical_protein	4xuf-assembly2.cif.gz_B	4xuf-assembly2.cif.gz_B Crystal structure of the FLT3 kinase domain bound to the inhibitor quizartinib (AC220)	5.987E-03	0.967	75	24	315	326	8	272	274	352	0.896	0.967
LOKIASV2_1503_ESMFold_hypothetical_protein	5jq5-assembly1.cif.gz_A	5jq5-assembly1.cif.gz_A Crystal structure of CDK2 in complex with inhibitor ICEC0942	9.686E-03	0.967	75	28	235	326	6	137	287	219	0.638	0.460
LOKIASV2_1503_ESMFold_hypothetical_protein	8x5z-assembly1.cif.gz_A	8x5z-assembly1.cif.gz_A The Crystal Structure of PAK1 kinase domain from Biortus.	2.685E-03	0.967	75	9	325	326	9	280	292	362	0.972	0.932
LOKIASV2_1503_ESMFold_hypothetical_protein	1csn-assembly1.cif.gz_A	1csn-assembly1.cif.gz_A BINARY COMPLEX OF CASEIN KINASE-1 WITH MGATP	1.026E-03	0.967	75	28	317	326	11	276	293	353	0.890	0.908
LOKIASV2_1503_ESMFold_hypothetical_protein	3mtl-assembly1.cif.gz_A	3mtl-assembly1.cif.gz_A Crystal structure of the PCTAIRE1 kinase in complex with Indirubin E804	7.056E-04	0.967	75	27	326	326	7	256	294	350	0.920	0.850
LOKIASV2_1503_ESMFold_hypothetical_protein	8xfl-assembly1.cif.gz_A	8xfl-assembly1.cif.gz_A The Crystal Structure of MARK4 from Biortus.	5.401E-04	0.967	75	26	318	326	5	247	299	326	0.899	0.813
LOKIASV2_1503_ESMFold_hypothetical_protein	5maf-assembly1.cif.gz_A	5maf-assembly1.cif.gz_A Crystal structure of MELK in complex with an inhibitor	2.844E-04	0.967	75	15	315	326	4	250	315	337	0.923	0.784
LOKIASV2_1503_ESMFold_hypothetical_protein	3iw4-assembly2.cif.gz_B	3iw4-assembly2.cif.gz_B Crystal structure of PKC alpha in complex with NVP-AEB071	1.340E-03	0.967	75	28	318	326	12	274	327	346	0.893	0.804
LOKIASV2_1503_ESMFold_hypothetical_protein	6c9h-assembly1.cif.gz_A	6c9h-assembly1.cif.gz_A non-phosphorylated AMP-activated protein kinase bound to pharmacological activator R734	1.847E-03	0.967	75	27	311	326	10	261	435	339	0.874	0.579
LOKIASV2_1503_ESMFold_hypothetical_protein	5ezv-assembly1.cif.gz_A	5ezv-assembly1.cif.gz_A X-ray crystal structure of AMP-activated protein kinase alpha-2/alpha-1 RIM chimaera (alpha-2(1-347)/alpha-1(349-401)/alpha-2(397-end) beta-1 gamma-1) co-crystallized with C2 (5-(5-hydroxyl-isoxazol-3-yl)-furan-2-phosphonic acid)	2.055E-03	0.967	75	27	320	326	11	271	442	348	0.902	0.590
LOKIASV2_1503_ESMFold_hypothetical_protein	6e2m-assembly1.cif.gz_B	6e2m-assembly1.cif.gz_B ASK1 kinase domain complex with inhibitor	3.904E-03	0.961	74	25	311	326	11	247	248	317	0.880	0.956
LOKIASV2_1503_ESMFold_hypothetical_protein	6nsl-assembly2.cif.gz_B	6nsl-assembly2.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound-6c AKA 6-((1-(4-CYANOPHENY L)-2-OXO-1,2-DIHYDRO-3-PYRIDINYL)AMINO)-N-CYCLOPROPYL-8-(M ETHYLAMINO)IMIDAZO[1,2-B]PYRIDAZINE-3-CARBOXAMIDE	1.200E-02	0.961	74	27	326	326	12	238	248	329	0.920	0.915
LOKIASV2_1503_ESMFold_hypothetical_protein	3vw6-assembly1.cif.gz_B	3vw6-assembly1.cif.gz_B Crystal structure of human apoptosis signal-regulating kinase 1 (ASK1) with imidazopyridine inhibitor	6.316E-03	0.961	74	26	310	326	12	252	253	325	0.874	0.953
LOKIASV2_1503_ESMFold_hypothetical_protein	6xih-assembly1.cif.gz_A	6xih-assembly1.cif.gz_A Structure-guided optimization of a novel class of ASK1 inhibitors with increased sp3 character and an exquisite selectivity profile	8.704E-03	0.961	74	28	310	326	14	256	258	324	0.868	0.942
LOKIASV2_1503_ESMFold_hypothetical_protein	3zxt-assembly2.cif.gz_C	3zxt-assembly2.cif.gz_C Dimeric structure of DAPK-1 catalytic domain in complex with AMPPCP- Mg	1.335E-02	0.961	74	27	310	326	9	258	259	331	0.871	0.965
LOKIASV2_1503_ESMFold_hypothetical_protein	1mrv-assembly1.cif.gz_A	1mrv-assembly1.cif.gz_A crystal structure of an inactive Akt2 kinase domain	1.573E-03	0.961	74	27	310	326	9	230	261	326	0.871	0.851
LOKIASV2_1503_ESMFold_hypothetical_protein	3a62-assembly1.cif.gz_A	3a62-assembly1.cif.gz_A Crystal structure of phosphorylated p70S6K1	4.344E-03	0.961	74	27	318	326	10	253	264	335	0.896	0.924
LOKIASV2_1503_ESMFold_hypothetical_protein	2z7r-assembly1.cif.gz_A	2z7r-assembly1.cif.gz_A Crystal Structure of the N-terminal Kinase Domain of Human RSK1 bound to Staurosporine	1.751E-03	0.961	74	27	326	326	13	259	265	347	0.920	0.932
LOKIASV2_1503_ESMFold_hypothetical_protein	3zfx-assembly4.cif.gz_D	3zfx-assembly4.cif.gz_D Crystal structure of EphB1	8.251E-03	0.961	74	27	324	326	9	256	265	343	0.914	0.936
LOKIASV2_1503_ESMFold_hypothetical_protein	6c1c-assembly2.cif.gz_B	6c1c-assembly2.cif.gz_B FGFR1 kinase complex with inhibitor SN37116	2.833E-03	0.961	74	19	324	326	13	264	267	343	0.939	0.944
LOKIASV2_1503_ESMFold_hypothetical_protein	6qav-assembly1.cif.gz_B	6qav-assembly1.cif.gz_B Crystal structure of ULK2 in complexed with MRT68921	2.545E-03	0.961	74	29	326	326	15	256	269	342	0.914	0.900
LOKIASV2_1503_ESMFold_hypothetical_protein	5nxd-assembly2.cif.gz_B	5nxd-assembly2.cif.gz_B LIM Domain Kinase 2 (LIMK2) In Complex With TH-300	1.948E-03	0.961	74	26	326	326	1	231	271	332	0.923	0.852
LOKIASV2_1503_ESMFold_hypothetical_protein	5vio-assembly4.cif.gz_D	5vio-assembly4.cif.gz_D Crystal structure of ASK1 kinase domain with a potent inhibitor (analog 13)	6.316E-03	0.961	74	25	326	326	12	258	271	337	0.926	0.911
LOKIASV2_1503_ESMFold_hypothetical_protein	3zhp-assembly2.cif.gz_C	3zhp-assembly2.cif.gz_C Human MST3 (STK24) in complex with MO25beta	3.152E-03	0.961	74	27	325	326	11	269	272	346	0.917	0.952
LOKIASV2_1503_ESMFold_hypothetical_protein	5d9k-assembly1.cif.gz_A	5d9k-assembly1.cif.gz_A Rsk2 N-terminal Kinase in Complex with BI-D1870	2.833E-03	0.961	74	27	318	326	10	263	280	338	0.896	0.907
LOKIASV2_1503_ESMFold_hypothetical_protein	6yg0-assembly1.cif.gz_A	6yg0-assembly1.cif.gz_A Crystal structure of S287D,T291D MKK7 (MAP2K7), apo form	1.847E-03	0.961	74	26	324	326	18	270	280	344	0.917	0.904
LOKIASV2_1503_ESMFold_hypothetical_protein	2wnt-assembly1.cif.gz_A	2wnt-assembly1.cif.gz_A Crystal Structure of the Human Ribosomal protein S6 kinase	2.685E-03	0.961	74	28	313	326	7	251	281	336	0.877	0.872
LOKIASV2_1503_ESMFold_hypothetical_protein	5lpw-assembly1.cif.gz_A	5lpw-assembly1.cif.gz_A Crystal structure of the apo-BRI1 kinase domain (865-1160)	2.988E-03	0.961	74	14	313	326	7	282	284	353	0.920	0.972
LOKIASV2_1503_ESMFold_hypothetical_protein	6t6d-assembly4.cif.gz_D	6t6d-assembly4.cif.gz_D Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2149	4.118E-03	0.961	74	26	301	326	5	208	285	295	0.847	0.716
LOKIASV2_1503_ESMFold_hypothetical_protein	4yc6-assembly4.cif.gz_G	4yc6-assembly4.cif.gz_G CDK1/CKS1	2.685E-03	0.961	74	28	316	326	8	214	285	315	0.887	0.726
LOKIASV2_1503_ESMFold_hypothetical_protein	5lvl-assembly1.cif.gz_A	5lvl-assembly1.cif.gz_A Human PDK1 Kinase Domain in Complex with Compound PS653 Bound to the ATP-Binding Site	6.316E-03	0.961	74	26	310	326	8	269	286	345	0.874	0.916
LOKIASV2_1503_ESMFold_hypothetical_protein	3o0g-assembly1.cif.gz_A	3o0g-assembly1.cif.gz_A Crystal Structure of Cdk5:p25 in complex with an ATP analogue	1.948E-03	0.961	74	27	310	326	7	286	289	368	0.871	0.969
LOKIASV2_1503_ESMFold_hypothetical_protein	5flf-assembly2.cif.gz_B	5flf-assembly2.cif.gz_B DISEASE LINKED MUTATION IN FGFR	7.414E-03	0.961	74	27	317	326	21	282	292	346	0.893	0.897
LOKIASV2_1503_ESMFold_hypothetical_protein	3tzm-assembly1.cif.gz_A	3tzm-assembly1.cif.gz_A TGF-beta Receptor type 1 in complex with SB431542	4.344E-03	0.961	74	28	301	326	10	217	295	295	0.840	0.705
LOKIASV2_1503_ESMFold_hypothetical_protein	4d2p-assembly2.cif.gz_D	4d2p-assembly2.cif.gz_D Structure of MELK in complex with inhibitors	2.696E-04	0.961	74	12	319	326	1	265	317	354	0.945	0.836
LOKIASV2_1503_ESMFold_hypothetical_protein	3qkm-assembly1.cif.gz_A	3qkm-assembly1.cif.gz_A Spirocyclic sulfonamides as AKT inhibitors	2.545E-03	0.961	74	27	318	326	10	274	330	346	0.896	0.803
LOKIASV2_1503_ESMFold_hypothetical_protein	3tku-assembly1.cif.gz_A	3tku-assembly1.cif.gz_A MRCK beta in complex with fasudil	1.751E-03	0.961	74	15	320	326	61	355	395	379	0.939	0.747
LOKIASV2_1503_ESMFold_hypothetical_protein	3tku-assembly1.cif.gz_B	3tku-assembly1.cif.gz_B MRCK beta in complex with fasudil	1.204E-03	0.961	74	9	326	326	55	369	395	394	0.975	0.797
LOKIASV2_1503_ESMFold_hypothetical_protein	5iso-assembly1.cif.gz_A	5iso-assembly1.cif.gz_A STRUCTURE OF FULL LENGTH HUMAN AMPK (NON-PHOSPHORYLATED AT T-LOOP) IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR, A BENZIMIDAZOLE DERIVATIVE (991)	1.751E-03	0.961	74	27	319	326	10	269	453	343	0.899	0.574
LOKIASV2_1503_ESMFold_hypothetical_protein	7ydx-assembly1.cif.gz_B-2	7ydx-assembly1.cif.gz_B-2 Crystal structure of human RIPK1 kinase domain in complex with compound RI-962	5.380E-03	0.956	73	29	322	326	9	218	261	316	0.902	0.805
LOKIASV2_1503_ESMFold_hypothetical_protein	4cfm-assembly2.cif.gz_C	4cfm-assembly2.cif.gz_C Structure-based design of C8-substituted O6-cyclohexylmethoxyguanine CDK1 and 2 inhibitors.	4.583E-03	0.956	73	28	325	326	9	251	267	338	0.914	0.910
LOKIASV2_1503_ESMFold_hypothetical_protein	7uos-assembly1.cif.gz_A	7uos-assembly1.cif.gz_A Structure of WNK1 inhibitor complex	4.118E-03	0.956	73	28	311	326	15	270	271	330	0.871	0.945
LOKIASV2_1503_ESMFold_hypothetical_protein	8pm3-assembly1.cif.gz_A	8pm3-assembly1.cif.gz_A Crystal structure of MAP2K6 with a covalent compound GCL94	5.401E-04	0.956	73	26	324	326	6	265	272	334	0.917	0.956
LOKIASV2_1503_ESMFold_hypothetical_protein	4wnp-assembly3.cif.gz_C	4wnp-assembly3.cif.gz_C Structure of ULK1 bound to a potent inhibitor	5.675E-03	0.956	73	28	326	326	13	260	272	343	0.917	0.912
LOKIASV2_1503_ESMFold_hypothetical_protein	8b9e-assembly1.cif.gz_A	8b9e-assembly1.cif.gz_A Crystal structure of JAK2 JH2-V617F in complex with Z902-A3	2.833E-03	0.956	73	28	326	326	14	261	274	343	0.917	0.905
LOKIASV2_1503_ESMFold_hypothetical_protein	1gjo-assembly1.cif.gz_A	1gjo-assembly1.cif.gz_A The FGFr2 tyrosine kinase domain	1.078E-02	0.956	73	27	324	326	17	279	280	355	0.914	0.939
LOKIASV2_1503_ESMFold_hypothetical_protein	7qhg-assembly1.cif.gz_A	7qhg-assembly1.cif.gz_A LIM domain kinase 2 (LIMK2) in complex with TH-470	6.663E-03	0.956	73	26	325	326	2	273	283	353	0.920	0.961
LOKIASV2_1503_ESMFold_hypothetical_protein	3ri1-assembly2.cif.gz_B	3ri1-assembly2.cif.gz_B Crystal structure of the catalytic domain of FGFR2 kinase in complex with ARQ 069	7.822E-03	0.956	73	24	324	326	11	280	283	360	0.923	0.954
LOKIASV2_1503_ESMFold_hypothetical_protein	3ri1-assembly1.cif.gz_A	3ri1-assembly1.cif.gz_A Crystal structure of the catalytic domain of FGFR2 kinase in complex with ARQ 069	8.251E-03	0.956	73	24	326	326	11	285	285	366	0.929	0.965
LOKIASV2_1503_ESMFold_hypothetical_protein	5ugl-assembly1.cif.gz_A	5ugl-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 Tyrosine Kinase Domain Harboring the D650V Activating Mutation	1.573E-03	0.956	73	27	315	326	16	283	285	347	0.887	0.940
LOKIASV2_1503_ESMFold_hypothetical_protein	5lpy-assembly1.cif.gz_A	5lpy-assembly1.cif.gz_A Crystal structure of the BRI1 kinase domain (865-1160) in complex with ATP from Arabidopsis thaliana	2.168E-03	0.956	73	14	313	326	6	284	286	352	0.920	0.976
LOKIASV2_1503_ESMFold_hypothetical_protein	7up5-assembly2.cif.gz_B	7up5-assembly2.cif.gz_B Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 23 (co-crystal)	1.948E-03	0.956	73	29	311	326	17	246	286	318	0.868	0.804
LOKIASV2_1503_ESMFold_hypothetical_protein	5s7o-assembly1.cif.gz_A	5s7o-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM007391c	4.118E-03	0.956	73	26	317	326	7	286	287	353	0.896	0.976
LOKIASV2_1503_ESMFold_hypothetical_protein	2xik-assembly1.cif.gz_A	2xik-assembly1.cif.gz_A Structure of Human YSK1 (Yeast Sps1-Ste20-related Kinase 1)	4.118E-03	0.956	73	27	325	326	21	283	289	350	0.917	0.910
LOKIASV2_1503_ESMFold_hypothetical_protein	3s95-assembly2.cif.gz_B	3s95-assembly2.cif.gz_B Crystal structure of the human LIMK1 kinase domain in complex with staurosporine	3.508E-03	0.956	73	26	326	326	11	248	290	341	0.923	0.821
LOKIASV2_1503_ESMFold_hypothetical_protein	4c0t-assembly1.cif.gz_A	4c0t-assembly1.cif.gz_A Candida albicans PKh Kinase Domain	1.204E-03	0.956	73	26	312	326	7	272	291	351	0.880	0.914
LOKIASV2_1503_ESMFold_hypothetical_protein	4j99-assembly2.cif.gz_B	4j99-assembly2.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659T Mutation.	9.724E-04	0.956	73	27	324	326	17	290	291	354	0.914	0.942
LOKIASV2_1503_ESMFold_hypothetical_protein	3js2-assembly2.cif.gz_B	3js2-assembly2.cif.gz_B Crystal structure of minimal kinase domain of fibroblast growth factor receptor 1 in complex with 5-(2-thienyl)nicotinic acid	2.685E-03	0.956	73	27	324	326	22	289	291	361	0.914	0.921
LOKIASV2_1503_ESMFold_hypothetical_protein	5s76-assembly2.cif.gz_B	5s76-assembly2.cif.gz_B XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010916a	5.100E-03	0.956	73	26	315	326	3	289	292	366	0.890	0.983
LOKIASV2_1503_ESMFold_hypothetical_protein	6t6d-assembly1.cif.gz_A	6t6d-assembly1.cif.gz_A Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2149	9.182E-03	0.956	73	27	301	326	8	214	292	295	0.844	0.709
LOKIASV2_1503_ESMFold_hypothetical_protein	6ylk-assembly1.cif.gz_A	6ylk-assembly1.cif.gz_A Cdk2(F80C) with Covalent Adduct TK22 at F80C	1.751E-03	0.956	73	28	326	326	13	272	295	351	0.917	0.881
LOKIASV2_1503_ESMFold_hypothetical_protein	2wot-assembly1.cif.gz_A	2wot-assembly1.cif.gz_A ALK5 IN COMPLEX WITH 4-((5,6-dimethyl-2-(2-pyridyl)-3-pyridyl)oxy)-N-(3,4,5-trimethoxyphenyl)pyridin-2-amine	2.685E-03	0.956	73	28	324	326	12	301	303	371	0.911	0.957
LOKIASV2_1503_ESMFold_hypothetical_protein	6yl6-assembly1.cif.gz_A	6yl6-assembly1.cif.gz_A Cdk2(F80C)	8.251E-03	0.956	73	28	235	326	13	153	303	224	0.638	0.465
LOKIASV2_1503_ESMFold_hypothetical_protein	7n93-assembly2.cif.gz_B	7n93-assembly2.cif.gz_B P70 S6K1 IN COMPLEX WITH MSC2363318A-1	3.701E-03	0.956	73	27	326	326	10	267	309	345	0.920	0.835
LOKIASV2_1503_ESMFold_hypothetical_protein	6fyv-assembly1.cif.gz_A	6fyv-assembly1.cif.gz_A X-RAY STRUCTURE OF CLK4-KD(146-480)/CX-4945 AT 2.46A	1.847E-03	0.956	73	24	312	326	9	327	329	397	0.887	0.970
LOKIASV2_1503_ESMFold_hypothetical_protein	7zkx-assembly1.cif.gz_A	7zkx-assembly1.cif.gz_A SRPK2 IN COMPLEX WITH INHIBITOR	3.686E-02	0.956	73	28	148	326	16	141	339	136	0.371	0.372
LOKIASV2_1503_ESMFold_hypothetical_protein	7nh5-assembly1.cif.gz_A	7nh5-assembly1.cif.gz_A Co-Crystal Structure of Akt1 in Complex with Covalent-Allosteric Akt Inhibitor 6	1.204E-03	0.956	73	18	318	326	104	356	383	348	0.923	0.661
LOKIASV2_1503_ESMFold_hypothetical_protein	3qfv-assembly1.cif.gz_B	3qfv-assembly1.cif.gz_B MRCK beta in complex with TPCA-1	2.413E-03	0.956	73	9	324	326	55	351	396	384	0.969	0.750
LOKIASV2_1503_ESMFold_hypothetical_protein	3fbv-assembly1.cif.gz_D	3fbv-assembly1.cif.gz_D Crystal structure of the oligomer formed by the kinase-ribonuclease domain of Ire1	1.653E-02	0.956	73	28	156	326	16	139	425	141	0.396	0.292
LOKIASV2_1503_ESMFold_hypothetical_protein	5iso-assembly2.cif.gz_C	5iso-assembly2.cif.gz_C STRUCTURE OF FULL LENGTH HUMAN AMPK (NON-PHOSPHORYLATED AT T-LOOP) IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR, A BENZIMIDAZOLE DERIVATIVE (991)	3.508E-03	0.956	73	21	320	326	2	270	429	352	0.920	0.627
LOKIASV2_1503_ESMFold_hypothetical_protein	3pfq-assembly1.cif.gz_A	3pfq-assembly1.cif.gz_A Crystal Structure and Allosteric Activation of Protein Kinase C beta II	3.152E-03	0.956	73	26	326	326	195	467	523	352	0.923	0.522
LOKIASV2_1503_ESMFold_hypothetical_protein	6nzh-assembly1.cif.gz_A	6nzh-assembly1.cif.gz_A CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound_40 AKA 6-cyclopropaneamido-4-[(2-methanesulfonylphenyl)amino]-N-methylpyridine-3-carboxamide	1.408E-02	0.949	72	27	326	326	12	240	249	332	0.920	0.920
LOKIASV2_1503_ESMFold_hypothetical_protein	7ovk-assembly1.cif.gz_A	7ovk-assembly1.cif.gz_A Protein kinase MKK7 in complex with 5-bromo-2-hydroxyphenyl-substituted pyrazolopyrimidine	1.847E-03	0.949	72	26	324	326	18	247	256	320	0.917	0.898
LOKIASV2_1503_ESMFold_hypothetical_protein	4fk3-assembly3.cif.gz_B	4fk3-assembly3.cif.gz_B B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX3203	4.834E-03	0.949	72	28	324	326	14	256	257	342	0.911	0.946
LOKIASV2_1503_ESMFold_hypothetical_protein	4rlp-assembly1.cif.gz_A	4rlp-assembly1.cif.gz_A Human p70s6k1 with ruthenium-based inhibitor FL772	4.834E-03	0.949	72	28	304	326	11	223	261	316	0.850	0.816
LOKIASV2_1503_ESMFold_hypothetical_protein	3zon-assembly1.cif.gz_A	3zon-assembly1.cif.gz_A Human TYK2 pseudokinase domain bound to a kinase inhibitor	2.685E-03	0.949	72	27	326	326	16	248	261	331	0.920	0.893
LOKIASV2_1503_ESMFold_hypothetical_protein	3a60-assembly1.cif.gz_A	3a60-assembly1.cif.gz_A Crystal structure of unphosphorylated p70S6K1 (Form I)	3.508E-03	0.949	72	27	325	326	10	227	263	334	0.917	0.829
LOKIASV2_1503_ESMFold_hypothetical_protein	6vvg-assembly1.cif.gz_B	6vvg-assembly1.cif.gz_B Structure of the Cydia pomonella Granulovirus kinase, PK-1	1.265E-02	0.949	72	15	310	326	5	263	264	349	0.908	0.981
LOKIASV2_1503_ESMFold_hypothetical_protein	3zhp-assembly1.cif.gz_D	3zhp-assembly1.cif.gz_D Human MST3 (STK24) in complex with MO25beta	4.583E-03	0.949	72	27	325	326	5	260	264	343	0.917	0.970
LOKIASV2_1503_ESMFold_hypothetical_protein	7b31-assembly1.cif.gz_A	7b31-assembly1.cif.gz_A MST3 in complex with compound MRIA9	5.100E-03	0.949	72	27	325	326	11	261	265	341	0.917	0.947
LOKIASV2_1503_ESMFold_hypothetical_protein	6yg3-assembly1.cif.gz_A	6yg3-assembly1.cif.gz_A Crystal structure of MKK7 (MAP2K7) covalently bound with CPT1-70-1	2.833E-03	0.949	72	26	324	326	17	257	265	328	0.917	0.909
LOKIASV2_1503_ESMFold_hypothetical_protein	6qfr-assembly1.cif.gz_A	6qfr-assembly1.cif.gz_A Structure of the mitogen activated kinase kinase 7 dfg-out conformation	2.168E-03	0.949	72	26	324	326	18	259	269	325	0.917	0.900
LOKIASV2_1503_ESMFold_hypothetical_protein	2vtq-assembly1.cif.gz_A	2vtq-assembly1.cif.gz_A Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design.	1.751E-03	0.949	72	28	316	326	8	193	274	312	0.887	0.679
LOKIASV2_1503_ESMFold_hypothetical_protein	2btr-assembly1.cif.gz_A	2btr-assembly1.cif.gz_A STRUCTURE OF CDK2 COMPLEXED WITH PNU-198873	3.701E-03	0.949	72	28	310	326	8	213	275	311	0.868	0.749
LOKIASV2_1503_ESMFold_hypothetical_protein	3gql-assembly4.cif.gz_B	3gql-assembly4.cif.gz_B Crystal Structure of activated receptor tyrosine kinase in complex with substrates	4.118E-03	0.949	72	27	315	326	18	264	276	330	0.887	0.895
LOKIASV2_1503_ESMFold_hypothetical_protein	3kk9-assembly1.cif.gz_A	3kk9-assembly1.cif.gz_A CaMKII Substrate Complex B	7.028E-03	0.949	72	26	326	326	8	253	276	342	0.923	0.891
LOKIASV2_1503_ESMFold_hypothetical_protein	7ozy-assembly2.cif.gz_BBB	7ozy-assembly2.cif.gz_BBB FGFR2 kinase domain (residues 461-763) in complex with 38.	7.028E-03	0.949	72	27	326	326	17	278	278	361	0.920	0.942
LOKIASV2_1503_ESMFold_hypothetical_protein	7xdx-assembly2.cif.gz_B	7xdx-assembly2.cif.gz_B Crystal structure of a receptor like kinase from Arabidopsis	1.200E-02	0.949	72	15	317	326	6	279	280	355	0.929	0.979
LOKIASV2_1503_ESMFold_hypothetical_protein	7ovn-assembly1.cif.gz_A	7ovn-assembly1.cif.gz_A Protein kinase MKK7 in complex with tolyl-substituted indazole	1.082E-03	0.949	72	21	324	326	15	273	283	348	0.933	0.915
LOKIASV2_1503_ESMFold_hypothetical_protein	4hni-assembly1.cif.gz_A	4hni-assembly1.cif.gz_A crystal structure of ck1e in complex with PF4800567	8.738E-04	0.949	72	27	326	326	9	273	284	368	0.920	0.933
LOKIASV2_1503_ESMFold_hypothetical_protein	6lvl-assembly2.cif.gz_B	6lvl-assembly2.cif.gz_B Crystal structure of FGFR2 in complex with 1,3,5-triazine derivative	6.663E-03	0.949	72	24	326	326	11	286	286	361	0.929	0.965
LOKIASV2_1503_ESMFold_hypothetical_protein	5s7z-assembly1.cif.gz_A	5s7z-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with NU074488b	5.987E-03	0.949	72	26	317	326	6	286	287	359	0.896	0.979
LOKIASV2_1503_ESMFold_hypothetical_protein	3eid-assembly2.cif.gz_C	3eid-assembly2.cif.gz_C CDK2/CyclinA complexed with a pyrazolopyridazine inhibitor	5.100E-03	0.949	72	28	311	326	8	281	290	362	0.871	0.945
LOKIASV2_1503_ESMFold_hypothetical_protein	6yz4-assembly1.cif.gz_A	6yz4-assembly1.cif.gz_A Crystal structure of MKK7 (MAP2K7) with ibrutinib bound at allosteric site	1.082E-03	0.949	72	26	324	326	19	278	290	346	0.917	0.897
LOKIASV2_1503_ESMFold_hypothetical_protein	3eid-assembly1.cif.gz_A	3eid-assembly1.cif.gz_A CDK2/CyclinA complexed with a pyrazolopyridazine inhibitor	5.380E-03	0.949	72	28	324	326	8	256	292	343	0.911	0.853
LOKIASV2_1503_ESMFold_hypothetical_protein	1yhv-assembly1.cif.gz_A	1yhv-assembly1.cif.gz_A Crystal Structure of PAK1 kinase domain with two point mutations (K299R, T423E)	5.100E-03	0.949	72	9	326	326	9	262	293	355	0.975	0.867
LOKIASV2_1503_ESMFold_hypothetical_protein	2xmy-assembly1.cif.gz_A	2xmy-assembly1.cif.gz_A Discovery and Characterisation of 2-Anilino-4-(thiazol-5-yl) pyrimidine Transcriptional CDK Inhibitors as Anticancer Agents	2.675E-02	0.949	72	28	235	326	8	145	295	219	0.638	0.468
LOKIASV2_1503_ESMFold_hypothetical_protein	6fha-assembly1.cif.gz_A	6fha-assembly1.cif.gz_A Death-associated Protein Kinase 1 (DAPK1) catalytic and auto-regulatory domains with S289A and S308A mutations	2.988E-03	0.949	72	26	325	326	11	282	299	353	0.920	0.910
LOKIASV2_1503_ESMFold_hypothetical_protein	5es1-assembly1.cif.gz_A	5es1-assembly1.cif.gz_A CRYSTAL STRUCTURE OF MICROTUBULE AFFINITY-REGULATING KINASE 4 CATALYTIC DOMAIN IN COMPLEX WITH A PYRAZOLOPYRIMIDINE INHIBITOR	1.847E-03	0.949	72	27	315	326	9	249	304	327	0.887	0.793
LOKIASV2_1503_ESMFold_hypothetical_protein	5y90-assembly1.cif.gz_A	5y90-assembly1.cif.gz_A MAP2K7 mutant -C218S	7.852E-04	0.949	72	26	324	326	17	279	304	349	0.917	0.865
LOKIASV2_1503_ESMFold_hypothetical_protein	6bdn-assembly1.cif.gz_A	6bdn-assembly1.cif.gz_A Crystal structure of human TAO3 kinase binding ADP	3.152E-03	0.949	72	16	325	326	2	289	307	368	0.951	0.938
LOKIASV2_1503_ESMFold_hypothetical_protein	2hak-assembly1.cif.gz_A	2hak-assembly1.cif.gz_A Catalytic and ubiqutin-associated domains of MARK1/PAR-1	2.833E-03	0.949	72	27	326	326	8	238	309	343	0.920	0.748
LOKIASV2_1503_ESMFold_hypothetical_protein	5twz-assembly1.cif.gz_A	5twz-assembly1.cif.gz_A Structure of Maternal Embryonic Leucine Zipper Kinase	1.847E-03	0.949	72	15	311	326	4	244	313	327	0.911	0.770
LOKIASV2_1503_ESMFold_hypothetical_protein	4l45-assembly1.cif.gz_A	4l45-assembly1.cif.gz_A Crystal structures of human p70S6K1-T389E	2.685E-03	0.949	72	27	325	326	14	272	317	343	0.917	0.817
LOKIASV2_1503_ESMFold_hypothetical_protein	4dc2-assembly1.cif.gz_A	4dc2-assembly1.cif.gz_A Structure of PKC in Complex with a Substrate Peptide from Par-3	5.380E-03	0.949	72	26	326	326	7	277	329	355	0.923	0.824
LOKIASV2_1503_ESMFold_hypothetical_protein	7k7z-assembly1.cif.gz_A	7k7z-assembly1.cif.gz_A Structure of a hit for G Protein Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure	3.701E-03	0.949	72	26	315	326	161	434	625	356	0.890	0.438
LOKIASV2_1503_ESMFold_hypothetical_protein	6n3l-assembly1.cif.gz_A	6n3l-assembly1.cif.gz_A Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agents	6.316E-03	0.941	71	27	309	326	10	229	231	309	0.868	0.952
LOKIASV2_1503_ESMFold_hypothetical_protein	8tb6-assembly2.cif.gz_B	8tb6-assembly2.cif.gz_B TYK2 JH2 bound to Compound14	1.335E-02	0.941	71	27	326	326	13	244	254	329	0.920	0.913
LOKIASV2_1503_ESMFold_hypothetical_protein	6tu9-assembly2.cif.gz_B	6tu9-assembly2.cif.gz_B The ROR1 Pseudokinase Domain Bound To Ponatinib	2.685E-03	0.941	71	28	317	326	13	255	259	335	0.890	0.938
LOKIASV2_1503_ESMFold_hypothetical_protein	4fg8-assembly2.cif.gz_B	4fg8-assembly2.cif.gz_B Crystal structure of human calcium/calmodulin-dependent protein kinase I 1-315 in complex with ATP	1.948E-03	0.941	71	26	326	326	8	234	268	340	0.923	0.847
LOKIASV2_1503_ESMFold_hypothetical_protein	5auw-assembly1.cif.gz_A	5auw-assembly1.cif.gz_A Crystal structure of DAPK1 in complex with quercetin.	1.137E-02	0.941	71	26	310	326	13	272	274	341	0.874	0.949
LOKIASV2_1503_ESMFold_hypothetical_protein	4itj-assembly2.cif.gz_B	4itj-assembly2.cif.gz_B Crystal structure of RIP1 kinase in complex with necrostatin-4	8.251E-03	0.941	71	26	317	326	10	275	276	345	0.896	0.964
LOKIASV2_1503_ESMFold_hypothetical_protein	7ovj-assembly1.cif.gz_A	7ovj-assembly1.cif.gz_A Protein kinase MKK7 in complex with difluoro-phenethyltriazole-substituted pyrazolopyrimidine	1.660E-03	0.941	71	21	324	326	15	265	276	340	0.933	0.909
LOKIASV2_1503_ESMFold_hypothetical_protein	3rak-assembly1.cif.gz_A	3rak-assembly1.cif.gz_A CDK2 in complex with inhibitor RC-2-32	2.833E-03	0.941	71	28	310	326	8	215	277	307	0.868	0.751
LOKIASV2_1503_ESMFold_hypothetical_protein	2hak-assembly2.cif.gz_B	2hak-assembly2.cif.gz_B Catalytic and ubiqutin-associated domains of MARK1/PAR-1	4.344E-03	0.941	71	27	310	326	10	223	279	315	0.871	0.767
LOKIASV2_1503_ESMFold_hypothetical_protein	6mzw-assembly1.cif.gz_A	6mzw-assembly1.cif.gz_A TAS-120 covalent complex with FGFR1	2.988E-03	0.941	71	27	324	326	17	277	282	356	0.914	0.926
LOKIASV2_1503_ESMFold_hypothetical_protein	5ugx-assembly1.cif.gz_B	5ugx-assembly1.cif.gz_B Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 Harboring a E565A/D650V double Gain-of-Function Mutation	9.686E-03	0.941	71	27	324	326	16	281	282	350	0.914	0.943
LOKIASV2_1503_ESMFold_hypothetical_protein	6gu7-assembly4.cif.gz_G	6gu7-assembly4.cif.gz_G CDK1/Cks2 in complex with AZD5438	5.987E-03	0.941	71	28	316	326	8	210	283	306	0.887	0.717
LOKIASV2_1503_ESMFold_hypothetical_protein	4czt-assembly2.cif.gz_B	4czt-assembly2.cif.gz_B Crystal structure of the kinase domain of CIPK23	1.751E-03	0.941	71	27	326	326	12	282	286	358	0.920	0.948
LOKIASV2_1503_ESMFold_hypothetical_protein	5oo3-assembly1.cif.gz_A	5oo3-assembly1.cif.gz_A Cdk2(F80C, C177A) with covalent ligand at F80C	1.948E-03	0.941	71	28	326	326	7	267	286	356	0.917	0.913
LOKIASV2_1503_ESMFold_hypothetical_protein	5s7l-assembly1.cif.gz_A	5s7l-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010943a	3.701E-03	0.941	71	27	317	326	11	285	286	348	0.893	0.962
LOKIASV2_1503_ESMFold_hypothetical_protein	4u44-assembly2.cif.gz_A	4u44-assembly2.cif.gz_A MAP4K4 in complex with inhibitor (compound 16)	1.270E-03	0.941	71	28	324	326	18	285	286	346	0.911	0.937
LOKIASV2_1503_ESMFold_hypothetical_protein	4hok-assembly13.cif.gz_E	4hok-assembly13.cif.gz_E crystal structure of apo ck1e	1.660E-03	0.941	71	27	315	326	11	275	291	358	0.887	0.911
LOKIASV2_1503_ESMFold_hypothetical_protein	6hxf-assembly1.cif.gz_B	6hxf-assembly1.cif.gz_B Human STK10 bound to a maleimide inhibitor	7.443E-04	0.941	71	28	326	326	17	291	291	356	0.917	0.945
LOKIASV2_1503_ESMFold_hypothetical_protein	5vnd-assembly3.cif.gz_B	5vnd-assembly3.cif.gz_B Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to H3B-6527	4.834E-03	0.941	71	27	324	326	21	290	295	360	0.914	0.915
LOKIASV2_1503_ESMFold_hypothetical_protein	7n91-assembly2.cif.gz_B	7n91-assembly2.cif.gz_B P70 S6K1 IN COMPLEX WITH MSC2317067A-1	3.904E-03	0.941	71	27	312	326	10	255	313	332	0.877	0.786
LOKIASV2_1503_ESMFold_hypothetical_protein	3zh8-assembly3.cif.gz_C	3zh8-assembly3.cif.gz_C A novel small molecule aPKC inhibitor	5.675E-03	0.941	71	26	325	326	8	275	314	354	0.920	0.854
LOKIASV2_1503_ESMFold_hypothetical_protein	3a8w-assembly3.cif.gz_A	3a8w-assembly3.cif.gz_A Crystal Structure of PKCiota kinase domain	7.028E-03	0.941	71	26	326	326	10	275	328	348	0.923	0.811
LOKIASV2_1503_ESMFold_hypothetical_protein	4lgd-assembly5.cif.gz_B	4lgd-assembly5.cif.gz_B Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5	3.152E-03	0.941	71	17	325	326	8	291	350	366	0.948	0.811
LOKIASV2_1503_ESMFold_hypothetical_protein	5t5t-assembly1.cif.gz_A	5t5t-assembly1.cif.gz_A AMPK bound to allosteric activator	3.701E-03	0.941	71	27	321	326	10	272	369	353	0.905	0.713
LOKIASV2_1503_ESMFold_hypothetical_protein	6c9d-assembly2.cif.gz_B	6c9d-assembly2.cif.gz_B Crystal structure of KA1-autoinhibited MARK1 kinase	4.344E-03	0.941	71	27	288	326	10	242	422	312	0.804	0.552
LOKIASV2_1503_ESMFold_hypothetical_protein	1ol6-assembly1.cif.gz_A	1ol6-assembly1.cif.gz_A Structure of unphosphorylated D274N mutant of Aurora-A	6.316E-03	0.933	70	26	326	326	7	230	245	329	0.923	0.914
LOKIASV2_1503_ESMFold_hypothetical_protein	2xne-assembly1.cif.gz_A	2xne-assembly1.cif.gz_A Structure of Aurora-A bound to an imidazopyrazine inhibitor	1.486E-02	0.933	70	26	313	326	6	244	246	334	0.883	0.972
LOKIASV2_1503_ESMFold_hypothetical_protein	6nzf-assembly1.cif.gz_A	6nzf-assembly1.cif.gz_A CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound_5 AKA 4-[(2-CARBAMOYLPHEN YL)AMINO]-6-[(5-FLUOROPYRIDIN-2-YL)AMINO]-N-METHYLPYRIDINE -3-CARBOXAMIDE	8.704E-03	0.933	70	27	326	326	13	239	247	334	0.920	0.919
LOKIASV2_1503_ESMFold_hypothetical_protein	6yg4-assembly1.cif.gz_A	6yg4-assembly1.cif.gz_A Crystal structure of MKK7 (MAP2K7) in complex with K00007	2.685E-03	0.933	70	26	326	326	17	260	260	329	0.923	0.938
LOKIASV2_1503_ESMFold_hypothetical_protein	3zfx-assembly8.cif.gz_H	3zfx-assembly8.cif.gz_H Crystal structure of EphB1	9.686E-03	0.933	70	27	324	326	9	258	266	339	0.914	0.940
LOKIASV2_1503_ESMFold_hypothetical_protein	8bzi-assembly1.cif.gz_A	8bzi-assembly1.cif.gz_A Human MST3 (STK24) kinase in complex with inhibitor MR39	7.414E-03	0.933	70	27	325	326	14	262	267	341	0.917	0.933
LOKIASV2_1503_ESMFold_hypothetical_protein	8c08-assembly1.cif.gz_B	8c08-assembly1.cif.gz_B Crystal structure of JAK2 JH2-K539L	6.316E-03	0.933	70	26	326	326	9	255	269	337	0.923	0.918
LOKIASV2_1503_ESMFold_hypothetical_protein	1gzo-assembly1.cif.gz_A	1gzo-assembly1.cif.gz_A Structure of protein kinase B unphosphorylated	7.822E-03	0.933	70	26	315	326	6	249	271	331	0.890	0.900
LOKIASV2_1503_ESMFold_hypothetical_protein	2vtt-assembly1.cif.gz_A	2vtt-assembly1.cif.gz_A Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design.	4.583E-03	0.933	70	28	311	326	8	261	272	356	0.871	0.934
LOKIASV2_1503_ESMFold_hypothetical_protein	5auu-assembly1.cif.gz_A	5auu-assembly1.cif.gz_A Crystal structure of DAPK1 in complex with luteolin.	1.078E-02	0.933	70	26	326	326	13	261	274	347	0.923	0.909
LOKIASV2_1503_ESMFold_hypothetical_protein	5i4n-assembly1.cif.gz_A	5i4n-assembly1.cif.gz_A Crystal Structure of the E596A V617F Mutant JAK2 Pseudokinase Domain Bound to Mg-ATP	3.904E-03	0.933	70	28	326	326	13	260	275	342	0.917	0.902
LOKIASV2_1503_ESMFold_hypothetical_protein	7jus-assembly1.cif.gz_B	7jus-assembly1.cif.gz_B Crystal Structure of KSR2:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor Cobimetinib	1.200E-02	0.933	70	26	317	326	14	272	276	349	0.896	0.938
LOKIASV2_1503_ESMFold_hypothetical_protein	2pe0-assembly1.cif.gz_A	2pe0-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK1) 5-Hydroxy-3-[1-(1H-pyrrol-2-yl)-eth-(Z)-ylidene]-1,3-dihydro-indol-2-one COMPLEX	2.545E-03	0.933	70	26	324	326	8	228	276	323	0.917	0.801
LOKIASV2_1503_ESMFold_hypothetical_protein	6qg7-assembly1.cif.gz_A	6qg7-assembly1.cif.gz_A Structure of the mitogen activated kinase kinase 7 in complex with pyrazolopyrimidine 1k	1.573E-03	0.933	70	26	324	326	18	273	282	340	0.917	0.908
LOKIASV2_1503_ESMFold_hypothetical_protein	7l24-assembly3.cif.gz_C	7l24-assembly3.cif.gz_C HPK1 IN COMPLEX WITH COMPOUND 11	5.380E-03	0.933	70	26	326	326	11	253	283	335	0.923	0.859
LOKIASV2_1503_ESMFold_hypothetical_protein	5lpv-assembly1.cif.gz_A	5lpv-assembly1.cif.gz_A Crystal structure of the BRI1 kinase domain (865-1160) in complex with AMPPNP and Mn from Arabidopsis thaliana	4.344E-03	0.933	70	14	313	326	6	283	285	352	0.920	0.975
LOKIASV2_1503_ESMFold_hypothetical_protein	6hxf-assembly4.cif.gz_D	6hxf-assembly4.cif.gz_D Human STK10 bound to a maleimide inhibitor	7.852E-04	0.933	70	28	319	326	18	287	287	348	0.896	0.941
LOKIASV2_1503_ESMFold_hypothetical_protein	7kia-assembly2.cif.gz_B	7kia-assembly2.cif.gz_B Crystal structure of FGFR2 kinase domain gatekeeper mutant V564F in complex with covalent compound 19	1.137E-02	0.933	70	24	324	326	12	284	288	357	0.923	0.948
LOKIASV2_1503_ESMFold_hypothetical_protein	3bhh-assembly2.cif.gz_B	3bhh-assembly2.cif.gz_B Crystal structure of human calcium/calmodulin-dependent protein kinase IIB isoform 1 (CAMK2B)	5.100E-03	0.933	70	26	325	326	4	287	289	363	0.920	0.983
LOKIASV2_1503_ESMFold_hypothetical_protein	6ib0-assembly1.cif.gz_A	6ib0-assembly1.cif.gz_A The structure of MKK7 in complex with the covalent 4-amino-pyrazolopyrimidine 3a	1.660E-03	0.933	70	26	324	326	19	282	290	353	0.917	0.910
LOKIASV2_1503_ESMFold_hypothetical_protein	6zgc-assembly1.cif.gz_A	6zgc-assembly1.cif.gz_A Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound Saracatinib (AZD0530)	2.545E-03	0.933	70	27	326	326	7	279	292	344	0.920	0.935
LOKIASV2_1503_ESMFold_hypothetical_protein	4tyg-assembly1.cif.gz_A	4tyg-assembly1.cif.gz_A Structural analysis of the human Fibroblast Growth Factor Receptor 4 Kinase	4.834E-03	0.933	70	24	326	326	21	293	293	364	0.929	0.932
LOKIASV2_1503_ESMFold_hypothetical_protein	5z1e-assembly1.cif.gz_A	5z1e-assembly1.cif.gz_A MAP2K7 C218S mutant-inhibitor	1.340E-03	0.933	70	26	324	326	17	269	296	339	0.917	0.855
LOKIASV2_1503_ESMFold_hypothetical_protein	2r0i-assembly2.cif.gz_B	2r0i-assembly2.cif.gz_B Crystal structure of a kinase MARK2/Par-1 mutant	1.026E-03	0.933	70	26	319	326	5	248	300	341	0.902	0.813
LOKIASV2_1503_ESMFold_hypothetical_protein	3tt0-assembly1.cif.gz_A	3tt0-assembly1.cif.gz_A Co-structure of Fibroblast Growth Factor Receptor 1 kinase domain with 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (BGJ398)	1.026E-03	0.933	70	27	324	326	20	300	305	358	0.914	0.921
LOKIASV2_1503_ESMFold_hypothetical_protein	3iec-assembly2.cif.gz_B	3iec-assembly2.cif.gz_B Helicobacter pylori CagA Inhibits PAR1/MARK Family Kinases by Mimicking Host Substrates	4.583E-03	0.933	70	26	316	326	4	215	313	317	0.893	0.677
LOKIASV2_1503_ESMFold_hypothetical_protein	6bxi-assembly2.cif.gz_B	6bxi-assembly2.cif.gz_B X-ray crystal structure of NDR1 kinase domain	2.988E-03	0.933	70	27	317	326	10	229	332	312	0.893	0.663
LOKIASV2_1503_ESMFold_hypothetical_protein	3iw4-assembly1.cif.gz_A	3iw4-assembly1.cif.gz_A Crystal structure of PKC alpha in complex with NVP-AEB071	4.118E-03	0.933	70	26	326	326	8	280	332	364	0.923	0.822
LOKIASV2_1503_ESMFold_hypothetical_protein	4h3q-assembly1.cif.gz_A	4h3q-assembly1.cif.gz_A Crystal structure of human ERK2 complexed with a MAPK docking peptide	6.663E-03	0.933	70	26	312	326	19	307	352	372	0.880	0.821
LOKIASV2_1503_ESMFold_hypothetical_protein	6e4t-assembly1.cif.gz_A	6e4t-assembly1.cif.gz_A Structure of AMPK bound to activator	3.152E-03	0.933	70	21	314	326	2	264	362	350	0.902	0.727
LOKIASV2_1503_ESMFold_hypothetical_protein	6c9j-assembly1.cif.gz_A	6c9j-assembly1.cif.gz_A AMP-activated protein kinase bound to pharmacological activator R734	3.701E-03	0.933	70	27	322	326	10	268	386	351	0.908	0.671
LOKIASV2_1503_ESMFold_hypothetical_protein	8sap-assembly2.cif.gz_B	8sap-assembly2.cif.gz_B Crystal structure of class III lanthipeptide synthetase ThurKC	7.852E-04	0.933	70	9	287	326	191	452	842	336	0.856	0.311
LOKIASV2_1503_ESMFold_hypothetical_protein	8s99-assembly3.cif.gz_C	8s99-assembly3.cif.gz_C Crystal structure of the TYK2 pseudokinase domain in complex with compound 11	1.078E-02	0.923	69	27	317	326	15	259	260	339	0.893	0.942
LOKIASV2_1503_ESMFold_hypothetical_protein	6fdz-assembly1.cif.gz_U	6fdz-assembly1.cif.gz_U Unc-51-Like Kinase 3 (ULK3) In Complex With Momelotinib	9.182E-03	0.923	69	28	325	326	11	248	265	341	0.914	0.898
LOKIASV2_1503_ESMFold_hypothetical_protein	7b36-assembly1.cif.gz_A	7b36-assembly1.cif.gz_A MST4 in complex with compound G-5555	2.833E-03	0.923	69	27	325	326	10	258	268	345	0.917	0.929
LOKIASV2_1503_ESMFold_hypothetical_protein	7kl2-assembly1.cif.gz_A	7kl2-assembly1.cif.gz_A Cocrystal structure of human CaMKII-alpha (CAMK2A)kinase domain and GluN2B(S1303D)	1.137E-02	0.923	69	26	312	326	6	267	268	344	0.880	0.978
LOKIASV2_1503_ESMFold_hypothetical_protein	2xvd-assembly1.cif.gz_A	2xvd-assembly1.cif.gz_A ephB4 kinase domain inhibitor complex	1.265E-02	0.923	69	26	324	326	10	262	270	341	0.917	0.937
LOKIASV2_1503_ESMFold_hypothetical_protein	4eor-assembly2.cif.gz_C	4eor-assembly2.cif.gz_C Thr 160 phosphorylated CDK2 WT - human cyclin A3 complex with the inhibitor NU6102	9.686E-03	0.923	69	28	314	326	9	258	271	344	0.880	0.923
LOKIASV2_1503_ESMFold_hypothetical_protein	5nxc-assembly1.cif.gz_L	5nxc-assembly1.cif.gz_L LIM Domain Kinase 1 (LIMK1) In Complex With PF-00477736	5.380E-03	0.923	69	26	326	326	11	237	274	334	0.923	0.828
LOKIASV2_1503_ESMFold_hypothetical_protein	4eoq-assembly2.cif.gz_C	4eoq-assembly2.cif.gz_C Thr 160 phosphorylated CDK2 WT - human cyclin A3 complex with ATP	4.834E-03	0.923	69	28	311	326	12	267	276	336	0.871	0.928
LOKIASV2_1503_ESMFold_hypothetical_protein	3wf6-assembly1.cif.gz_A	3wf6-assembly1.cif.gz_A Crystal structure of S6K1 kinase domain in complex with a pyrazolopyrimidine derivative 4-[4-(1H-indol-3-yl)-3,6-dihydropyridin-1(2H)-yl]-1H-pyrazolo[3,4-d]pyrimidine	3.508E-03	0.923	69	24	318	326	3	265	278	353	0.905	0.946
LOKIASV2_1503_ESMFold_hypothetical_protein	3a7f-assembly1.cif.gz_A	3a7f-assembly1.cif.gz_A Human MST3 kinase	5.380E-03	0.923	69	19	325	326	8	276	284	357	0.942	0.947
LOKIASV2_1503_ESMFold_hypothetical_protein	1y91-assembly1.cif.gz_A	1y91-assembly1.cif.gz_A Crystal structure of human CDK2 complexed with a pyrazolo[1,5-a]pyrimidine inhibitor	8.704E-03	0.923	69	28	316	326	8	205	286	310	0.887	0.692
LOKIASV2_1503_ESMFold_hypothetical_protein	6yg2-assembly1.cif.gz_A	6yg2-assembly1.cif.gz_A Crystal structure of MKK7 (MAP2K7) in complex with ibrutnib, with covalent and allosteric binding modes	3.325E-03	0.923	69	26	324	326	18	278	290	350	0.917	0.900
LOKIASV2_1503_ESMFold_hypothetical_protein	4czt-assembly1.cif.gz_A	4czt-assembly1.cif.gz_A Crystal structure of the kinase domain of CIPK23	1.026E-03	0.923	69	27	321	326	14	291	294	362	0.905	0.946
LOKIASV2_1503_ESMFold_hypothetical_protein	3f5x-assembly1.cif.gz_A-3	3f5x-assembly1.cif.gz_A-3 CDK-2-Cyclin complex with indazole inhibitor 9 bound at its active site	7.822E-03	0.923	69	28	290	326	8	214	297	297	0.807	0.697
LOKIASV2_1503_ESMFold_hypothetical_protein	8gmd-assembly2.cif.gz_B	8gmd-assembly2.cif.gz_B CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH (5P)-3-({(8R)-5-[(4-aminopiperidin-1-yl)methyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl}amino)-5-[2-(propan-2-yl)-2H-tetrazol-5-yl]phenol	7.028E-03	0.923	69	28	326	326	22	271	299	331	0.917	0.836
LOKIASV2_1503_ESMFold_hypothetical_protein	4oh4-assembly1.cif.gz_A	4oh4-assembly1.cif.gz_A Crystal structure of BRI1 in complex with BKI1	2.833E-03	0.923	69	14	313	326	21	301	303	362	0.920	0.927
LOKIASV2_1503_ESMFold_hypothetical_protein	2bdw-assembly1.cif.gz_B	2bdw-assembly1.cif.gz_B Crystal Structure of the Auto-Inhibited Kinase Domain of Calcium/Calmodulin Activated Kinase II	7.822E-03	0.923	69	26	326	326	6	251	309	333	0.923	0.796
LOKIASV2_1503_ESMFold_hypothetical_protein	6npz-assembly1.cif.gz_A	6npz-assembly1.cif.gz_A Crystal structure of Akt1 (aa 123-480) kinase with a bisubstrate	4.118E-03	0.923	69	27	318	326	12	276	322	346	0.896	0.823
LOKIASV2_1503_ESMFold_hypothetical_protein	4ynz-assembly1.cif.gz_B	4ynz-assembly1.cif.gz_B Structure of the N-terminal domain of SAD	2.988E-03	0.923	69	27	313	326	14	254	323	330	0.880	0.746
LOKIASV2_1503_ESMFold_hypothetical_protein	6khd-assembly2.cif.gz_B	6khd-assembly2.cif.gz_B Crystal structure of CLK1 in complex with CX-4945	1.270E-03	0.923	69	28	312	326	17	329	332	376	0.874	0.943
LOKIASV2_1503_ESMFold_hypothetical_protein	7e75-assembly1.cif.gz_A	7e75-assembly1.cif.gz_A Crystal structure of human ERK2 mutant (G37C)	2.833E-03	0.923	69	26	321	326	18	311	349	383	0.908	0.842
LOKIASV2_1503_ESMFold_hypothetical_protein	2vd5-assembly1.cif.gz_A-2	2vd5-assembly1.cif.gz_A-2 Structure of Human Myotonic Dystrophy Protein Kinase in Complex with the Bisindoylmaleide inhibitor BIM VIII	3.904E-03	0.923	69	17	318	326	49	338	390	372	0.926	0.744
LOKIASV2_1503_ESMFold_hypothetical_protein	6s9w-assembly1.cif.gz_A	6s9w-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 16a	9.218E-04	0.923	69	27	315	326	122	385	411	346	0.887	0.642
LOKIASV2_1503_ESMFold_hypothetical_protein	4zhx-assembly2.cif.gz_C	4zhx-assembly2.cif.gz_C Novel binding site for allosteric activation of AMPK	5.675E-03	0.923	69	27	320	326	10	271	453	347	0.902	0.578
LOKIASV2_1503_ESMFold_hypothetical_protein	6b1u-assembly2.cif.gz_C	6b1u-assembly2.cif.gz_C Structure of full-length human AMPK (a2b1g1) in complex with a small molecule activator SC4	5.987E-03	0.923	69	27	320	326	10	270	460	351	0.902	0.567
LOKIASV2_1503_ESMFold_hypothetical_protein	4qox-assembly1.cif.gz_A	4qox-assembly1.cif.gz_A Crystal Structure of CDPK4 from Plasmodium Falciparum, PF3D7_0717500	8.283E-04	0.923	69	29	314	326	25	276	462	331	0.877	0.545
LOKIASV2_1503_ESMFold_hypothetical_protein	4mk0-assembly1.cif.gz_A	4mk0-assembly1.cif.gz_A Crystal structure of G protein-coupled receptor kinase 2 in complex with a a rationally designed paroxetine derivative	7.822E-03	0.923	69	26	315	326	163	434	631	355	0.890	0.431
LOKIASV2_1503_ESMFold_hypothetical_protein	6nzh-assembly1.cif.gz_B	6nzh-assembly1.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound_40 AKA 6-cyclopropaneamido-4-[(2-methanesulfonylphenyl)amino]-N-methylpyridine-3-carboxamide	1.335E-02	0.912	68	27	326	326	13	239	249	327	0.920	0.912
LOKIASV2_1503_ESMFold_hypothetical_protein	5jt2-assembly1.cif.gz_A	5jt2-assembly1.cif.gz_A BRAFV600E Kinase Domain In Complex with Chemically Linked Vemurafenib Inhibitor VEM-BISAMIDE	1.137E-02	0.912	68	26	313	326	15	256	257	331	0.883	0.942
LOKIASV2_1503_ESMFold_hypothetical_protein	5jsm-assembly2.cif.gz_D	5jsm-assembly2.cif.gz_D BRAFV600E Kinase Domain In Complex with Chemically Linked Vemurafenib Inhibitor VEM-3-VEM	1.408E-02	0.912	68	28	324	326	18	258	259	334	0.911	0.931
LOKIASV2_1503_ESMFold_hypothetical_protein	8s99-assembly1.cif.gz_A	8s99-assembly1.cif.gz_A Crystal structure of the TYK2 pseudokinase domain in complex with compound 11	5.380E-03	0.912	68	27	319	326	15	261	261	341	0.899	0.946
LOKIASV2_1503_ESMFold_hypothetical_protein	3ii5-assembly3.cif.gz_A	3ii5-assembly3.cif.gz_A The Complex of wild-type B-RAF with Pyrazolo pyrimidine inhibitor	1.137E-02	0.912	68	28	319	326	14	240	262	319	0.896	0.866
LOKIASV2_1503_ESMFold_hypothetical_protein	5uq0-assembly1.cif.gz_A	5uq0-assembly1.cif.gz_A FGFR1 kinase domain complex with fragment 2,2-dimethyl-2,3-dihydrobenzofuran-7-carboxamide	7.822E-03	0.912	68	24	313	326	12	259	266	330	0.890	0.932
LOKIASV2_1503_ESMFold_hypothetical_protein	3my5-assembly2.cif.gz_C	3my5-assembly2.cif.gz_C CDk2/cyclinA in complex with DRB	7.822E-03	0.912	68	28	311	326	9	258	267	336	0.871	0.936
LOKIASV2_1503_ESMFold_hypothetical_protein	8qlt-assembly1.cif.gz_A	8qlt-assembly1.cif.gz_A Human MST3 (STK24) kinase in complex with inhibitor MR30	3.140E-02	0.912	68	27	319	326	15	268	268	338	0.899	0.948
LOKIASV2_1503_ESMFold_hypothetical_protein	4bco-assembly2.cif.gz_C	4bco-assembly2.cif.gz_C Structure of CDK2 in complex with cyclin A and a 2-amino-4-heteroaryl- pyrimidine inhibitor	2.287E-03	0.912	68	28	316	326	9	257	270	332	0.887	0.922
LOKIASV2_1503_ESMFold_hypothetical_protein	7bcm-assembly1.cif.gz_A	7bcm-assembly1.cif.gz_A The DDR1 Kinase Domain Bound To SR302	3.904E-03	0.912	68	24	326	326	4	260	273	356	0.929	0.941
LOKIASV2_1503_ESMFold_hypothetical_protein	7juz-assembly1.cif.gz_A	7juz-assembly1.cif.gz_A Crystal Structure of KSR1:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor Selumetinib	3.152E-03	0.912	68	26	317	326	14	269	273	345	0.896	0.938
LOKIASV2_1503_ESMFold_hypothetical_protein	8pm3-assembly3.cif.gz_C	8pm3-assembly3.cif.gz_C Crystal structure of MAP2K6 with a covalent compound GCL94	2.055E-03	0.912	68	28	324	326	11	266	273	334	0.911	0.938
LOKIASV2_1503_ESMFold_hypothetical_protein	7b8w-assembly2.cif.gz_B	7b8w-assembly2.cif.gz_B Structure of LIMK1 Kinase domain with allosteric inhibitor TH-470	1.265E-02	0.912	68	26	325	326	9	267	275	346	0.920	0.942
LOKIASV2_1503_ESMFold_hypothetical_protein	4l00-assembly3.cif.gz_A	4l00-assembly3.cif.gz_A Crystal structure of the apo Jak1 pseudokinase domain	9.686E-03	0.912	68	26	326	326	19	263	277	340	0.923	0.884
LOKIASV2_1503_ESMFold_hypothetical_protein	4tyi-assembly1.cif.gz_A	4tyi-assembly1.cif.gz_A Structural analysis of the human Fibroblast Growth Factor Receptor 4	1.022E-02	0.912	68	27	324	326	22	276	277	348	0.914	0.921
LOKIASV2_1503_ESMFold_hypothetical_protein	3hrc-assembly1.cif.gz_A	3hrc-assembly1.cif.gz_A Crystal structure of a mutant of human PDK1 Kinase domain in complex with ATP	1.335E-02	0.912	68	26	324	326	6	232	280	332	0.917	0.811
LOKIASV2_1503_ESMFold_hypothetical_protein	8fko-assembly2.cif.gz_B	8fko-assembly2.cif.gz_B Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-{4-[(2S,5R)-5-Amino-2-methylpiperidin-1-yl]-6-chloro-7H-pyrrolo[2,3-d]pyrimidin-5-yl}benzonitrile	5.100E-03	0.912	68	26	326	326	14	252	281	340	0.923	0.851
LOKIASV2_1503_ESMFold_hypothetical_protein	6gtt-assembly1.cif.gz_A	6gtt-assembly1.cif.gz_A Human STK10 bound to BIRB-796	8.738E-04	0.912	68	28	325	326	25	279	282	348	0.914	0.904
LOKIASV2_1503_ESMFold_hypothetical_protein	6g78-assembly1.cif.gz_A	6g78-assembly1.cif.gz_A RSK4 N-terminal Kinase Domain S232E in complex with AMP-PNP	2.833E-03	0.912	68	27	318	326	23	273	283	340	0.896	0.887
LOKIASV2_1503_ESMFold_hypothetical_protein	1f3m-assembly1.cif.gz_D	1f3m-assembly1.cif.gz_D CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE KINASE PAK1	1.491E-03	0.912	68	9	326	326	9	253	285	340	0.975	0.860
LOKIASV2_1503_ESMFold_hypothetical_protein	4obp-assembly3.cif.gz_A	4obp-assembly3.cif.gz_A MAP4K4 in complex with inhibitor (compound 29), 6-(2-FLUOROPYRIDIN-4-YL)PYRIDO[3,2-D]PYRIMIDIN-4-AMINE	1.948E-03	0.912	68	19	324	326	9	284	285	361	0.939	0.968
LOKIASV2_1503_ESMFold_hypothetical_protein	6p68-assembly2.cif.gz_B	6p68-assembly2.cif.gz_B Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to compound 22.	6.316E-03	0.912	68	27	324	326	19	283	286	353	0.914	0.927
LOKIASV2_1503_ESMFold_hypothetical_protein	6qhr-assembly1.cif.gz_A	6qhr-assembly1.cif.gz_A Structure of the mitogen activated kinase kinase 7 in complex with pyrazolopyrimidine 1m	2.055E-03	0.912	68	26	324	326	19	277	286	343	0.917	0.906
LOKIASV2_1503_ESMFold_hypothetical_protein	3alo-assembly1.cif.gz_A	3alo-assembly1.cif.gz_A Crystal structure of human non-phosphorylated MKK4 kinase domain ternary complex with AMP-PNP and p38 peptide	2.055E-03	0.912	68	26	326	326	10	256	289	345	0.923	0.855
LOKIASV2_1503_ESMFold_hypothetical_protein	4v04-assembly2.cif.gz_B	4v04-assembly2.cif.gz_B FGFR1 in complex with ponatinib.	6.663E-03	0.912	68	27	324	326	23	284	289	347	0.914	0.907
LOKIASV2_1503_ESMFold_hypothetical_protein	7opo-assembly6.cif.gz_K	7opo-assembly6.cif.gz_K RSK2 N-terminal kinase domain in complex with ORF45	1.491E-03	0.912	68	26	325	326	24	255	293	342	0.920	0.792
LOKIASV2_1503_ESMFold_hypothetical_protein	5kz7-assembly2.cif.gz_B	5kz7-assembly2.cif.gz_B Mark2 complex with 7-[(1S)-1-(4-fluorophenyl)ethyl]-5,5-dimethyl-2-(3-pyridylamino)pyrrolo[2,3-d]pyrimidin-6-one	5.675E-03	0.912	68	26	294	326	5	218	296	306	0.825	0.723
LOKIASV2_1503_ESMFold_hypothetical_protein	6itt-assembly1.cif.gz_B	6itt-assembly1.cif.gz_B Crystal structure of unactivated c-KIT in complex with compound	7.028E-03	0.912	68	24	326	326	21	297	297	358	0.929	0.933
LOKIASV2_1503_ESMFold_hypothetical_protein	3mvh-assembly1.cif.gz_A	3mvh-assembly1.cif.gz_A Crystal structure of Akt-1-inhibitor complexes	7.028E-03	0.912	68	27	318	326	9	273	312	342	0.896	0.849
LOKIASV2_1503_ESMFold_hypothetical_protein	3ocb-assembly1.cif.gz_A	3ocb-assembly1.cif.gz_A Akt1 kinase domain with pyrrolopyrimidine inhibitor	4.583E-03	0.912	68	27	318	326	10	274	316	351	0.896	0.839
LOKIASV2_1503_ESMFold_hypothetical_protein	6fyo-assembly1.cif.gz_A	6fyo-assembly1.cif.gz_A X-RAY STRUCTURE OF CLK1-KD(148-484)/Cpd-2 AT 2.32A	3.904E-03	0.912	68	28	312	326	18	329	331	390	0.874	0.943
LOKIASV2_1503_ESMFold_hypothetical_protein	5li9-assembly1.cif.gz_A	5li9-assembly1.cif.gz_A Structure of a nucleotide-bound form of PKCiota core kinase domain	7.028E-03	0.912	68	26	318	326	9	273	331	346	0.899	0.801
LOKIASV2_1503_ESMFold_hypothetical_protein	4red-assembly1.cif.gz_B	4red-assembly1.cif.gz_B Crystal structure of human AMPK alpha1 KD-AID with K43A mutation	2.988E-03	0.912	68	27	320	326	9	262	332	340	0.902	0.765
LOKIASV2_1503_ESMFold_hypothetical_protein	6e4u-assembly1.cif.gz_A	6e4u-assembly1.cif.gz_A Structure of AMPK bound to activator	7.414E-03	0.912	68	21	322	326	2	268	366	361	0.926	0.730
LOKIASV2_1503_ESMFold_hypothetical_protein	6c9g-assembly1.cif.gz_A	6c9g-assembly1.cif.gz_A AMP-activated protein kinase bound to pharmacological activator R739	6.316E-03	0.912	68	27	311	326	10	261	386	343	0.874	0.653
LOKIASV2_1503_ESMFold_hypothetical_protein	8sam-assembly1.cif.gz_A	8sam-assembly1.cif.gz_A Crystal structure of class III lanthipeptide synthetase LP-GS-ThurKC in complex with ATP	8.283E-04	0.912	68	15	291	326	210	470	859	341	0.850	0.304
LOKIASV2_1503_ESMFold_hypothetical_protein	6bx6-assembly1.cif.gz_A	6bx6-assembly1.cif.gz_A AMP-Activated protein kinase (AMPK) inhibition by SBI-0206965: alpha 2 kinase domain bound to SBI-0206965	7.414E-03	0.900	67	27	287	326	6	215	243	298	0.801	0.864
LOKIASV2_1503_ESMFold_hypothetical_protein	8sso-assembly2.cif.gz_D	8sso-assembly2.cif.gz_D AurA bound to danusertib and inhibiting monobody Mb2	2.535E-02	0.900	67	26	326	326	8	235	252	330	0.923	0.905
LOKIASV2_1503_ESMFold_hypothetical_protein	3kl8-assembly2.cif.gz_I	3kl8-assembly2.cif.gz_I CaMKIINtide Inhibitor Complex	6.316E-03	0.900	67	28	311	326	6	253	254	331	0.871	0.976
LOKIASV2_1503_ESMFold_hypothetical_protein	3kl8-assembly4.cif.gz_E	3kl8-assembly4.cif.gz_E CaMKIINtide Inhibitor Complex	6.663E-03	0.900	67	28	310	326	5	252	256	328	0.868	0.969
LOKIASV2_1503_ESMFold_hypothetical_protein	6yg5-assembly1.cif.gz_A	6yg5-assembly1.cif.gz_A Crystal structure of MKK7 (MAP2K7) in complex with ASC69	2.685E-03	0.900	67	26	324	326	19	251	262	324	0.917	0.889
LOKIASV2_1503_ESMFold_hypothetical_protein	7b32-assembly1.cif.gz_A	7b32-assembly1.cif.gz_A MST3 in complex with MRIA7	1.335E-02	0.900	67	27	325	326	14	246	264	328	0.917	0.883
LOKIASV2_1503_ESMFold_hypothetical_protein	7ujs-assembly1.cif.gz_A	7ujs-assembly1.cif.gz_A Cocrystal structure of human CaMKII-alpha (CAMK2A)kinase domain and GluN2B in complex with ADP	5.380E-03	0.900	67	28	310	326	11	265	268	337	0.868	0.951
LOKIASV2_1503_ESMFold_hypothetical_protein	3rny-assembly3.cif.gz_B	3rny-assembly3.cif.gz_B Crystal structure of human RSK1 C-terminal kinase domain	1.078E-02	0.900	67	43	313	326	14	241	271	317	0.831	0.841
LOKIASV2_1503_ESMFold_hypothetical_protein	5z1d-assembly1.cif.gz_A	5z1d-assembly1.cif.gz_A MAP2K7 C276S mutant-inhibitor	7.414E-03	0.900	67	26	324	326	17	263	274	332	0.917	0.901
LOKIASV2_1503_ESMFold_hypothetical_protein	7jv1-assembly1.cif.gz_D	7jv1-assembly1.cif.gz_D Crystal Structure of KSR1:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor APS-9-95-1	3.904E-03	0.900	67	27	317	326	16	271	275	349	0.893	0.931
LOKIASV2_1503_ESMFold_hypothetical_protein	1vyz-assembly1.cif.gz_A	1vyz-assembly1.cif.gz_A Structure of CDK2 complexed with PNU-181227	4.834E-03	0.900	67	28	325	326	8	261	279	360	0.914	0.910
LOKIASV2_1503_ESMFold_hypothetical_protein	3dls-assembly7.cif.gz_B	3dls-assembly7.cif.gz_B Crystal structure of human PAS kinase bound to ADP	1.137E-02	0.900	67	28	309	326	22	275	280	331	0.865	0.907
LOKIASV2_1503_ESMFold_hypothetical_protein	7m2f-assembly1.cif.gz_A	7m2f-assembly1.cif.gz_A CDK2 with compound 14 inhibitor with carboxylate	3.508E-03	0.900	67	28	326	326	8	258	281	343	0.917	0.893
LOKIASV2_1503_ESMFold_hypothetical_protein	4j97-assembly5.cif.gz_A	4j97-assembly5.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659E Mutation Identified in Endometrial Cancer.	1.408E-02	0.900	67	24	317	326	11	275	282	348	0.902	0.940
LOKIASV2_1503_ESMFold_hypothetical_protein	3dls-assembly8.cif.gz_D	3dls-assembly8.cif.gz_D Crystal structure of human PAS kinase bound to ADP	8.251E-03	0.900	67	28	326	326	22	258	284	344	0.917	0.835
LOKIASV2_1503_ESMFold_hypothetical_protein	7xqk-assembly1.cif.gz_A	7xqk-assembly1.cif.gz_A The Crystal Structure of CDK3 and CyclinE1 Complex from Biortus.	4.118E-03	0.900	67	28	326	326	6	273	286	360	0.917	0.937
LOKIASV2_1503_ESMFold_hypothetical_protein	1ung-assembly1.cif.gz_A	1ung-assembly1.cif.gz_A Structural mechanism for the inhibition of CDK5-p25 by roscovitine, aloisine and indirubin.	3.508E-03	0.900	67	27	311	326	4	283	288	371	0.874	0.972
LOKIASV2_1503_ESMFold_hypothetical_protein	8ak2-assembly1.cif.gz_A	8ak2-assembly1.cif.gz_A Drosophila melanogaster UNC89 Protein Kinase Domain 1 (apo)	3.140E-02	0.900	67	26	174	326	4	190	289	195	0.457	0.647
LOKIASV2_1503_ESMFold_hypothetical_protein	7vds-assembly1.cif.gz_A	7vds-assembly1.cif.gz_A The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 24	1.265E-02	0.900	67	27	310	326	6	285	290	375	0.871	0.966
LOKIASV2_1503_ESMFold_hypothetical_protein	7opo-assembly1.cif.gz_A	7opo-assembly1.cif.gz_A RSK2 N-terminal kinase domain in complex with ORF45	2.168E-03	0.900	67	27	325	326	24	257	295	337	0.917	0.793
LOKIASV2_1503_ESMFold_hypothetical_protein	6zgc-assembly3.cif.gz_C	6zgc-assembly3.cif.gz_C Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound Saracatinib (AZD0530)	4.834E-03	0.900	67	26	315	326	7	294	296	356	0.890	0.973
LOKIASV2_1503_ESMFold_hypothetical_protein	7egb-assembly1.cif.gz_8	7egb-assembly1.cif.gz_8 TFIID-based holo PIC on SCP promoter	1.200E-02	0.900	67	27	311	326	6	282	298	367	0.874	0.930
LOKIASV2_1503_ESMFold_hypothetical_protein	4eon-assembly2.cif.gz_C	4eon-assembly2.cif.gz_C Thr 160 phosphorylated CDK2 H84S, Q85M, Q131E - human cyclin A3 complex with the inhibitor RO3306	1.941E-02	0.900	67	28	256	326	10	189	299	256	0.702	0.602
LOKIASV2_1503_ESMFold_hypothetical_protein	2wzj-assembly3.cif.gz_B	2wzj-assembly3.cif.gz_B Catalytic and UBA domain of kinase MARK2/(Par-1) K82R, T208E double mutant	2.685E-03	0.900	67	26	326	326	4	240	310	340	0.923	0.765
LOKIASV2_1503_ESMFold_hypothetical_protein	3fe3-assembly1.cif.gz_B	3fe3-assembly1.cif.gz_B Crystal structure of the kinase MARK3/Par-1: T211A-S215A double mutant	1.414E-03	0.900	67	26	314	326	6	216	317	313	0.887	0.666
LOKIASV2_1503_ESMFold_hypothetical_protein	1o6k-assembly1.cif.gz_A	1o6k-assembly1.cif.gz_A Structure of activated form of PKB kinase domain S474D with GSK3 peptide and AMP-PNP	7.414E-03	0.900	67	27	315	326	10	274	318	360	0.887	0.833
LOKIASV2_1503_ESMFold_hypothetical_protein	8fp1-assembly1.cif.gz_A	8fp1-assembly1.cif.gz_A PKCeta kinase domain in complex with compound 2	1.265E-02	0.900	67	27	318	326	10	275	328	342	0.896	0.811
LOKIASV2_1503_ESMFold_hypothetical_protein	3a8w-assembly3.cif.gz_B	3a8w-assembly3.cif.gz_B Crystal Structure of PKCiota kinase domain	6.663E-03	0.900	67	26	311	326	8	264	329	335	0.877	0.781
LOKIASV2_1503_ESMFold_hypothetical_protein	4lgd-assembly5.cif.gz_A	4lgd-assembly5.cif.gz_A Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5	1.026E-03	0.900	67	26	325	326	13	285	350	367	0.920	0.780
LOKIASV2_1503_ESMFold_hypothetical_protein	7jhh-assembly1.cif.gz_A	7jhh-assembly1.cif.gz_A Cryo-EM structure of ATP-bound fully inactive AMPK in complex with Fab and nanobody	8.704E-03	0.900	67	27	306	326	8	214	379	315	0.859	0.546
LOKIASV2_1503_ESMFold_hypothetical_protein	6c9d-assembly1.cif.gz_A	6c9d-assembly1.cif.gz_A Crystal structure of KA1-autoinhibited MARK1 kinase	5.675E-03	0.900	67	26	310	326	7	259	425	337	0.874	0.595
LOKIASV2_1503_ESMFold_hypothetical_protein	4cfe-assembly2.cif.gz_A	4cfe-assembly2.cif.gz_A Structure of full length human AMPK in complex with a small molecule activator, a benzimidazole derivative (991)	8.704E-03	0.900	67	27	311	326	11	262	426	337	0.874	0.592
LOKIASV2_1503_ESMFold_hypothetical_protein	5ezv-assembly2.cif.gz_C	5ezv-assembly2.cif.gz_C X-ray crystal structure of AMP-activated protein kinase alpha-2/alpha-1 RIM chimaera (alpha-2(1-347)/alpha-1(349-401)/alpha-2(397-end) beta-1 gamma-1) co-crystallized with C2 (5-(5-hydroxyl-isoxazol-3-yl)-furan-2-phosphonic acid)	7.028E-03	0.900	67	27	320	326	10	271	441	351	0.902	0.594
LOKIASV2_1503_ESMFold_hypothetical_protein	7wj6-assembly1.cif.gz_B	7wj6-assembly1.cif.gz_B Crystal Structure of the Kinase Domain of a Class III Lanthipeptide Synthetase CurKC	1.078E-02	0.887	66	28	233	326	9	155	241	220	0.632	0.610
LOKIASV2_1503_ESMFold_hypothetical_protein	6mzq-assembly2.cif.gz_B	6mzq-assembly2.cif.gz_B TAS-120 in reversible binding mode with FGFR1	1.200E-02	0.887	66	19	324	326	14	259	260	338	0.939	0.946
LOKIASV2_1503_ESMFold_hypothetical_protein	7xmk-assembly1.cif.gz_A	7xmk-assembly1.cif.gz_A Crystal structure of human RIPK1 kinase domain in complex with compound SKLB923	7.822E-03	0.887	66	29	326	326	8	243	261	325	0.914	0.904
LOKIASV2_1503_ESMFold_hypothetical_protein	5jsm-assembly2.cif.gz_C	5jsm-assembly2.cif.gz_C BRAFV600E Kinase Domain In Complex with Chemically Linked Vemurafenib Inhibitor VEM-3-VEM	1.840E-02	0.887	66	27	315	326	13	260	262	332	0.887	0.947
LOKIASV2_1503_ESMFold_hypothetical_protein	7b36-assembly2.cif.gz_C	7b36-assembly2.cif.gz_C MST4 in complex with compound G-5555	1.491E-03	0.887	66	27	324	326	11	266	267	325	0.914	0.959
LOKIASV2_1503_ESMFold_hypothetical_protein	8c08-assembly1.cif.gz_A	8c08-assembly1.cif.gz_A Crystal structure of JAK2 JH2-K539L	8.704E-03	0.887	66	26	325	326	8	265	270	357	0.920	0.956
LOKIASV2_1503_ESMFold_hypothetical_protein	7vdp-assembly2.cif.gz_B	7vdp-assembly2.cif.gz_B The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 1	9.182E-03	0.887	66	26	310	326	1	277	279	366	0.874	0.993
LOKIASV2_1503_ESMFold_hypothetical_protein	5lqf-assembly2.cif.gz_D	5lqf-assembly2.cif.gz_D CDK1/CyclinB1/CKS2 in complex with NU6102	8.251E-03	0.887	66	28	310	326	11	283	285	359	0.868	0.958
LOKIASV2_1503_ESMFold_hypothetical_protein	6v6q-assembly1.cif.gz_A	6v6q-assembly1.cif.gz_A Crystal Structure of Monophosphorylated FGF Receptor 2 isoform IIIb with PTR657	2.403E-02	0.887	66	27	324	326	18	284	286	357	0.914	0.934
LOKIASV2_1503_ESMFold_hypothetical_protein	6qfl-assembly1.cif.gz_A	6qfl-assembly1.cif.gz_A Structure of the mitogen activated kinase kinase 7 active conformation	1.948E-03	0.887	66	26	326	326	18	279	287	348	0.923	0.913
LOKIASV2_1503_ESMFold_hypothetical_protein	5oy6-assembly3.cif.gz_C	5oy6-assembly3.cif.gz_C Crystal structure of the ACVR1 (ALK2) kinase in complex with cyclical inhibitor OD36.	7.028E-03	0.887	66	27	301	326	8	214	291	294	0.844	0.711
LOKIASV2_1503_ESMFold_hypothetical_protein	5x18-assembly2.cif.gz_B	5x18-assembly2.cif.gz_B Crystal structure of Casein kinase I homolog 1	2.545E-03	0.887	66	28	315	326	12	275	294	350	0.883	0.898
LOKIASV2_1503_ESMFold_hypothetical_protein	8fh4-assembly2.cif.gz_B	8fh4-assembly2.cif.gz_B Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-[6-chloro-4-(9-methyl-1-oxa-4,9-diazaspiro[5.5]undec-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile	1.200E-02	0.887	66	26	326	326	13	258	297	338	0.923	0.828
LOKIASV2_1503_ESMFold_hypothetical_protein	4l46-assembly1.cif.gz_A	4l46-assembly1.cif.gz_A Crystal structures of human p70S6K1-WT	1.200E-02	0.887	66	27	318	326	15	278	318	343	0.896	0.830
LOKIASV2_1503_ESMFold_hypothetical_protein	4ra4-assembly1.cif.gz_A	4ra4-assembly1.cif.gz_A Crystal Structure of Human Protein Kinase C Alpha in Complex with Compound 28 ((R)-6-((3S,4S)-1,3-Dimethyl-piperidin-4-yl)-7-(2-fluoro-phenyl)-4-methyl-2,10-dihydro-9-oxa-1,2,4a-triaza-phenanthren-3-one)	1.078E-02	0.887	66	27	315	326	11	276	320	344	0.887	0.831
LOKIASV2_1503_ESMFold_hypothetical_protein	2qnj-assembly1.cif.gz_B	2qnj-assembly1.cif.gz_B Kinase and Ubiquitin-associated domains of MARK3/Par-1	3.701E-03	0.887	66	26	320	326	13	227	322	320	0.905	0.668
LOKIASV2_1503_ESMFold_hypothetical_protein	4yom-assembly1.cif.gz_B	4yom-assembly1.cif.gz_B Structure of SAD kinase	5.380E-03	0.887	66	27	309	326	10	259	322	329	0.868	0.776
LOKIASV2_1503_ESMFold_hypothetical_protein	6i5i-assembly1.cif.gz_A	6i5i-assembly1.cif.gz_A Crystal structure of CLK1 in complexed with furo[3,2-b]pyridine compound 12h	1.660E-03	0.887	66	28	312	326	20	331	335	393	0.874	0.931
LOKIASV2_1503_ESMFold_hypothetical_protein	6hhg-assembly1.cif.gz_A	6hhg-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 27	1.847E-03	0.887	66	18	318	326	104	359	386	350	0.923	0.663
LOKIASV2_1503_ESMFold_hypothetical_protein	7k7l-assembly1.cif.gz_A	7k7l-assembly1.cif.gz_A Structure of a hit for G Protein Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure	8.704E-03	0.887	66	26	315	326	161	434	616	364	0.890	0.445
LOKIASV2_1503_ESMFold_hypothetical_protein	8sam-assembly2.cif.gz_B	8sam-assembly2.cif.gz_B Crystal structure of class III lanthipeptide synthetase LP-GS-ThurKC in complex with ATP	5.697E-04	0.887	66	15	325	326	209	465	858	369	0.954	0.300
LOKIASV2_1503_ESMFold_hypothetical_protein	6c1b-assembly2.cif.gz_B	6c1b-assembly2.cif.gz_B FGFR1 kinase complex with inhibitor SN37118	9.686E-03	0.872	65	19	324	326	13	254	256	340	0.939	0.945
LOKIASV2_1503_ESMFold_hypothetical_protein	6nzq-assembly3.cif.gz_B	6nzq-assembly3.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound_29 AKA 6-[(5-FLUORO-4-METH YLPYRIDIN-2-YL)AMINO]-4-({2-METHOXY-3-[(PYRIDIN-2-YLMETHYL )CARBAMOYL]PHENYL}AMINO)-N-METHYLPYRIDINE-3-CARBOXAMIDE	9.686E-03	0.872	65	27	315	326	13	219	258	305	0.887	0.802
LOKIASV2_1503_ESMFold_hypothetical_protein	8s99-assembly2.cif.gz_B	8s99-assembly2.cif.gz_B Crystal structure of the TYK2 pseudokinase domain in complex with compound 11	1.486E-02	0.872	65	27	317	326	14	260	261	338	0.893	0.946
LOKIASV2_1503_ESMFold_hypothetical_protein	6ib2-assembly1.cif.gz_A	6ib2-assembly1.cif.gz_A The structure of MKK7 in complex with the covalent 4-amino-pyrazolopyrimidine 4a	2.287E-03	0.872	65	26	324	326	18	256	265	336	0.917	0.902
LOKIASV2_1503_ESMFold_hypothetical_protein	3com-assembly1.cif.gz_A	3com-assembly1.cif.gz_A Crystal structure of Mst1 kinase	2.675E-02	0.872	65	27	326	326	2	266	266	348	0.920	0.996
LOKIASV2_1503_ESMFold_hypothetical_protein	2iw8-assembly2.cif.gz_C	2iw8-assembly2.cif.gz_C STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A F82H-L83V-H84D MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR	1.022E-02	0.872	65	28	314	326	9	251	266	337	0.880	0.914
LOKIASV2_1503_ESMFold_hypothetical_protein	3aqv-assembly1.cif.gz_A	3aqv-assembly1.cif.gz_A Human AMP-activated protein kinase alpha 2 subunit kinase domain (T172D) complexed with compound C	7.028E-03	0.872	65	27	322	326	12	264	267	345	0.908	0.948
LOKIASV2_1503_ESMFold_hypothetical_protein	4usd-assembly1.cif.gz_A	4usd-assembly1.cif.gz_A Human STK10 (LOK) with SB-633825	2.413E-03	0.872	65	26	326	326	14	268	268	338	0.923	0.951
LOKIASV2_1503_ESMFold_hypothetical_protein	5kbq-assembly2.cif.gz_B	5kbq-assembly2.cif.gz_B Pak1 in complex with bis-anilino pyrimidine inhibitor	9.182E-03	0.872	65	9	326	326	3	241	273	342	0.975	0.875
LOKIASV2_1503_ESMFold_hypothetical_protein	2bts-assembly1.cif.gz_A	2bts-assembly1.cif.gz_A STRUCTURE OF CDK2 COMPLEXED WITH PNU-230032	1.941E-02	0.872	65	28	256	326	8	163	274	242	0.702	0.569
LOKIASV2_1503_ESMFold_hypothetical_protein	3ezv-assembly1.cif.gz_A	3ezv-assembly1.cif.gz_A CDK-2 with indazole inhibitor 9 bound at its active site	1.137E-02	0.872	65	28	326	326	8	254	277	345	0.917	0.892
LOKIASV2_1503_ESMFold_hypothetical_protein	1agw-assembly1.cif.gz_A	1agw-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH SU4984 INHIBITOR	8.251E-03	0.872	65	27	324	326	15	276	278	349	0.914	0.942
LOKIASV2_1503_ESMFold_hypothetical_protein	4aot-assembly1.cif.gz_A	4aot-assembly1.cif.gz_A Crystal Structure of Human Serine Threonine Kinase-10 (LOK) Bound to GW830263A	1.660E-03	0.872	65	28	326	326	25	278	278	341	0.917	0.914
LOKIASV2_1503_ESMFold_hypothetical_protein	4fg9-assembly2.cif.gz_B	4fg9-assembly2.cif.gz_B Crystal structure of human calcium/calmodulin-dependent protein kinase I 1-320 in complex with ATP	4.344E-03	0.872	65	26	325	326	8	269	279	366	0.920	0.939
LOKIASV2_1503_ESMFold_hypothetical_protein	4fzf-assembly1.cif.gz_B	4fzf-assembly1.cif.gz_B Crystal structure of MST4-MO25 complex with DKI	1.022E-02	0.872	65	12	325	326	1	272	279	365	0.963	0.975
LOKIASV2_1503_ESMFold_hypothetical_protein	3g51-assembly1.cif.gz_A	3g51-assembly1.cif.gz_A Structural diversity of the active conformation of the N-terminal kinase domain of p90 ribosomal S6 kinase 2	1.948E-03	0.872	65	27	318	326	25	270	280	342	0.896	0.879
LOKIASV2_1503_ESMFold_hypothetical_protein	8qlq-assembly1.cif.gz_A	8qlq-assembly1.cif.gz_A Human MST3 (STK24) kinase in complex with macrocyclic inhibitor JA310	1.941E-02	0.872	65	27	326	326	13	247	280	333	0.920	0.839
LOKIASV2_1503_ESMFold_hypothetical_protein	7uxi-assembly1.cif.gz_A	7uxi-assembly1.cif.gz_A Structure of CDK2 in complex with FP19711, a Helicon Polypeptide	9.182E-03	0.872	65	26	316	326	5	199	280	310	0.893	0.696
LOKIASV2_1503_ESMFold_hypothetical_protein	3com-assembly2.cif.gz_B	3com-assembly2.cif.gz_B Crystal structure of Mst1 kinase	3.701E-03	0.872	65	16	325	326	4	277	281	361	0.951	0.975
LOKIASV2_1503_ESMFold_hypothetical_protein	1xjd-assembly1.cif.gz_A	1xjd-assembly1.cif.gz_A Crystal Structure of PKC-theta complexed with Staurosporine at 2A resolution	2.278E-02	0.872	65	27	326	326	6	271	282	353	0.920	0.943
LOKIASV2_1503_ESMFold_hypothetical_protein	4j97-assembly5.cif.gz_C-2	4j97-assembly5.cif.gz_C-2 Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659E Mutation Identified in Endometrial Cancer.	1.941E-02	0.872	65	27	317	326	15	276	283	348	0.893	0.926
LOKIASV2_1503_ESMFold_hypothetical_protein	8cdw-assembly1.cif.gz_A	8cdw-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN HPK1 (MAP4K1) COMPLEX WITH 7-(1-methyl-1H-pyrazol-4-yl)-N-[4-(1-methylpiperidin-4-yl)phenyl]quinazolin-2-amine	5.100E-03	0.872	65	26	326	326	12	254	285	335	0.923	0.853
LOKIASV2_1503_ESMFold_hypothetical_protein	5dh3-assembly1.cif.gz_B	5dh3-assembly1.cif.gz_B Crystal structure of MST2 in complex with XMU-MP-1	2.403E-02	0.872	65	26	325	326	11	283	285	359	0.920	0.958
LOKIASV2_1503_ESMFold_hypothetical_protein	6p69-assembly2.cif.gz_B	6p69-assembly2.cif.gz_B Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to compound 11.	1.200E-02	0.872	65	27	324	326	20	284	286	355	0.914	0.927
LOKIASV2_1503_ESMFold_hypothetical_protein	3ns9-assembly1.cif.gz_A	3ns9-assembly1.cif.gz_A Crystal structure of CDK2 in complex with inhibitor BS-194	1.486E-02	0.872	65	28	235	326	6	139	289	218	0.638	0.464
LOKIASV2_1503_ESMFold_hypothetical_protein	2i40-assembly1.cif.gz_A	2i40-assembly1.cif.gz_A Cdk2/Cyclin A complexed with a thiophene carboxamide inhibitor	5.987E-03	0.872	65	28	324	326	8	255	291	343	0.911	0.852
LOKIASV2_1503_ESMFold_hypothetical_protein	6zgc-assembly4.cif.gz_D	6zgc-assembly4.cif.gz_D Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound Saracatinib (AZD0530)	8.704E-03	0.872	65	26	301	326	5	214	291	296	0.847	0.722
LOKIASV2_1503_ESMFold_hypothetical_protein	8b54-assembly2.cif.gz_C	8b54-assembly2.cif.gz_C CDK2/cyclin A2 in complex with pyrazolo[4,3-d]pyrimidine inhibitor LGR6768	1.335E-02	0.872	65	28	326	326	8	273	292	356	0.917	0.911
LOKIASV2_1503_ESMFold_hypothetical_protein	6guc-assembly1.cif.gz_A	6guc-assembly1.cif.gz_A CDK2/CyclinA in complex with SU9516	2.278E-02	0.872	65	28	256	326	9	183	292	256	0.702	0.599
LOKIASV2_1503_ESMFold_hypothetical_protein	6w4p-assembly1.cif.gz_H	6w4p-assembly1.cif.gz_H CaMKII alpha-30 Cryo-EM reconstruction - Class B	1.486E-02	0.872	65	26	325	326	8	290	293	360	0.920	0.966
LOKIASV2_1503_ESMFold_hypothetical_protein	1zmu-assembly1.cif.gz_A	1zmu-assembly1.cif.gz_A Catalytic and ubiqutin-associated domains of MARK2/PAR-1: Wild type	6.637E-02	0.872	65	26	131	326	2	112	293	120	0.325	0.379
LOKIASV2_1503_ESMFold_hypothetical_protein	4eok-assembly1.cif.gz_A	4eok-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 H84S, Q85M, K89D - human cyclin A3 complex with the inhibitor NU6102	2.160E-02	0.872	65	28	316	326	9	214	294	321	0.887	0.701
LOKIASV2_1503_ESMFold_hypothetical_protein	4eoo-assembly1.cif.gz_A	4eoo-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 Q131E - human cyclin A3 complex with ATP	1.567E-02	0.872	65	28	326	326	10	273	295	353	0.917	0.895
LOKIASV2_1503_ESMFold_hypothetical_protein	4eos-assembly1.cif.gz_A	4eos-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 WT - human cyclin A3 complex with the inhibitor RO3306	1.022E-02	0.872	65	28	326	326	11	275	297	359	0.917	0.892
LOKIASV2_1503_ESMFold_hypothetical_protein	8aoh-assembly1.cif.gz_A	8aoh-assembly1.cif.gz_A Specific covalent inhibitor(18) of ERK2	7.822E-03	0.872	65	26	322	326	17	307	334	378	0.911	0.871
LOKIASV2_1503_ESMFold_hypothetical_protein	3oz6-assembly1.cif.gz_A	3oz6-assembly1.cif.gz_A Crystal structure of MapK from Cryptosporidium Parvum, cgd2_1960	2.685E-03	0.872	65	16	321	326	2	307	343	401	0.939	0.892
LOKIASV2_1503_ESMFold_hypothetical_protein	6s9x-assembly1.cif.gz_A	6s9x-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 15c	2.168E-03	0.872	65	17	318	326	102	356	382	351	0.926	0.668
LOKIASV2_1503_ESMFold_hypothetical_protein	4rer-assembly1.cif.gz_A	4rer-assembly1.cif.gz_A Crystal structure of the phosphorylated human alpha1 beta2 gamma1 holo-AMPK complex bound to AMP and cyclodextrin	4.344E-03	0.872	65	26	311	326	12	261	459	341	0.877	0.545
LOKIASV2_1503_ESMFold_hypothetical_protein	7fcz-assembly1.cif.gz_A	7fcz-assembly1.cif.gz_A Crystal Structure of human RIPK1 kinase domain in complex with a novel inhibitor	3.325E-03	0.855	64	29	326	326	8	230	248	326	0.914	0.899
LOKIASV2_1503_ESMFold_hypothetical_protein	6v2u-assembly2.cif.gz_B	6v2u-assembly2.cif.gz_B Crystal structure of the insect cell-expressed WT-BRAF kinase in complex with Dabrafenib	1.265E-02	0.855	64	28	319	326	13	228	250	315	0.896	0.864
LOKIASV2_1503_ESMFold_hypothetical_protein	8sso-assembly1.cif.gz_A	8sso-assembly1.cif.gz_A AurA bound to danusertib and inhibiting monobody Mb2	1.567E-02	0.855	64	26	313	326	8	253	256	334	0.883	0.961
LOKIASV2_1503_ESMFold_hypothetical_protein	3vqu-assembly1.cif.gz_A	3vqu-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH 4-[(4-amino-5-cyano-6-ethoxypyridin-2- yl)amino]benzamide	4.118E-03	0.855	64	28	326	326	14	243	258	323	0.917	0.891
LOKIASV2_1503_ESMFold_hypothetical_protein	2yza-assembly1.cif.gz_A	2yza-assembly1.cif.gz_A Crystal structure of kinase domain of Human 5'-AMP-activated protein kinase alpha-2 subunit mutant (T172D)	3.701E-03	0.855	64	27	326	326	9	237	258	335	0.920	0.888
LOKIASV2_1503_ESMFold_hypothetical_protein	4h58-assembly2.cif.gz_B	4h58-assembly2.cif.gz_B BRAF in complex with compound 3	2.822E-02	0.855	64	28	324	326	14	260	262	339	0.911	0.943
LOKIASV2_1503_ESMFold_hypothetical_protein	4usd-assembly2.cif.gz_B	4usd-assembly2.cif.gz_B Human STK10 (LOK) with SB-633825	1.751E-03	0.855	64	26	326	326	14	267	267	338	0.923	0.951
LOKIASV2_1503_ESMFold_hypothetical_protein	7ydx-assembly1.cif.gz_A	7ydx-assembly1.cif.gz_A Crystal structure of human RIPK1 kinase domain in complex with compound RI-962	1.840E-02	0.855	64	29	317	326	10	270	271	340	0.887	0.963
LOKIASV2_1503_ESMFold_hypothetical_protein	6inl-assembly1.cif.gz_A	6inl-assembly1.cif.gz_A Crystal structure of CDK2 IN complex with Inhibitor CVT-313	6.316E-03	0.855	64	28	291	326	8	189	272	285	0.810	0.669
LOKIASV2_1503_ESMFold_hypothetical_protein	5kkr-assembly1.cif.gz_B	5kkr-assembly1.cif.gz_B KSR2:MEK1 Complex Bound to the Small Molecule APS-2-79	2.047E-02	0.855	64	19	312	326	7	270	272	343	0.902	0.971
LOKIASV2_1503_ESMFold_hypothetical_protein	4fzd-assembly1.cif.gz_B	4fzd-assembly1.cif.gz_B Crystal structure of MST4-MO25 complex with WSF motif	4.344E-03	0.855	64	27	325	326	8	268	275	357	0.917	0.949
LOKIASV2_1503_ESMFold_hypothetical_protein	8xfl-assembly2.cif.gz_B	8xfl-assembly2.cif.gz_B The Crystal Structure of MARK4 from Biortus.	5.987E-03	0.855	64	27	318	326	8	226	278	322	0.896	0.788
LOKIASV2_1503_ESMFold_hypothetical_protein	4nka-assembly1.cif.gz_A	4nka-assembly1.cif.gz_A Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazolaminopyrimidine 2	1.486E-02	0.855	64	24	324	326	12	274	279	354	0.923	0.943
LOKIASV2_1503_ESMFold_hypothetical_protein	4fza-assembly1.cif.gz_B	4fza-assembly1.cif.gz_B Crystal structure of MST4-MO25 complex	1.847E-03	0.855	64	27	287	326	8	272	281	314	0.801	0.943
LOKIASV2_1503_ESMFold_hypothetical_protein	6g78-assembly2.cif.gz_B	6g78-assembly2.cif.gz_B RSK4 N-terminal Kinase Domain S232E in complex with AMP-PNP	3.508E-03	0.855	64	27	318	326	26	271	281	334	0.896	0.875
LOKIASV2_1503_ESMFold_hypothetical_protein	4zsa-assembly2.cif.gz_B	4zsa-assembly2.cif.gz_B Crystal structure of FGFR1 kinase domain in complex with 7n	9.686E-03	0.855	64	24	324	326	14	281	282	358	0.923	0.950
LOKIASV2_1503_ESMFold_hypothetical_protein	2fvd-assembly1.cif.gz_A	2fvd-assembly1.cif.gz_A Cyclin Dependent Kinase 2 (CDK2) with diaminopyrimidine inhibitor	1.265E-02	0.855	64	28	310	326	8	222	284	316	0.868	0.757
LOKIASV2_1503_ESMFold_hypothetical_protein	5b2l-assembly1.cif.gz_A	5b2l-assembly1.cif.gz_A A crucial role of Cys218 in the stabilization of an unprecedented auto-inhibition form of MAP2K7	3.152E-03	0.855	64	26	324	326	16	277	288	351	0.917	0.910
LOKIASV2_1503_ESMFold_hypothetical_protein	6szm-assembly1.cif.gz_A	6szm-assembly1.cif.gz_A Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2009	2.833E-03	0.855	64	27	317	326	10	287	288	355	0.893	0.965
LOKIASV2_1503_ESMFold_hypothetical_protein	4eor-assembly1.cif.gz_A	4eor-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 WT - human cyclin A3 complex with the inhibitor NU6102	2.403E-02	0.855	64	28	326	326	9	272	294	356	0.917	0.898
LOKIASV2_1503_ESMFold_hypothetical_protein	7lvi-assembly1.cif.gz_A	7lvi-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 ISOFORM 1 COMPLEXED WITH LIGAND (2R)-2-AMINO-N-[3-METHOXY-4- (1,3-OXAZOL-5-YL)PHENYL]-4-METHYLPENTANAMIDE	1.137E-02	0.855	64	28	326	326	17	266	294	344	0.917	0.850
LOKIASV2_1503_ESMFold_hypothetical_protein	3uc4-assembly1.cif.gz_A	3uc4-assembly1.cif.gz_A The crystal structure of Snf1-related kinase 2.6	5.380E-03	0.855	64	19	322	326	7	262	295	356	0.933	0.868
LOKIASV2_1503_ESMFold_hypothetical_protein	6yfz-assembly1.cif.gz_A	6yfz-assembly1.cif.gz_A Crystal structure of MKK7 (MAP2K7), apo form	2.545E-03	0.855	64	26	324	326	21	283	296	350	0.917	0.889
LOKIASV2_1503_ESMFold_hypothetical_protein	4l43-assembly1.cif.gz_A	4l43-assembly1.cif.gz_A Crystal structures of human p70S6K1-T389A (form I)	1.200E-02	0.855	64	24	325	326	7	272	316	350	0.926	0.842
LOKIASV2_1503_ESMFold_hypothetical_protein	3e88-assembly2.cif.gz_B	3e88-assembly2.cif.gz_B Crystal structures of the kinase domain of AKT2 in complex with ATP-competitive inhibitors	2.047E-02	0.855	64	27	318	326	10	273	321	344	0.896	0.822
LOKIASV2_1503_ESMFold_hypothetical_protein	6z2v-assembly1.cif.gz_A	6z2v-assembly1.cif.gz_A CLK3 A319V mutant bound with beta-carboline KH-CARB13 (Cpd 3)	4.118E-03	0.855	64	28	311	326	27	332	339	384	0.871	0.903
LOKIASV2_1503_ESMFold_hypothetical_protein	4cfe-assembly1.cif.gz_C	4cfe-assembly1.cif.gz_C Structure of full length human AMPK in complex with a small molecule activator, a benzimidazole derivative (991)	1.200E-02	0.855	64	27	311	326	9	260	404	341	0.874	0.624
LOKIASV2_1503_ESMFold_hypothetical_protein	7myj-assembly1.cif.gz_A	7myj-assembly1.cif.gz_A Structure of full length human AMPK (a2b1g1) in complex with a small molecule activator MSG011	9.686E-03	0.855	64	27	320	326	12	272	435	350	0.902	0.600
LOKIASV2_1503_ESMFold_hypothetical_protein	8em8-assembly1.cif.gz_A	8em8-assembly1.cif.gz_A Co-crystal structure of the cGMP-dependent protein kinase PKG from Plasmodium falciparum in complex with RY-1-165	1.078E-02	0.855	64	26	294	326	505	736	779	316	0.825	0.298
LOKIASV2_1503_ESMFold_hypothetical_protein	3kl8-assembly3.cif.gz_C	3kl8-assembly3.cif.gz_C CaMKIINtide Inhibitor Complex	9.182E-03	0.837	63	28	310	326	5	252	256	332	0.868	0.969
LOKIASV2_1503_ESMFold_hypothetical_protein	8s9a-assembly2.cif.gz_B	8s9a-assembly2.cif.gz_B Crystal structure of the TYK2 pseudokinase domain in complex with TAK-279	5.675E-03	0.837	63	27	326	326	15	253	263	335	0.920	0.909
LOKIASV2_1503_ESMFold_hypothetical_protein	8f7p-assembly1.cif.gz_B	8f7p-assembly1.cif.gz_B BRAF kinase in complex with LXH254 (naporafenib)	1.486E-02	0.837	63	28	315	326	14	264	265	336	0.883	0.947
LOKIASV2_1503_ESMFold_hypothetical_protein	5uq3-assembly1.cif.gz_A	5uq3-assembly1.cif.gz_A Crystal structure of human Cdk2-Spy1-P27 ternary complex	4.102E-02	0.837	63	28	242	326	1	133	270	216	0.660	0.493
LOKIASV2_1503_ESMFold_hypothetical_protein	6hho-assembly1.cif.gz_A	6hho-assembly1.cif.gz_A Crystal structure of RIP1 kinase in complex with GSK547	1.653E-02	0.837	63	26	317	326	9	272	273	345	0.896	0.967
LOKIASV2_1503_ESMFold_hypothetical_protein	5jq8-assembly1.cif.gz_A	5jq8-assembly1.cif.gz_A Crystal structure of CDK2 in complex with inhibitor ICEC0943	1.486E-02	0.837	63	28	291	326	6	195	278	288	0.810	0.683
LOKIASV2_1503_ESMFold_hypothetical_protein	6jgm-assembly1.cif.gz_A	6jgm-assembly1.cif.gz_A Crystal structure of CDK2 IN complex with Inhibitor NU-6140	5.100E-03	0.837	63	26	316	326	3	198	279	314	0.893	0.703
LOKIASV2_1503_ESMFold_hypothetical_protein	7s85-assembly1.cif.gz_A	7s85-assembly1.cif.gz_A Crystal structure of CDK2 liganded with compound WN316	4.834E-03	0.837	63	28	316	326	6	266	281	361	0.887	0.929
LOKIASV2_1503_ESMFold_hypothetical_protein	3dls-assembly5.cif.gz_E	3dls-assembly5.cif.gz_E Crystal structure of human PAS kinase bound to ADP	2.278E-02	0.837	63	17	310	326	5	266	282	351	0.902	0.929
LOKIASV2_1503_ESMFold_hypothetical_protein	5lpb-assembly1.cif.gz_A	5lpb-assembly1.cif.gz_A Crystal structure of the BRI1 kinase domain (865-1160) in complex with ADP from Arabidopsis thaliana	1.408E-02	0.837	63	14	319	326	6	284	284	361	0.939	0.982
LOKIASV2_1503_ESMFold_hypothetical_protein	7dhl-assembly1.cif.gz_A	7dhl-assembly1.cif.gz_A Crystal structure of FGFR3 in complex with pyrimidine derivative	9.182E-03	0.837	63	27	324	326	15	288	289	346	0.914	0.948
LOKIASV2_1503_ESMFold_hypothetical_protein	4u45-assembly2.cif.gz_A	4u45-assembly2.cif.gz_A MAP4K4 in complex with inhibitor (compound 25)	4.118E-03	0.837	63	28	326	326	18	289	289	354	0.917	0.941
LOKIASV2_1503_ESMFold_hypothetical_protein	6gro-assembly1.cif.gz_A	6gro-assembly1.cif.gz_A Human CSNK1G3 bound to SB-223133	3.904E-03	0.837	63	25	317	326	5	275	293	355	0.899	0.925
LOKIASV2_1503_ESMFold_hypothetical_protein	4eop-assembly1.cif.gz_A	4eop-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 Q131E - human cyclin A3 complex with the inhibitor RO3306	8.704E-03	0.837	63	28	324	326	11	262	298	341	0.911	0.846
LOKIASV2_1503_ESMFold_hypothetical_protein	2izr-assembly1.cif.gz_A	2izr-assembly1.cif.gz_A Structure of casein kinase gamma 3 in complex with inhibitor	2.685E-03	0.837	63	25	317	326	6	275	298	355	0.899	0.906
LOKIASV2_1503_ESMFold_hypothetical_protein	6u6a-assembly1.cif.gz_A	6u6a-assembly1.cif.gz_A Crystal structure of Yck2 from Candida albicans in complex with kinase inhibitor GW461484A	1.567E-02	0.837	63	28	320	326	12	284	306	360	0.899	0.892
LOKIASV2_1503_ESMFold_hypothetical_protein	3qkl-assembly1.cif.gz_A	3qkl-assembly1.cif.gz_A Spirochromane Akt Inhibitors	1.200E-02	0.837	63	27	318	326	10	274	318	350	0.896	0.833
LOKIASV2_1503_ESMFold_hypothetical_protein	3txo-assembly1.cif.gz_A	3txo-assembly1.cif.gz_A PKC eta kinase in complex with a naphthyridine	1.941E-02	0.837	63	26	318	326	2	262	318	346	0.899	0.821
LOKIASV2_1503_ESMFold_hypothetical_protein	6qx9-assembly1.cif.gz_K	6qx9-assembly1.cif.gz_K Structure of a human fully-assembled precatalytic spliceosome (pre-B complex).	4.583E-03	0.837	63	28	311	326	16	321	322	383	0.871	0.950
LOKIASV2_1503_ESMFold_hypothetical_protein	7o7i-assembly1.cif.gz_A	7o7i-assembly1.cif.gz_A Crystal structure of the human HIPK3 kinase domain	2.413E-03	0.837	63	27	326	326	17	360	367	427	0.920	0.937
LOKIASV2_1503_ESMFold_hypothetical_protein	4ejn-assembly1.cif.gz_A	4ejn-assembly1.cif.gz_A Crystal structure of autoinhibited form of AKT1 in complex with N-(4-(5-(3-acetamidophenyl)-2-(2-aminopyridin-3-yl)-3H-imidazo[4,5-b]pyridin-3-yl)benzyl)-3-fluorobenzamide	3.904E-03	0.837	63	27	326	326	109	359	376	354	0.920	0.668
LOKIASV2_1503_ESMFold_hypothetical_protein	6b1u-assembly1.cif.gz_A	6b1u-assembly1.cif.gz_A Structure of full-length human AMPK (a2b1g1) in complex with a small molecule activator SC4	1.078E-02	0.837	63	27	320	326	11	271	442	349	0.902	0.590
LOKIASV2_1503_ESMFold_hypothetical_protein	5dyk-assembly1.cif.gz_A	5dyk-assembly1.cif.gz_A Crystal structure of the cGMP-dependent protein kinase PKG from Plasmodium falciparum - Apo form	1.335E-02	0.837	63	28	320	326	528	795	809	347	0.899	0.331
LOKIASV2_1503_ESMFold_hypothetical_protein	4c3r-assembly1.cif.gz_A	4c3r-assembly1.cif.gz_A Structure of dephosphorylated Aurora A (122-403) bound to AMPPCP	1.200E-02	0.817	62	26	313	326	6	250	252	332	0.883	0.972
LOKIASV2_1503_ESMFold_hypothetical_protein	8tb5-assembly1.cif.gz_A	8tb5-assembly1.cif.gz_A TYK2 JH2 bound to Compound7	1.408E-02	0.817	62	27	317	326	13	216	257	307	0.893	0.794
LOKIASV2_1503_ESMFold_hypothetical_protein	4mne-assembly2.cif.gz_G	4mne-assembly2.cif.gz_G Crystal structure of the BRAF:MEK1 complex	2.535E-02	0.817	62	27	323	326	9	258	259	342	0.911	0.965
LOKIASV2_1503_ESMFold_hypothetical_protein	6c1o-assembly2.cif.gz_B	6c1o-assembly2.cif.gz_B FGFR1 kinase domain complexed with FIIN-1	3.889E-02	0.817	62	19	324	326	12	259	262	341	0.939	0.947
LOKIASV2_1503_ESMFold_hypothetical_protein	3v5q-assembly1.cif.gz_A	3v5q-assembly1.cif.gz_A Discovery of a selective TRK Inhibitor with efficacy in rodent cancer tumor models	8.251E-03	0.817	62	26	326	326	11	246	263	336	0.923	0.897
LOKIASV2_1503_ESMFold_hypothetical_protein	5ur1-assembly2.cif.gz_B	5ur1-assembly2.cif.gz_B FGFR1 kinase domain complex with SN37333 in reversible binding mode	1.941E-02	0.817	62	27	324	326	17	262	265	336	0.914	0.928
LOKIASV2_1503_ESMFold_hypothetical_protein	7vjl-assembly2.cif.gz_B	7vjl-assembly2.cif.gz_B The crystal structure of FGFR4 kinase domain in complex with N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-(2,2,2-trifluoroacetyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide	1.408E-02	0.817	62	27	315	326	15	262	266	327	0.887	0.932
LOKIASV2_1503_ESMFold_hypothetical_protein	6c4d-assembly1.cif.gz_A	6c4d-assembly1.cif.gz_A Structure based design of RIP1 kinase inhibitors	1.653E-02	0.817	62	29	317	326	10	266	267	339	0.887	0.963
LOKIASV2_1503_ESMFold_hypothetical_protein	1oit-assembly1.cif.gz_A	1oit-assembly1.cif.gz_A Imidazopyridines: a potent and selective class of Cyclin-dependent Kinase inhibitors identified through Structure-based hybridisation	8.251E-03	0.817	62	26	310	326	1	211	273	315	0.874	0.773
LOKIASV2_1503_ESMFold_hypothetical_protein	3udb-assembly7.cif.gz_A	3udb-assembly7.cif.gz_A Crystal structure of SnRK2.6	1.265E-02	0.817	62	12	322	326	2	259	275	354	0.954	0.938
LOKIASV2_1503_ESMFold_hypothetical_protein	7cbx-assembly1.cif.gz_A	7cbx-assembly1.cif.gz_A Crystal structure of MAP2K7 complexed with a covalent inhibitor 12	3.325E-03	0.817	62	22	324	326	15	271	281	344	0.929	0.915
LOKIASV2_1503_ESMFold_hypothetical_protein	6cqf-assembly1.cif.gz_A-2	6cqf-assembly1.cif.gz_A-2 Crystal structure of HPK1 in complex an inhibitor G1858	1.265E-02	0.817	62	26	326	326	13	252	282	337	0.923	0.851
LOKIASV2_1503_ESMFold_hypothetical_protein	6gu7-assembly1.cif.gz_A	6gu7-assembly1.cif.gz_A CDK1/Cks2 in complex with AZD5438	1.022E-02	0.817	62	28	306	326	8	224	284	314	0.856	0.764
LOKIASV2_1503_ESMFold_hypothetical_protein	4use-assembly1.cif.gz_A	4use-assembly1.cif.gz_A Human STK10 (LOK) with SB-633825	2.988E-03	0.817	62	26	325	326	14	283	286	353	0.920	0.944
LOKIASV2_1503_ESMFold_hypothetical_protein	7kac-assembly1.cif.gz_B	7kac-assembly1.cif.gz_B Crystal structure of HPK1 (MAP4K1) kinase in complex with 5-{[4-{[(1S)-2-HYDROXY-1-PHENYLETHYL]AMINO}-5-(1,3,4-OXADIAZOL-2-YL)PYRIMIDIN-2-YL]AMINO}-3,3-DIMETHYL-2-BENZOFURAN-1(3H)-ONE	1.265E-02	0.817	62	26	326	326	12	257	288	333	0.923	0.854
LOKIASV2_1503_ESMFold_hypothetical_protein	6gue-assembly2.cif.gz_C	6gue-assembly2.cif.gz_C CDK2/CyclinA in complex with AZD5438	1.486E-02	0.817	62	28	311	326	9	280	289	353	0.871	0.941
LOKIASV2_1503_ESMFold_hypothetical_protein	2iw8-assembly1.cif.gz_A	2iw8-assembly1.cif.gz_A STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A F82H-L83V-H84D MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR	1.567E-02	0.817	62	28	326	326	9	276	298	366	0.917	0.899
LOKIASV2_1503_ESMFold_hypothetical_protein	1fot-assembly1.cif.gz_A	1fot-assembly1.cif.gz_A STRUCTURE OF THE UNLIGANDED CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT FROM SACCHAROMYCES CEREVISIAE	2.822E-02	0.817	62	26	310	326	5	260	300	338	0.874	0.853
LOKIASV2_1503_ESMFold_hypothetical_protein	7opo-assembly4.cif.gz_G	7opo-assembly4.cif.gz_G RSK2 N-terminal kinase domain in complex with ORF45	7.028E-03	0.817	62	26	325	326	24	263	301	337	0.920	0.797
LOKIASV2_1503_ESMFold_hypothetical_protein	6z4z-assembly2.cif.gz_B	6z4z-assembly2.cif.gz_B Crystal structure of CLK1 in complex with macrocycle ODS2004070	3.701E-03	0.817	62	28	312	326	20	334	339	392	0.874	0.929
LOKIASV2_1503_ESMFold_hypothetical_protein	5kcv-assembly1.cif.gz_A	5kcv-assembly1.cif.gz_A Crystal structure of allosteric inhibitor, ARQ 092, in complex with autoinhibited form of AKT1	3.325E-03	0.817	62	15	326	326	86	336	353	356	0.957	0.711
LOKIASV2_1503_ESMFold_hypothetical_protein	8gds-assembly3.cif.gz_C	8gds-assembly3.cif.gz_C CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH 4-(4-(2-(2,3-DIHYDRO-1H- INDOL-1-YL)-2-OXOETHYL)PHENYL)-1(2H)-PHTHALAZINONE	2.047E-02	0.817	62	10	317	326	47	336	385	375	0.945	0.753
LOKIASV2_1503_ESMFold_hypothetical_protein	3soa-assembly1.cif.gz_A	3soa-assembly1.cif.gz_A Full-length human CaMKII	1.567E-02	0.817	62	26	325	326	8	290	436	360	0.920	0.649
LOKIASV2_1503_ESMFold_hypothetical_protein	5wg3-assembly1.cif.gz_A	5wg3-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG258748	1.408E-02	0.817	62	26	315	326	163	429	618	349	0.890	0.432
LOKIASV2_1503_ESMFold_hypothetical_protein	8jpd-assembly1.cif.gz_G	8jpd-assembly1.cif.gz_G Focused refinement structure of GRK2 in NTSR1-GRK2-Galpha(q) complexes	7.414E-03	0.817	62	28	326	326	194	485	658	373	0.917	0.444
LOKIASV2_1503_ESMFold_hypothetical_protein	5tkd-assembly3.cif.gz_A-2	5tkd-assembly3.cif.gz_A-2 CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH 6-[(3,5-DIMETHYLPHE NYL)AMINO]-8- (METHYLAMINO)IMIDAZO[1,2-B]PYRIDAZINE-3-CARBO XAMIDE	2.977E-02	0.795	61	27	326	326	12	239	248	331	0.920	0.919
LOKIASV2_1503_ESMFold_hypothetical_protein	7k7q-assembly1.cif.gz_B	7k7q-assembly1.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH COMPOUND-12 AKA:6-[(cyclopropanecarbonyl)amino]-4-({3-[6-(dimethylcarbamoyl)pyridazin-3-yl]-2-methoxyphenyl}amino)-N-methylpyridazine-3-carboxamide	7.822E-03	0.795	61	26	326	326	9	240	251	326	0.923	0.924
LOKIASV2_1503_ESMFold_hypothetical_protein	5one-assembly1.cif.gz_A	5one-assembly1.cif.gz_A Crystal structure of Aurora-A in complex with FMF-03-145-1 (compound 2)	1.335E-02	0.795	61	26	326	326	6	238	257	341	0.923	0.907
LOKIASV2_1503_ESMFold_hypothetical_protein	3bht-assembly2.cif.gz_C	3bht-assembly2.cif.gz_C Structure of phosphorylated Thr160 CDK2/cyclin A in complex with the inhibitor meriolin 3	1.078E-02	0.795	61	28	311	326	9	262	271	333	0.871	0.937
LOKIASV2_1503_ESMFold_hypothetical_protein	1zyc-assembly2.cif.gz_C	1zyc-assembly2.cif.gz_C Crystal Structure of eIF2alpha Protein Kinase GCN2: Wild-Type in Apo Form.	1.653E-02	0.795	61	28	325	326	12	245	271	337	0.914	0.863
LOKIASV2_1503_ESMFold_hypothetical_protein	3uc3-assembly1.cif.gz_A	3uc3-assembly1.cif.gz_A The crystal structure of Snf1-related kinase 2.3	1.941E-02	0.795	61	19	318	326	9	270	272	358	0.920	0.963
LOKIASV2_1503_ESMFold_hypothetical_protein	7ovm-assembly1.cif.gz_A	7ovm-assembly1.cif.gz_A Protein kinase MKK7 in complex with cyclobutyl-substituted indazole	7.414E-03	0.795	61	26	324	326	18	272	282	345	0.917	0.904
LOKIASV2_1503_ESMFold_hypothetical_protein	3bhh-assembly3.cif.gz_C	3bhh-assembly3.cif.gz_C Crystal structure of human calcium/calmodulin-dependent protein kinase IIB isoform 1 (CAMK2B)	1.567E-02	0.795	61	36	326	326	13	285	285	354	0.893	0.958
LOKIASV2_1503_ESMFold_hypothetical_protein	5o49-assembly2.cif.gz_B	5o49-assembly2.cif.gz_B Human FGF in complex with a covalent inhibitor	6.663E-03	0.795	61	27	318	326	21	284	286	345	0.896	0.923
LOKIASV2_1503_ESMFold_hypothetical_protein	7kia-assembly1.cif.gz_A	7kia-assembly1.cif.gz_A Crystal structure of FGFR2 kinase domain gatekeeper mutant V564F in complex with covalent compound 19	8.704E-03	0.795	61	24	324	326	12	286	287	353	0.923	0.958
LOKIASV2_1503_ESMFold_hypothetical_protein	6yl1-assembly1.cif.gz_A	6yl1-assembly1.cif.gz_A Cdk2(F80C) with Covalent Adduct TK37 at F80C	1.265E-02	0.795	61	26	290	326	8	203	287	288	0.813	0.683
LOKIASV2_1503_ESMFold_hypothetical_protein	6lvm-assembly1.cif.gz_A	6lvm-assembly1.cif.gz_A Crystal structure of FGFR3 in complex with pyrimidine derivative	2.278E-02	0.795	61	27	324	326	15	287	288	351	0.914	0.948
LOKIASV2_1503_ESMFold_hypothetical_protein	5ih8-assembly1.cif.gz_A	5ih8-assembly1.cif.gz_A MELK in complex with NVS-MELK1	4.834E-03	0.795	61	15	315	326	3	247	306	338	0.923	0.801
LOKIASV2_1503_ESMFold_hypothetical_protein	4ra5-assembly1.cif.gz_B	4ra5-assembly1.cif.gz_B Human Protein Kinase C THETA IN COMPLEX WITH LIGAND COMPOUND 11a (6-[(1,3-Dimethyl-azetidin-3-yl)-methyl-amino]-4(R)-methyl-7-phenyl-2,10-dihydro-9-oxa-1,2,4a-triaza-phenanthren-3-one)	2.822E-02	0.795	61	19	326	326	3	273	312	362	0.945	0.869
LOKIASV2_1503_ESMFold_hypothetical_protein	6cnh-assembly1.cif.gz_A	6cnh-assembly1.cif.gz_A Human PRPF4B in complex with Rebastinib	5.987E-03	0.795	61	28	311	326	28	320	321	384	0.871	0.913
LOKIASV2_1503_ESMFold_hypothetical_protein	6r6e-assembly1.cif.gz_A	6r6e-assembly1.cif.gz_A Crystal structure of di-phosphorylated human CLK1 in complex with 5-(6,7-dichloro-1-methyl-1H-indol-3-yl)pyrimidin-4-amine	7.822E-03	0.795	61	28	310	326	13	323	327	391	0.868	0.951
LOKIASV2_1503_ESMFold_hypothetical_protein	5kq5-assembly1.cif.gz_A	5kq5-assembly1.cif.gz_A AMPK bound to allosteric activator	6.316E-03	0.795	61	28	314	326	6	263	363	352	0.880	0.711
LOKIASV2_1503_ESMFold_hypothetical_protein	4qfg-assembly1.cif.gz_A	4qfg-assembly1.cif.gz_A Structure of AMPK in complex with STAUROSPORINE inhibitor and in the absence of a synthetic activator	1.200E-02	0.795	61	27	311	326	10	261	366	331	0.874	0.689
LOKIASV2_1503_ESMFold_hypothetical_protein	7nh4-assembly1.cif.gz_A	7nh4-assembly1.cif.gz_A Co-Crystal Structure of Akt1 in Complex with Covalent-Allosteric Akt Inhibitor 3	2.545E-03	0.795	61	18	318	326	104	356	383	353	0.923	0.661
LOKIASV2_1503_ESMFold_hypothetical_protein	5jt2-assembly2.cif.gz_D	5jt2-assembly2.cif.gz_D BRAFV600E Kinase Domain In Complex with Chemically Linked Vemurafenib Inhibitor VEM-BISAMIDE	3.889E-02	0.772	60	28	317	326	16	233	234	313	0.890	0.932
LOKIASV2_1503_ESMFold_hypothetical_protein	6nyh-assembly2.cif.gz_B	6nyh-assembly2.cif.gz_B Structure of human RIPK1 kinase domain in complex with GNE684	2.047E-02	0.772	60	29	317	326	7	245	246	327	0.887	0.972
LOKIASV2_1503_ESMFold_hypothetical_protein	4fk3-assembly2.cif.gz_A	4fk3-assembly2.cif.gz_A B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX3203	2.977E-02	0.772	60	26	315	326	9	248	251	335	0.890	0.956
LOKIASV2_1503_ESMFold_hypothetical_protein	6nzp-assembly2.cif.gz_A	6nzp-assembly2.cif.gz_A CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH COMPOUND-11 AKA 6-CYCLOPROPANEAMIDO-4-{[2-METHOXY-3-(1-METHYL-1H-1,2,4-TRI AZOL-3-YL)PHENYL]AMINO}-N-(?H?)METHYLPYRIDAZINE-3-CARBOXAMIDE	9.182E-03	0.772	60	27	315	326	13	219	259	304	0.887	0.799
LOKIASV2_1503_ESMFold_hypothetical_protein	6nzr-assembly1.cif.gz_A	6nzr-assembly1.cif.gz_A CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound_12 AKA 4-[(2-methanesulfonylphenyl)amino]-N-(H3)methyl-6-[(pyridin-2- yl)amino]pyridazine-3-carboxamide	7.414E-03	0.772	60	26	326	326	11	250	260	336	0.923	0.923
LOKIASV2_1503_ESMFold_hypothetical_protein	7ax4-assembly2.cif.gz_B	7ax4-assembly2.cif.gz_B Human TYK2 pseudokinase domain (575-869) in complex with 5-(4-Fluoro-phenyl)-2-ureido-thiophene-3-carboxylic acid amide.	3.312E-02	0.772	60	26	319	326	10	261	261	346	0.902	0.966
LOKIASV2_1503_ESMFold_hypothetical_protein	6fdy-assembly1.cif.gz_U	6fdy-assembly1.cif.gz_U Unc-51-Like Kinase 3 (ULK3) In Complex With Bosutinib	2.822E-02	0.772	60	29	311	326	6	258	261	336	0.868	0.969
LOKIASV2_1503_ESMFold_hypothetical_protein	5jsm-assembly1.cif.gz_A	5jsm-assembly1.cif.gz_A BRAFV600E Kinase Domain In Complex with Chemically Linked Vemurafenib Inhibitor VEM-3-VEM	2.047E-02	0.772	60	27	326	326	13	249	265	332	0.920	0.894
LOKIASV2_1503_ESMFold_hypothetical_protein	7k0v-assembly1.cif.gz_C	7k0v-assembly1.cif.gz_C Crystal structure of bRaf in complex with inhibitor GNE-0749	2.047E-02	0.772	60	28	315	326	14	265	267	338	0.883	0.944
LOKIASV2_1503_ESMFold_hypothetical_protein	1zxe-assembly1.cif.gz_A	1zxe-assembly1.cif.gz_A Crystal Structure of eIF2alpha Protein Kinase GCN2: D835N Inactivating Mutant in Apo Form	1.941E-02	0.772	60	28	325	326	12	243	269	331	0.914	0.862
LOKIASV2_1503_ESMFold_hypothetical_protein	1dm2-assembly1.cif.gz_A	1dm2-assembly1.cif.gz_A HUMAN CYCLIN-DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR HYMENIALDISINE	2.278E-02	0.772	60	28	309	326	8	211	274	306	0.865	0.745
LOKIASV2_1503_ESMFold_hypothetical_protein	6qho-assembly1.cif.gz_A	6qho-assembly1.cif.gz_A Dual specificity mitogen-activated protein kinase kinase 7 in complex with pyrazolopyrimidine 1a	6.663E-03	0.772	60	26	324	326	18	267	275	339	0.917	0.909
LOKIASV2_1503_ESMFold_hypothetical_protein	4d28-assembly2.cif.gz_B	4d28-assembly2.cif.gz_B Crystal structure of the kinase domain of CIPK24/SOS2	2.160E-02	0.772	60	26	326	326	6	241	277	344	0.923	0.852
LOKIASV2_1503_ESMFold_hypothetical_protein	5fp6-assembly1.cif.gz_A	5fp6-assembly1.cif.gz_A Structure of cyclin-dependent kinase 2 with small-molecule ligand 3-(4,7-dichloro-1H-indol-3-yl)prop-2-yn-1-ol (AT17833) in an alternate binding site.	9.686E-03	0.772	60	28	325	326	8	264	278	359	0.914	0.924
LOKIASV2_1503_ESMFold_hypothetical_protein	5lpz-assembly1.cif.gz_A	5lpz-assembly1.cif.gz_A Crystal structure of the BRI1 kinase domain (865-1196) in complex with ADP from Arabidopsis thaliana	1.137E-02	0.772	60	15	313	326	8	284	286	357	0.917	0.969
LOKIASV2_1503_ESMFold_hypothetical_protein	2uv2-assembly1.cif.gz_A-2	2uv2-assembly1.cif.gz_A-2 Crystal Structure Of Human Ste20-Like Kinase Bound To 4-(4-(5- Cyclopropyl-1H-pyrazol-3-ylamino)-quinazolin-2-ylamino)-phenyl)- acetonitrile	5.987E-03	0.772	60	28	326	326	18	259	286	329	0.917	0.846
LOKIASV2_1503_ESMFold_hypothetical_protein	2c47-assembly4.cif.gz_D	2c47-assembly4.cif.gz_D Structure of casein kinase 1 gamma 2	8.251E-03	0.772	60	25	321	326	3	272	291	353	0.911	0.928
LOKIASV2_1503_ESMFold_hypothetical_protein	6g77-assembly2.cif.gz_B	6g77-assembly2.cif.gz_B RSK4 N-terminal Kinase Domain in complex with AMP-PNP	3.904E-03	0.772	60	27	318	326	26	281	291	354	0.896	0.880
LOKIASV2_1503_ESMFold_hypothetical_protein	1zmv-assembly1.cif.gz_A	1zmv-assembly1.cif.gz_A Catalytic and ubiqutin-associated domains of MARK2/PAR-1: K82R mutant	1.941E-02	0.772	60	26	313	326	2	228	293	325	0.883	0.775
LOKIASV2_1503_ESMFold_hypothetical_protein	6unp-assembly1.cif.gz_A	6unp-assembly1.cif.gz_A Crystal structure of the kinase domain of BMPR2-D485G	1.022E-02	0.772	60	19	317	326	2	294	299	374	0.917	0.980
LOKIASV2_1503_ESMFold_hypothetical_protein	5kz8-assembly1.cif.gz_A	5kz8-assembly1.cif.gz_A Mark2 complex with 7-[(1S)-1-(4-fluorophenyl)ethyl]-5,5-dimethyl-2-(3-pyridylamino)pyrrolo[2,3-d]pyrimidin-6-one	1.078E-02	0.772	60	27	326	326	9	232	302	331	0.920	0.742
LOKIASV2_1503_ESMFold_hypothetical_protein	2xh5-assembly1.cif.gz_A	2xh5-assembly1.cif.gz_A Structure of 4-(4-tert-Butylbenzyl)-1-(7H-pyrrolo(2,3-d)pyrimidin-4- yl)piperidin-4-amine bound to PKB	2.278E-02	0.772	60	27	315	326	10	274	317	345	0.887	0.836
LOKIASV2_1503_ESMFold_hypothetical_protein	3d0e-assembly1.cif.gz_A	3d0e-assembly1.cif.gz_A Crystal structure of human Akt2 in complex with GSK690693	4.102E-02	0.772	60	27	318	326	10	273	324	346	0.896	0.815
LOKIASV2_1503_ESMFold_hypothetical_protein	3llt-assembly1.cif.gz_A	3llt-assembly1.cif.gz_A Crystal structure of PF14_0431, kinase domain.	1.022E-02	0.772	60	28	310	326	22	340	341	399	0.868	0.935
LOKIASV2_1503_ESMFold_hypothetical_protein	4pl5-assembly2.cif.gz_C	4pl5-assembly2.cif.gz_C Crystal structure of murine IRE1 in complex with OICR573 inhibitor	1.840E-02	0.772	60	29	310	326	15	255	386	321	0.865	0.624
LOKIASV2_1503_ESMFold_hypothetical_protein	4yzb-assembly2.cif.gz_B	4yzb-assembly2.cif.gz_B CDPK1 from Eimeria tenella in complex with inhibitor UW1521	1.078E-02	0.772	60	28	320	326	25	278	464	350	0.899	0.547
LOKIASV2_1503_ESMFold_hypothetical_protein	8uaq-assembly1.cif.gz_A	8uaq-assembly1.cif.gz_A Crystal Structure of Human G Protein-Coupled Receptor Kinase 5 in Complex with GRL018-21	2.278E-02	0.772	60	28	325	326	166	433	501	346	0.914	0.535
LOKIASV2_1503_ESMFold_hypothetical_protein	5flf-assembly5.cif.gz_E	5flf-assembly5.cif.gz_E DISEASE LINKED MUTATION IN FGFR	1.941E-02	0.747	59	24	313	326	10	255	258	337	0.890	0.953
LOKIASV2_1503_ESMFold_hypothetical_protein	6nzr-assembly1.cif.gz_B	6nzr-assembly1.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound_12 AKA 4-[(2-methanesulfonylphenyl)amino]-N-(H3)methyl-6-[(pyridin-2- yl)amino]pyridazine-3-carboxamide	8.251E-03	0.747	59	26	326	326	9	248	259	337	0.923	0.927
LOKIASV2_1503_ESMFold_hypothetical_protein	4xv9-assembly1.cif.gz_A-2	4xv9-assembly1.cif.gz_A-2 B-Raf Kinase domain in complex with PLX5568	4.327E-02	0.747	59	27	324	326	10	259	261	337	0.914	0.958
LOKIASV2_1503_ESMFold_hypothetical_protein	6nvl-assembly2.cif.gz_B	6nvl-assembly2.cif.gz_B FGFR1 complex with N-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3-methylphenyl)acrylamide	3.494E-02	0.747	59	27	324	326	18	262	263	327	0.914	0.932
LOKIASV2_1503_ESMFold_hypothetical_protein	2wmb-assembly2.cif.gz_C	2wmb-assembly2.cif.gz_C Structural and thermodynamic consequences of cyclization of peptide ligands for the recruitment site of cyclin A	1.744E-02	0.747	59	28	311	326	9	258	267	346	0.871	0.936
LOKIASV2_1503_ESMFold_hypothetical_protein	7k0v-assembly1.cif.gz_D	7k0v-assembly1.cif.gz_D Crystal structure of bRaf in complex with inhibitor GNE-0749	2.675E-02	0.747	59	28	315	326	13	269	271	339	0.883	0.948
LOKIASV2_1503_ESMFold_hypothetical_protein	7jv0-assembly1.cif.gz_A	7jv0-assembly1.cif.gz_A Crystal Structure of KSR1:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor PD0325901	1.078E-02	0.747	59	26	317	326	14	272	276	348	0.896	0.938
LOKIASV2_1503_ESMFold_hypothetical_protein	6nfy-assembly1.cif.gz_A	6nfy-assembly1.cif.gz_A Crystal structure of nonphosphorylated, HPK1 kinase domain in complex with sunitinib in the inactive state.	1.137E-02	0.747	59	26	311	326	11	265	282	337	0.877	0.904
LOKIASV2_1503_ESMFold_hypothetical_protein	3dls-assembly7.cif.gz_A	3dls-assembly7.cif.gz_A Crystal structure of human PAS kinase bound to ADP	1.840E-02	0.747	59	28	309	326	22	281	285	351	0.865	0.912
LOKIASV2_1503_ESMFold_hypothetical_protein	6cqe-assembly1.cif.gz_B	6cqe-assembly1.cif.gz_B Crystal structure of HPK1 kinase domain S171A mutant	2.278E-02	0.747	59	27	326	326	13	256	287	337	0.920	0.850
LOKIASV2_1503_ESMFold_hypothetical_protein	7r9p-assembly1.cif.gz_A	7r9p-assembly1.cif.gz_A Crystal structure of HPK1 in complex with compound 14	1.744E-02	0.747	59	27	326	326	13	256	287	337	0.920	0.850
LOKIASV2_1503_ESMFold_hypothetical_protein	7ukz-assembly3.cif.gz_C	7ukz-assembly3.cif.gz_C CDK11 in complex with small molecule inhibitor OTS964	2.278E-02	0.747	59	26	311	326	2	281	294	358	0.877	0.952
LOKIASV2_1503_ESMFold_hypothetical_protein	6eim-assembly1.cif.gz_B	6eim-assembly1.cif.gz_B Human STK10 bound to GW683134A	7.028E-03	0.747	59	28	325	326	18	291	295	356	0.914	0.929
LOKIASV2_1503_ESMFold_hypothetical_protein	7ukz-assembly1.cif.gz_A	7ukz-assembly1.cif.gz_A CDK11 in complex with small molecule inhibitor OTS964	2.160E-02	0.747	59	28	311	326	7	282	296	357	0.871	0.932
LOKIASV2_1503_ESMFold_hypothetical_protein	6b3e-assembly2.cif.gz_C	6b3e-assembly2.cif.gz_C Crystal structure of human CDK12/CyclinK in complex with an inhibitor	1.408E-02	0.747	59	28	311	326	13	293	308	362	0.871	0.912
LOKIASV2_1503_ESMFold_hypothetical_protein	4bkz-assembly1.cif.gz_A	4bkz-assembly1.cif.gz_A Crystal structure of unphosphorylated Maternal Embryonic Leucine zipper Kinase (MELK) in complex with a benzodipyrazole inhibitor	5.987E-03	0.747	59	15	311	326	3	239	309	334	0.911	0.767
LOKIASV2_1503_ESMFold_hypothetical_protein	2gcd-assembly1.cif.gz_A	2gcd-assembly1.cif.gz_A TAO2 kinase domain-staurosporine structure	1.078E-02	0.747	59	26	325	326	19	301	309	370	0.920	0.916
LOKIASV2_1503_ESMFold_hypothetical_protein	8aod-assembly1.cif.gz_A	8aod-assembly1.cif.gz_A Specific covalent inhibitor(14) of ERK2	1.840E-02	0.747	59	26	322	326	17	307	335	381	0.911	0.869
LOKIASV2_1503_ESMFold_hypothetical_protein	4xhg-assembly1.cif.gz_A	4xhg-assembly1.cif.gz_A Structure of C. glabrata Hrr25 bound to ADP (formate condition)	1.078E-02	0.747	59	28	311	326	12	273	357	343	0.871	0.734
LOKIASV2_1503_ESMFold_hypothetical_protein	3lj0-assembly1.cif.gz_A	3lj0-assembly1.cif.gz_A IRE1 complexed with ADP and Quercetin	2.160E-02	0.747	59	28	326	326	14	261	407	349	0.917	0.609
LOKIASV2_1503_ESMFold_hypothetical_protein	7fd0-assembly1.cif.gz_B-2	7fd0-assembly1.cif.gz_B-2 Crystal Structure of human RIPK1 kinase domain in complex with a novel inhibitor	2.047E-02	0.720	58	29	326	326	8	239	257	326	0.914	0.903
LOKIASV2_1503_ESMFold_hypothetical_protein	6m7z-assembly2.cif.gz_B	6m7z-assembly2.cif.gz_B A divergent kinase lacking the glycine-rich loop regulates membrane ultrastructure of the Toxoplasma parasitophorous vacuole	2.047E-02	0.720	58	45	318	326	66	250	258	290	0.840	0.717
LOKIASV2_1503_ESMFold_hypothetical_protein	5c03-assembly1.cif.gz_A	5c03-assembly1.cif.gz_A Crystal Structure of kinase	1.200E-02	0.720	58	27	326	326	14	248	260	331	0.920	0.904
LOKIASV2_1503_ESMFold_hypothetical_protein	8bem-assembly1.cif.gz_A	8bem-assembly1.cif.gz_A STE20-like serine/threonine-protein kinase (SLK) in complex with Tivozanib	5.380E-03	0.720	58	28	317	326	22	268	274	330	0.890	0.901
LOKIASV2_1503_ESMFold_hypothetical_protein	4l01-assembly3.cif.gz_A	4l01-assembly3.cif.gz_A Crystal structure of the V658F apo Jak1 pseudokinase domain	1.744E-02	0.720	58	27	319	326	21	274	274	327	0.899	0.927
LOKIASV2_1503_ESMFold_hypothetical_protein	8h75-assembly1.cif.gz_C	8h75-assembly1.cif.gz_C FGFR2 in complex with YJ001	5.359E-02	0.720	58	28	317	326	19	269	275	337	0.890	0.913
LOKIASV2_1503_ESMFold_hypothetical_protein	7l26-assembly3.cif.gz_C	7l26-assembly3.cif.gz_C HPK1 IN COMPLEX WITH COMPOUND 38	9.686E-03	0.720	58	27	326	326	10	249	280	334	0.920	0.857
LOKIASV2_1503_ESMFold_hypothetical_protein	8fjz-assembly2.cif.gz_B	8fjz-assembly2.cif.gz_B Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-{4-[(3R,5S)-3-Amino-5-methylpiperidin-1-yl]-6-chloro-7H-pyrrolo[2,3-d]pyrimidin-5-yl}benzonitrile	9.686E-03	0.720	58	26	294	326	14	283	284	311	0.825	0.951
LOKIASV2_1503_ESMFold_hypothetical_protein	6guh-assembly1.cif.gz_A	6guh-assembly1.cif.gz_A CDK2 in complex with AZD5438	2.047E-02	0.720	58	18	310	326	2	222	284	327	0.899	0.778
LOKIASV2_1503_ESMFold_hypothetical_protein	4lg4-assembly2.cif.gz_B	4lg4-assembly2.cif.gz_B Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5	3.686E-02	0.720	58	27	325	326	10	276	284	354	0.917	0.940
LOKIASV2_1503_ESMFold_hypothetical_protein	7vdp-assembly1.cif.gz_A	7vdp-assembly1.cif.gz_A The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 1	1.567E-02	0.720	58	29	310	326	3	282	287	368	0.865	0.976
LOKIASV2_1503_ESMFold_hypothetical_protein	2c47-assembly1.cif.gz_A	2c47-assembly1.cif.gz_A Structure of casein kinase 1 gamma 2	7.822E-03	0.720	58	25	321	326	1	270	289	368	0.911	0.934
LOKIASV2_1503_ESMFold_hypothetical_protein	8gmc-assembly1.cif.gz_A	8gmc-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH 5-[(4-aminopiperidin-1-yl)methyl]-N-{3-[5-(propan-2-yl)-1,3,4-thiadiazol-2-yl]phenyl}pyrrolo[2,1-f][1,2,4]triazin-4-amine	1.744E-02	0.720	58	28	326	326	17	265	293	345	0.917	0.850
LOKIASV2_1503_ESMFold_hypothetical_protein	4eoi-assembly1.cif.gz_A	4eoi-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 K89D, Q131E - human cyclin A3 complex with the inhibitor RO3306	3.494E-02	0.720	58	28	326	326	9	272	295	350	0.917	0.895
LOKIASV2_1503_ESMFold_hypothetical_protein	4eol-assembly2.cif.gz_C	4eol-assembly2.cif.gz_C Thr 160 phosphorylated CDK2 H84S, Q85M, K89D - human cyclin A3 complex with the inhibitor RO3306	3.889E-02	0.720	58	28	310	326	11	239	300	323	0.868	0.763
LOKIASV2_1503_ESMFold_hypothetical_protein	4q9z-assembly1.cif.gz_B	4q9z-assembly1.cif.gz_B Human Protein Kinase C Theta in Complex with Compound35 ((1R)-9-(AZETIDIN-3-YLAMINO)-1,8-DIMETHYL-3,5-DIHYDRO[1,2,4]TRIAZINO[3,4-C][1,4]BENZOXAZIN-2(1H)-ONE)	3.494E-02	0.720	58	26	326	326	8	274	309	356	0.923	0.864
LOKIASV2_1503_ESMFold_hypothetical_protein	3iec-assembly4.cif.gz_D	3iec-assembly4.cif.gz_D Helicobacter pylori CagA Inhibits PAR1/MARK Family Kinases by Mimicking Host Substrates	1.744E-02	0.720	58	26	312	326	4	254	311	338	0.880	0.807
LOKIASV2_1503_ESMFold_hypothetical_protein	5yks-assembly1.cif.gz_A	5yks-assembly1.cif.gz_A Crystal structure of sucrose nonfermenting-related kinase (SNRK)	3.889E-02	0.720	58	14	325	326	1	308	312	386	0.957	0.987
LOKIASV2_1503_ESMFold_hypothetical_protein	3e87-assembly2.cif.gz_B	3e87-assembly2.cif.gz_B Crystal structures of the kinase domain of AKT2 in complex with ATP-competitive inhibitors	3.889E-02	0.720	58	27	326	326	10	277	323	350	0.920	0.830
LOKIASV2_1503_ESMFold_hypothetical_protein	3tei-assembly1.cif.gz_A	3tei-assembly1.cif.gz_A Crystal structure of human ERK2 complexed with a MAPK docking peptide	1.744E-02	0.720	58	26	321	326	18	301	339	371	0.908	0.838
LOKIASV2_1503_ESMFold_hypothetical_protein	6fyk-assembly2.cif.gz_B	6fyk-assembly2.cif.gz_B X-Ray structure of CLK2-KD(136-496)/Indazole1 at 2.39A	4.834E-03	0.720	58	28	310	326	31	343	349	390	0.868	0.897
LOKIASV2_1503_ESMFold_hypothetical_protein	4zhx-assembly1.cif.gz_A	4zhx-assembly1.cif.gz_A Novel binding site for allosteric activation of AMPK	1.941E-02	0.720	58	27	315	326	10	299	409	373	0.887	0.709
LOKIASV2_1503_ESMFold_hypothetical_protein	4cff-assembly1.cif.gz_C	4cff-assembly1.cif.gz_C Structure of full length human AMPK in complex with a small molecule activator, a thienopyridone derivative (A-769662)	2.278E-02	0.720	58	27	311	326	9	260	423	337	0.874	0.596
LOKIASV2_1503_ESMFold_hypothetical_protein	6nze-assembly1.cif.gz_A	6nze-assembly1.cif.gz_A CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound_5 AKA 4-[(2-CARBAMOYLPHEN YL)AMINO]-6-[(5-FLUOROPYRIDIN-2-YL)AMINO]-N-METHYLPYRIDINE -3-CARBOXAMIDE	1.941E-02	0.692	57	27	326	326	12	244	250	333	0.920	0.932
LOKIASV2_1503_ESMFold_hypothetical_protein	5ct7-assembly2.cif.gz_B	5ct7-assembly2.cif.gz_B BRAF in Complex with RAF265	5.653E-02	0.692	57	28	324	326	13	253	254	333	0.911	0.949
LOKIASV2_1503_ESMFold_hypothetical_protein	6m7z-assembly4.cif.gz_D	6m7z-assembly4.cif.gz_D A divergent kinase lacking the glycine-rich loop regulates membrane ultrastructure of the Toxoplasma parasitophorous vacuole	2.822E-02	0.692	57	45	318	326	58	246	255	289	0.840	0.741
LOKIASV2_1503_ESMFold_hypothetical_protein	5nwz-assembly2.cif.gz_B	5nwz-assembly2.cif.gz_B FIBROBLAST GROWTH FACTOR RECEPTOR 4 KINASE DOMAIN (449-753) IN COMPLEX WITH IRREVERSIBLE LIGAND CGA159527	7.386E-02	0.692	57	19	324	326	11	265	268	339	0.939	0.951
LOKIASV2_1503_ESMFold_hypothetical_protein	5vam-assembly1.cif.gz_A	5vam-assembly1.cif.gz_A BRAF in Complex with RAF709	3.140E-02	0.692	57	28	324	326	13	268	269	350	0.911	0.952
LOKIASV2_1503_ESMFold_hypothetical_protein	1gij-assembly1.cif.gz_A	1gij-assembly1.cif.gz_A HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4 INHIBITOR	1.744E-02	0.692	57	28	326	326	8	250	273	345	0.917	0.890
LOKIASV2_1503_ESMFold_hypothetical_protein	1g5s-assembly1.cif.gz_A	1g5s-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH THE INHIBITOR H717	2.535E-02	0.692	57	28	324	326	8	238	275	333	0.911	0.840
LOKIASV2_1503_ESMFold_hypothetical_protein	7l26-assembly2.cif.gz_B	7l26-assembly2.cif.gz_B HPK1 IN COMPLEX WITH COMPOUND 38	1.022E-02	0.692	57	27	326	326	10	244	275	334	0.920	0.855
LOKIASV2_1503_ESMFold_hypothetical_protein	8bem-assembly2.cif.gz_B	8bem-assembly2.cif.gz_B STE20-like serine/threonine-protein kinase (SLK) in complex with Tivozanib	5.987E-03	0.692	57	28	324	326	22	276	277	338	0.911	0.921
LOKIASV2_1503_ESMFold_hypothetical_protein	7ovl-assembly1.cif.gz_A	7ovl-assembly1.cif.gz_A Protein kinase MKK7 in complex with methoxycyclohexyl-substituted indazole	1.200E-02	0.692	57	26	324	326	18	269	279	342	0.917	0.903
LOKIASV2_1503_ESMFold_hypothetical_protein	3dls-assembly7.cif.gz_C	3dls-assembly7.cif.gz_C Crystal structure of human PAS kinase bound to ADP	1.840E-02	0.692	57	28	309	326	22	276	281	336	0.865	0.907
LOKIASV2_1503_ESMFold_hypothetical_protein	8a66-assembly2.cif.gz_B	8a66-assembly2.cif.gz_B Crystal structure of MST2 in complex with XMU-MP-1	1.653E-02	0.692	57	26	325	326	11	278	282	355	0.920	0.950
LOKIASV2_1503_ESMFold_hypothetical_protein	4eoj-assembly2.cif.gz_C	4eoj-assembly2.cif.gz_C Thr 160 phosphorylated CDK2 H84S, Q85M, K89D - human cyclin A3 complex with ATP	3.686E-02	0.692	57	28	326	326	12	262	283	346	0.917	0.887
LOKIASV2_1503_ESMFold_hypothetical_protein	3sqq-assembly1.cif.gz_A	3sqq-assembly1.cif.gz_A CDK2 in complex with inhibitor RC-3-96	4.102E-02	0.692	57	28	316	326	8	207	288	310	0.887	0.694
LOKIASV2_1503_ESMFold_hypothetical_protein	2iw6-assembly1.cif.gz_A	2iw6-assembly1.cif.gz_A STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR	4.102E-02	0.692	57	28	311	326	9	285	293	359	0.871	0.945
LOKIASV2_1503_ESMFold_hypothetical_protein	5oxg-assembly3.cif.gz_C	5oxg-assembly3.cif.gz_C Crystal structure of the ACVR1 (ALK2) kinase in complex with LDN-212854	1.567E-02	0.692	57	26	315	326	9	298	301	364	0.890	0.963
LOKIASV2_1503_ESMFold_hypothetical_protein	4qpm-assembly1.cif.gz_A	4qpm-assembly1.cif.gz_A Structure of Bub1 kinase domain	4.583E-03	0.692	57	28	325	326	53	319	330	355	0.914	0.809
LOKIASV2_1503_ESMFold_hypothetical_protein	6yty-assembly1.cif.gz_A	6yty-assembly1.cif.gz_A CLK3 A319V mutant bound with benzothiazole Tg003 (Cpd 2)	1.137E-02	0.692	57	28	323	326	34	352	353	403	0.908	0.904
LOKIASV2_1503_ESMFold_hypothetical_protein	3kl8-assembly1.cif.gz_A	3kl8-assembly1.cif.gz_A CaMKIINtide Inhibitor Complex	3.312E-02	0.663	56	28	310	326	2	252	256	336	0.868	0.980
LOKIASV2_1503_ESMFold_hypothetical_protein	4yht-assembly1.cif.gz_A	4yht-assembly1.cif.gz_A bRaf complexed with an inhibitor	6.637E-02	0.663	56	28	326	326	13	242	256	323	0.917	0.898
LOKIASV2_1503_ESMFold_hypothetical_protein	6mzw-assembly2.cif.gz_B	6mzw-assembly2.cif.gz_B TAS-120 covalent complex with FGFR1	4.816E-02	0.663	56	24	317	326	13	250	258	328	0.902	0.922
LOKIASV2_1503_ESMFold_hypothetical_protein	4mne-assembly1.cif.gz_C	4mne-assembly1.cif.gz_C Crystal structure of the BRAF:MEK1 complex	7.001E-02	0.663	56	25	323	326	5	259	260	353	0.917	0.981
LOKIASV2_1503_ESMFold_hypothetical_protein	6nvl-assembly3.cif.gz_C	6nvl-assembly3.cif.gz_C FGFR1 complex with N-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3-methylphenyl)acrylamide	1.200E-02	0.663	56	27	324	326	14	264	265	337	0.914	0.947
LOKIASV2_1503_ESMFold_hypothetical_protein	3zfx-assembly1.cif.gz_A	3zfx-assembly1.cif.gz_A Crystal structure of EphB1	3.140E-02	0.663	56	27	324	326	9	258	267	348	0.914	0.936
LOKIASV2_1503_ESMFold_hypothetical_protein	6m7z-assembly5.cif.gz_E	6m7z-assembly5.cif.gz_E A divergent kinase lacking the glycine-rich loop regulates membrane ultrastructure of the Toxoplasma parasitophorous vacuole	2.535E-02	0.663	56	45	318	326	71	260	269	290	0.840	0.706
LOKIASV2_1503_ESMFold_hypothetical_protein	1r78-assembly1.cif.gz_A	1r78-assembly1.cif.gz_A CDK2 complex with a 4-alkynyl oxindole inhibitor	2.977E-02	0.663	56	28	290	326	8	189	273	284	0.807	0.667
LOKIASV2_1503_ESMFold_hypothetical_protein	7sj3-assembly1.cif.gz_A	7sj3-assembly1.cif.gz_A Structure of CDK4-Cyclin D3 bound to abemaciclib	2.977E-02	0.663	56	27	309	326	5	273	274	360	0.868	0.982
LOKIASV2_1503_ESMFold_hypothetical_protein	1ckp-assembly1.cif.gz_A	1ckp-assembly1.cif.gz_A HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR PURVALANOL B	6.291E-02	0.663	56	28	310	326	8	217	279	309	0.868	0.753
LOKIASV2_1503_ESMFold_hypothetical_protein	4tpt-assembly1.cif.gz_A	4tpt-assembly1.cif.gz_A Crystal Structure of the Human LIMK2 Kinase Domain In Complex With a Non-ATP Competitive Inhibitor	3.312E-02	0.663	56	30	326	326	8	240	279	338	0.911	0.835
LOKIASV2_1503_ESMFold_hypothetical_protein	8atb-assembly1.cif.gz_AAA	8atb-assembly1.cif.gz_AAA Discovery of IRAK4 Inhibitor 16	9.686E-03	0.663	56	28	319	326	23	280	280	345	0.896	0.921
LOKIASV2_1503_ESMFold_hypothetical_protein	3fz1-assembly1.cif.gz_A	3fz1-assembly1.cif.gz_A Crystal structure of a benzthiophene inhibitor bound to human Cyclin-dependent Kinase-2 (CDK-2)	1.941E-02	0.663	56	28	311	326	8	273	284	362	0.871	0.937
LOKIASV2_1503_ESMFold_hypothetical_protein	1buh-assembly1.cif.gz_A	1buh-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE HUMAN CDK2 KINASE COMPLEX WITH CELL CYCLE-REGULATORY PROTEIN CKSHS1	1.137E-02	0.663	56	26	319	326	6	281	287	361	0.902	0.962
LOKIASV2_1503_ESMFold_hypothetical_protein	1f5q-assembly2.cif.gz_C	1f5q-assembly2.cif.gz_C CRYSTAL STRUCTURE OF MURINE GAMMA HERPESVIRUS CYCLIN COMPLEXED TO HUMAN CYCLIN DEPENDENT KINASE 2	7.386E-02	0.663	56	28	236	326	3	150	288	235	0.641	0.514
LOKIASV2_1503_ESMFold_hypothetical_protein	5f9e-assembly2.cif.gz_B	5f9e-assembly2.cif.gz_B Structure of Protein Kinase C theta with compound 10: 2,2-dimethyl-7-(2-oxidanylidene-3~{H}-imidazo[4,5-b]pyridin-1-yl)-1-(phenylmethyl)-3~{H}-quinazolin-4-one	5.359E-02	0.663	56	28	326	326	10	273	294	352	0.917	0.898
LOKIASV2_1503_ESMFold_hypothetical_protein	2wtk-assembly1.cif.gz_E	2wtk-assembly1.cif.gz_E Structure of the heterotrimeric LKB1-STRADalpha-MO25alpha complex	2.047E-02	0.663	56	27	311	326	10	266	308	337	0.874	0.834
LOKIASV2_1503_ESMFold_hypothetical_protein	6k0j-assembly1.cif.gz_A	6k0j-assembly1.cif.gz_A The co-crystal structure of DYRK2 with a small molecule inhibitor	5.080E-02	0.663	56	28	311	326	15	242	327	328	0.871	0.697
LOKIASV2_1503_ESMFold_hypothetical_protein	3udb-assembly5.cif.gz_E	3udb-assembly5.cif.gz_E Crystal structure of SnRK2.6	2.822E-02	0.632	55	27	206	326	9	195	255	208	0.552	0.733
LOKIASV2_1503_ESMFold_hypothetical_protein	4yht-assembly2.cif.gz_B	4yht-assembly2.cif.gz_B bRaf complexed with an inhibitor	9.147E-02	0.632	55	28	325	326	13	237	258	318	0.914	0.872
LOKIASV2_1503_ESMFold_hypothetical_protein	7k0v-assembly1.cif.gz_A	7k0v-assembly1.cif.gz_A Crystal structure of bRaf in complex with inhibitor GNE-0749	3.312E-02	0.632	55	28	324	326	13	260	262	341	0.911	0.947
LOKIASV2_1503_ESMFold_hypothetical_protein	5fd2-assembly1.cif.gz_A	5fd2-assembly1.cif.gz_A B-Raf wild-type kinase domain in complex with a purinylpyridinylamino-based inhibitor	4.327E-02	0.632	55	28	326	326	14	249	264	331	0.917	0.894
LOKIASV2_1503_ESMFold_hypothetical_protein	8cdw-assembly1.cif.gz_B	8cdw-assembly1.cif.gz_B CRYSTAL STRUCTURE OF HUMAN HPK1 (MAP4K1) COMPLEX WITH 7-(1-methyl-1H-pyrazol-4-yl)-N-[4-(1-methylpiperidin-4-yl)phenyl]quinazolin-2-amine	2.535E-02	0.632	55	26	326	326	10	234	265	330	0.923	0.849
LOKIASV2_1503_ESMFold_hypothetical_protein	5wax-assembly2.cif.gz_B	5wax-assembly2.cif.gz_B Crystal Structure of Sugarcane SAPK10 (serine/threonine-protein kinase 10)	7.028E-03	0.632	55	27	310	326	10	248	274	328	0.871	0.872
LOKIASV2_1503_ESMFold_hypothetical_protein	6iuo-assembly1.cif.gz_A	6iuo-assembly1.cif.gz_A Crystal structure of FGFR4 kinase domain in complex with a covalent inhibitor	3.889E-02	0.632	55	24	324	326	21	274	275	335	0.923	0.924
LOKIASV2_1503_ESMFold_hypothetical_protein	5oo1-assembly1.cif.gz_A	5oo1-assembly1.cif.gz_A Cdk2(F80C, C177A) covalent adduct with C37 at F80C	1.567E-02	0.632	55	28	311	326	5	267	278	355	0.871	0.946
LOKIASV2_1503_ESMFold_hypothetical_protein	7xdy-assembly2.cif.gz_B	7xdy-assembly2.cif.gz_B Crystal structure of a receptor like kinase from Arabidopsis	1.653E-02	0.632	55	28	319	326	19	280	280	342	0.896	0.936
LOKIASV2_1503_ESMFold_hypothetical_protein	6yg7-assembly2.cif.gz_B	6yg7-assembly2.cif.gz_B Crystal structure of MKK7 (MAP2K7) covalently bound with type-II inhibitor SB1-G-23	2.160E-02	0.632	55	26	324	326	17	269	280	350	0.917	0.904
LOKIASV2_1503_ESMFold_hypothetical_protein	7siu-assembly1.cif.gz_B	7siu-assembly1.cif.gz_B Crystal structure of HPK1 (MAP4K1) complex with inhibitor A-745	3.312E-02	0.632	55	26	326	326	8	253	284	340	0.923	0.866
LOKIASV2_1503_ESMFold_hypothetical_protein	5uq1-assembly1.cif.gz_A	5uq1-assembly1.cif.gz_A Crystal structure of human Cdk2-Spy1 complex	4.565E-02	0.632	55	28	321	326	6	280	288	373	0.902	0.955
LOKIASV2_1503_ESMFold_hypothetical_protein	7opo-assembly5.cif.gz_I	7opo-assembly5.cif.gz_I RSK2 N-terminal kinase domain in complex with ORF45	6.663E-03	0.632	55	26	326	326	24	284	292	358	0.923	0.894
LOKIASV2_1503_ESMFold_hypothetical_protein	5kz8-assembly2.cif.gz_B	5kz8-assembly2.cif.gz_B Mark2 complex with 7-[(1S)-1-(4-fluorophenyl)ethyl]-5,5-dimethyl-2-(3-pyridylamino)pyrrolo[2,3-d]pyrimidin-6-one	8.251E-03	0.632	55	27	311	326	9	242	300	326	0.874	0.780
LOKIASV2_1503_ESMFold_hypothetical_protein	4imy-assembly1.cif.gz_A	4imy-assembly1.cif.gz_A The AFF4 scaffold binds human P-TEFb adjacent to HIV Tat	2.403E-02	0.632	55	19	311	326	9	301	315	378	0.899	0.930
LOKIASV2_1503_ESMFold_hypothetical_protein	5f9e-assembly1.cif.gz_A	5f9e-assembly1.cif.gz_A Structure of Protein Kinase C theta with compound 10: 2,2-dimethyl-7-(2-oxidanylidene-3~{H}-imidazo[4,5-b]pyridin-1-yl)-1-(phenylmethyl)-3~{H}-quinazolin-4-one	4.816E-02	0.632	55	26	326	326	8	274	336	358	0.923	0.795
LOKIASV2_1503_ESMFold_hypothetical_protein	7t4l-assembly1.cif.gz_A	7t4l-assembly1.cif.gz_A Structure of dimeric phosphorylated Pediculus humanus (Ph) PINK1 with extended alpha-C helix in chain B	2.160E-02	0.632	55	26	317	326	33	312	378	363	0.896	0.741
LOKIASV2_1503_ESMFold_hypothetical_protein	4rew-assembly1.cif.gz_A	4rew-assembly1.cif.gz_A Crystal structure of the non-phosphorylated human alpha1 beta2 gamma1 holo-AMPK complex	9.182E-03	0.632	55	27	287	326	10	241	411	316	0.801	0.564
LOKIASV2_1503_ESMFold_hypothetical_protein	5wg4-assembly1.cif.gz_A	5wg4-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG257284	4.816E-02	0.632	55	26	315	326	162	431	621	349	0.890	0.435
LOKIASV2_1503_ESMFold_hypothetical_protein	6p7g-assembly2.cif.gz_C	6p7g-assembly2.cif.gz_C The co-crystal structure of BRAF(V600E) with PHI1	4.327E-02	0.601	54	28	315	326	13	255	256	327	0.883	0.949
LOKIASV2_1503_ESMFold_hypothetical_protein	6m7z-assembly3.cif.gz_C	6m7z-assembly3.cif.gz_C A divergent kinase lacking the glycine-rich loop regulates membrane ultrastructure of the Toxoplasma parasitophorous vacuole	3.312E-02	0.601	54	45	318	326	66	253	262	296	0.840	0.718
LOKIASV2_1503_ESMFold_hypothetical_protein	8bem-assembly1.cif.gz_G	8bem-assembly1.cif.gz_G STE20-like serine/threonine-protein kinase (SLK) in complex with Tivozanib	1.022E-02	0.601	54	28	315	326	22	268	272	331	0.883	0.908
LOKIASV2_1503_ESMFold_hypothetical_protein	3uc4-assembly2.cif.gz_B	3uc4-assembly2.cif.gz_B The crystal structure of Snf1-related kinase 2.6	4.102E-02	0.601	54	26	326	326	8	241	277	323	0.923	0.845
LOKIASV2_1503_ESMFold_hypothetical_protein	7vdq-assembly2.cif.gz_B	7vdq-assembly2.cif.gz_B The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 7	3.686E-02	0.601	54	29	310	326	2	275	277	365	0.865	0.989
LOKIASV2_1503_ESMFold_hypothetical_protein	4tyj-assembly1.cif.gz_A	4tyj-assembly1.cif.gz_A Structural analysis of the human Fibroblast Growth Factor Receptor 4 Kinase	8.219E-02	0.601	54	27	324	326	26	274	278	334	0.914	0.896
LOKIASV2_1503_ESMFold_hypothetical_protein	3udb-assembly2.cif.gz_B	3udb-assembly2.cif.gz_B Crystal structure of SnRK2.6	2.822E-02	0.601	54	27	322	326	10	260	278	344	0.908	0.903
LOKIASV2_1503_ESMFold_hypothetical_protein	6yg7-assembly1.cif.gz_A	6yg7-assembly1.cif.gz_A Crystal structure of MKK7 (MAP2K7) covalently bound with type-II inhibitor SB1-G-23	1.486E-02	0.601	54	26	324	326	18	267	278	350	0.917	0.899
LOKIASV2_1503_ESMFold_hypothetical_protein	2qkw-assembly1.cif.gz_B	2qkw-assembly1.cif.gz_B Structural basis for activation of plant immunity by bacterial effector protein AvrPto	1.941E-02	0.601	54	26	315	326	13	286	292	355	0.890	0.938
LOKIASV2_1503_ESMFold_hypothetical_protein	7ukz-assembly2.cif.gz_B	7ukz-assembly2.cif.gz_B CDK11 in complex with small molecule inhibitor OTS964	5.964E-02	0.601	54	27	311	326	6	283	296	370	0.874	0.939
LOKIASV2_1503_ESMFold_hypothetical_protein	1zmw-assembly1.cif.gz_B	1zmw-assembly1.cif.gz_B Catalytic and ubiqutin-associated domains of MARK2/PAR-1: T208A/S212A inactive double mutant	1.744E-02	0.601	54	26	319	326	5	251	302	347	0.902	0.818
LOKIASV2_1503_ESMFold_hypothetical_protein	4r5y-assembly1.cif.gz_A	4r5y-assembly1.cif.gz_A The complex structure of Braf V600E kinase domain with a novel Braf inhibitor	2.977E-02	0.569	53	28	326	326	13	238	253	327	0.917	0.893
LOKIASV2_1503_ESMFold_hypothetical_protein	3ckw-assembly1.cif.gz_A	3ckw-assembly1.cif.gz_A Crystal structure of sterile 20-like kinase 3 (MST3, STK24)	2.535E-02	0.569	53	27	287	326	5	248	255	300	0.801	0.957
LOKIASV2_1503_ESMFold_hypothetical_protein	4itj-assembly1.cif.gz_A	4itj-assembly1.cif.gz_A Crystal structure of RIP1 kinase in complex with necrostatin-4	3.889E-02	0.569	53	29	326	326	10	243	261	339	0.914	0.897
LOKIASV2_1503_ESMFold_hypothetical_protein	6m7z-assembly1.cif.gz_A	6m7z-assembly1.cif.gz_A A divergent kinase lacking the glycine-rich loop regulates membrane ultrastructure of the Toxoplasma parasitophorous vacuole	2.403E-02	0.569	53	45	318	326	65	253	262	298	0.840	0.721
LOKIASV2_1503_ESMFold_hypothetical_protein	7k0v-assembly1.cif.gz_B	7k0v-assembly1.cif.gz_B Crystal structure of bRaf in complex with inhibitor GNE-0749	8.219E-02	0.569	53	25	315	326	5	262	264	345	0.893	0.977
LOKIASV2_1503_ESMFold_hypothetical_protein	6c4d-assembly2.cif.gz_B	6c4d-assembly2.cif.gz_B Structure based design of RIP1 kinase inhibitors	3.140E-02	0.569	53	29	326	326	11	248	266	346	0.914	0.895
LOKIASV2_1503_ESMFold_hypothetical_protein	7fd0-assembly1.cif.gz_A	7fd0-assembly1.cif.gz_A Crystal Structure of human RIPK1 kinase domain in complex with a novel inhibitor	4.565E-02	0.569	53	26	326	326	11	248	266	336	0.923	0.895
LOKIASV2_1503_ESMFold_hypothetical_protein	5wax-assembly1.cif.gz_A	5wax-assembly1.cif.gz_A Crystal Structure of Sugarcane SAPK10 (serine/threonine-protein kinase 10)	3.312E-02	0.569	53	27	326	326	11	241	279	323	0.920	0.828
LOKIASV2_1503_ESMFold_hypothetical_protein	7kac-assembly1.cif.gz_A	7kac-assembly1.cif.gz_A Crystal structure of HPK1 (MAP4K1) kinase in complex with 5-{[4-{[(1S)-2-HYDROXY-1-PHENYLETHYL]AMINO}-5-(1,3,4-OXADIAZOL-2-YL)PYRIMIDIN-2-YL]AMINO}-3,3-DIMETHYL-2-BENZOFURAN-1(3H)-ONE	2.403E-02	0.569	53	26	326	326	12	242	283	336	0.923	0.816
LOKIASV2_1503_ESMFold_hypothetical_protein	4bc6-assembly1.cif.gz_A-2	4bc6-assembly1.cif.gz_A-2 Crystal structure of human serine threonine kinase-10 bound to novel Bosutinib Isoform 1, previously thought to be Bosutinib	7.028E-03	0.569	53	28	325	326	17	282	285	349	0.914	0.933
LOKIASV2_1503_ESMFold_hypothetical_protein	4lg4-assembly1.cif.gz_A	4lg4-assembly1.cif.gz_A Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5	5.080E-02	0.569	53	27	325	326	10	274	289	351	0.917	0.917
LOKIASV2_1503_ESMFold_hypothetical_protein	3tnw-assembly2.cif.gz_C	3tnw-assembly2.cif.gz_C Structure of CDK2/cyclin A in complex with CAN508	3.889E-02	0.569	53	28	324	326	8	259	292	346	0.911	0.863
LOKIASV2_1503_ESMFold_hypothetical_protein	4red-assembly1.cif.gz_A	4red-assembly1.cif.gz_A Crystal structure of human AMPK alpha1 KD-AID with K43A mutation	1.408E-02	0.569	53	27	326	326	9	235	327	343	0.920	0.694
LOKIASV2_1503_ESMFold_hypothetical_protein	4cfh-assembly1.cif.gz_A	4cfh-assembly1.cif.gz_A Structure of an active form of mammalian AMPK	1.486E-02	0.569	53	27	311	326	7	260	402	336	0.874	0.632
LOKIASV2_1503_ESMFold_hypothetical_protein	3v5w-assembly1.cif.gz_A	3v5w-assembly1.cif.gz_A Human G Protein-Coupled Receptor Kinase 2 in Complex with Soluble Gbetagamma Subunits and Paroxetine	4.327E-02	0.569	53	26	326	326	163	437	623	364	0.923	0.441
LOKIASV2_1503_ESMFold_hypothetical_protein	4xv2-assembly1.cif.gz_B	4xv2-assembly1.cif.gz_B B-Raf Kinase V600E oncogenic mutant in complex with Dabrafenib	6.291E-02	0.537	52	28	313	326	14	247	249	323	0.877	0.940
LOKIASV2_1503_ESMFold_hypothetical_protein	5ita-assembly3.cif.gz_B	5ita-assembly3.cif.gz_B Crystal Structure of BRAF Kinase Domain Bound to AZ-VEM	7.001E-02	0.537	52	27	313	326	10	249	252	331	0.880	0.952
LOKIASV2_1503_ESMFold_hypothetical_protein	6p7g-assembly1.cif.gz_A	6p7g-assembly1.cif.gz_A The co-crystal structure of BRAF(V600E) with PHI1	6.291E-02	0.537	52	28	313	326	13	254	256	326	0.877	0.945
LOKIASV2_1503_ESMFold_hypothetical_protein	4nzw-assembly1.cif.gz_B	4nzw-assembly1.cif.gz_B Crystal Structure of STK25-MO25 Complex	4.565E-02	0.537	52	27	326	326	13	233	266	319	0.920	0.831
LOKIASV2_1503_ESMFold_hypothetical_protein	4bcp-assembly2.cif.gz_C	4bcp-assembly2.cif.gz_C Structure of CDK2 in complex with cyclin A and a 2-amino-4-heteroaryl- pyrimidine inhibitor	2.977E-02	0.537	52	28	314	326	9	253	268	332	0.880	0.914
LOKIASV2_1503_ESMFold_hypothetical_protein	7z6u-assembly1.cif.gz_A	7z6u-assembly1.cif.gz_A Pim1 in complex with (E)-4-((6-amino-2-oxoindolin-3-ylidene)methyl)benzoic acid and Pimtide	8.219E-02	0.537	52	26	319	326	7	268	268	352	0.902	0.978
LOKIASV2_1503_ESMFold_hypothetical_protein	7juw-assembly1.cif.gz_B	7juw-assembly1.cif.gz_B Crystal Structure of KSR1:MEK1 in complex with AMP-PNP	2.822E-02	0.537	52	26	326	326	14	264	277	349	0.923	0.906
LOKIASV2_1503_ESMFold_hypothetical_protein	4usf-assembly1.cif.gz_A	4usf-assembly1.cif.gz_A Human SLK with SB-440719	5.675E-03	0.537	52	29	317	326	29	274	277	335	0.887	0.888
LOKIASV2_1503_ESMFold_hypothetical_protein	3gni-assembly1.cif.gz_B	3gni-assembly1.cif.gz_B Structure of STRAD and MO25	1.335E-02	0.537	52	27	320	326	24	292	304	358	0.902	0.885
LOKIASV2_1503_ESMFold_hypothetical_protein	7t3x-assembly1.cif.gz_A	7t3x-assembly1.cif.gz_A Structure of unphosphorylated Pediculus humanus (Ph) PINK1 D334A mutant	4.583E-03	0.537	52	19	319	326	29	399	399	416	0.923	0.930
LOKIASV2_1503_ESMFold_hypothetical_protein	6u7c-assembly1.cif.gz_A	6u7c-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG258747	5.359E-02	0.537	52	26	315	326	163	434	631	355	0.890	0.431
LOKIASV2_1503_ESMFold_hypothetical_protein	3a61-assembly1.cif.gz_A	3a61-assembly1.cif.gz_A Crystal structure of unphosphorylated p70S6K1 (Form II)	9.649E-02	0.505	51	27	312	326	8	237	254	324	0.877	0.906
LOKIASV2_1503_ESMFold_hypothetical_protein	4cfv-assembly1.cif.gz_C	4cfv-assembly1.cif.gz_C Structure-based design of C8-substituted O6-cyclohexylmethoxyguanine CDK1 and 2 inhibitors.	3.494E-02	0.505	51	28	311	326	9	256	265	330	0.871	0.936
LOKIASV2_1503_ESMFold_hypothetical_protein	2dyl-assembly1.cif.gz_A	2dyl-assembly1.cif.gz_A Crystal structure of human mitogen-activated protein kinase kinase 7 activated mutant (S287D, T291D)	3.140E-02	0.505	51	26	324	326	17	262	272	341	0.917	0.904
LOKIASV2_1503_ESMFold_hypothetical_protein	6p7g-assembly1.cif.gz_B	6p7g-assembly1.cif.gz_B The co-crystal structure of BRAF(V600E) with PHI1	8.670E-02	0.505	51	28	315	326	13	272	273	344	0.883	0.952
LOKIASV2_1503_ESMFold_hypothetical_protein	3zuu-assembly1.cif.gz_A	3zuu-assembly1.cif.gz_A The structure of OST1 (D160A, S175D) kinase in complex with gold	4.327E-02	0.505	51	27	326	326	12	243	281	324	0.920	0.826
LOKIASV2_1503_ESMFold_hypothetical_protein	7l24-assembly1.cif.gz_A	7l24-assembly1.cif.gz_A HPK1 IN COMPLEX WITH COMPOUND 11	7.386E-02	0.505	51	26	289	326	12	196	283	274	0.810	0.654
LOKIASV2_1503_ESMFold_hypothetical_protein	7b5r-assembly1.cif.gz_L	7b5r-assembly1.cif.gz_L Ubiquitin ligation to F-box protein substrates by SCF-RBR E3-E3 super-assembly: CUL1-RBX1-SKP1-SKP2-CKSHS1-Cyclin A-CDK2-p27	2.977E-02	0.505	51	27	311	326	6	273	284	364	0.874	0.944
LOKIASV2_1503_ESMFold_hypothetical_protein	4lg4-assembly3.cif.gz_C	4lg4-assembly3.cif.gz_C Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5	2.278E-02	0.505	51	26	325	326	11	274	288	357	0.920	0.917
LOKIASV2_1503_ESMFold_hypothetical_protein	6yg1-assembly2.cif.gz_B	6yg1-assembly2.cif.gz_B Crystal structure of MKK7 (MAP2K7) in an active state, allosterically triggered by the N-terminal helix	2.160E-02	0.505	51	26	324	326	27	295	307	354	0.917	0.876
LOKIASV2_1503_ESMFold_hypothetical_protein	4lg4-assembly5.cif.gz_E	4lg4-assembly5.cif.gz_E Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5	5.359E-02	0.473	50	27	325	326	10	267	275	344	0.917	0.938
LOKIASV2_1503_ESMFold_hypothetical_protein	4usf-assembly2.cif.gz_B	4usf-assembly2.cif.gz_B Human SLK with SB-440719	8.704E-03	0.473	50	29	317	326	29	282	285	342	0.887	0.891
LOKIASV2_1503_ESMFold_hypothetical_protein	6ng0-assembly1.cif.gz_A	6ng0-assembly1.cif.gz_A Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with sunitinib in the inactive state.	6.637E-02	0.473	50	27	326	326	12	250	289	335	0.920	0.827
LOKIASV2_1503_ESMFold_hypothetical_protein	2cci-assembly2.cif.gz_C	2cci-assembly2.cif.gz_C Crystal structure of phospho-CDK2 Cyclin A in complex with a peptide containing both the substrate and recruitment sites of CDC6	7.791E-02	0.473	50	28	311	326	9	288	297	362	0.871	0.943
LOKIASV2_1503_ESMFold_hypothetical_protein	4bbm-assembly1.cif.gz_A	4bbm-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE HUMAN CDKL2 KINASE DOMAIN WITH BOUND TCS 2312	3.312E-02	0.473	50	27	325	326	12	309	314	388	0.917	0.949
LOKIASV2_1503_ESMFold_hypothetical_protein	2jed-assembly2.cif.gz_B	2jed-assembly2.cif.gz_B The crystal structure of the kinase domain of the protein kinase C theta in complex with NVP-XAA228 at 2.32A resolution.	7.386E-02	0.473	50	26	326	326	5	273	322	364	0.923	0.835
LOKIASV2_1503_ESMFold_hypothetical_protein	1kob-assembly1.cif.gz_B	1kob-assembly1.cif.gz_B TWITCHIN KINASE FRAGMENT (APLYSIA), AUTOREGULATED PROTEIN KINASE DOMAIN	3.686E-02	0.473	50	27	326	326	34	275	352	332	0.920	0.688
LOKIASV2_1503_ESMFold_hypothetical_protein	4cff-assembly2.cif.gz_A	4cff-assembly2.cif.gz_A Structure of full length human AMPK in complex with a small molecule activator, a thienopyridone derivative (A-769662)	3.312E-02	0.473	50	27	311	326	11	262	425	336	0.874	0.593
LOKIASV2_1503_ESMFold_hypothetical_protein	6m7z-assembly6.cif.gz_F	6m7z-assembly6.cif.gz_F A divergent kinase lacking the glycine-rich loop regulates membrane ultrastructure of the Toxoplasma parasitophorous vacuole	3.140E-02	0.442	49	45	318	326	66	250	259	287	0.840	0.714
LOKIASV2_1503_ESMFold_hypothetical_protein	4rc3-assembly1.cif.gz_A	4rc3-assembly1.cif.gz_A Crystal structure of Ser/Thr kinase Pim1 in complex with Mitoxantrone derivatives	1.330E-01	0.442	49	26	317	326	7	271	272	355	0.896	0.974
LOKIASV2_1503_ESMFold_hypothetical_protein	6yg6-assembly2.cif.gz_B	6yg6-assembly2.cif.gz_B Crystal structure of MKK7 (MAP2K7) covalently bound with type-II inhibitor TL10-105	6.637E-02	0.442	49	26	324	326	16	270	281	347	0.917	0.907
LOKIASV2_1503_ESMFold_hypothetical_protein	6eim-assembly1.cif.gz_A	6eim-assembly1.cif.gz_A Human STK10 bound to GW683134A	2.675E-02	0.442	49	27	326	326	11	252	286	338	0.920	0.846
LOKIASV2_1503_ESMFold_hypothetical_protein	6cqe-assembly1.cif.gz_A	6cqe-assembly1.cif.gz_A Crystal structure of HPK1 kinase domain S171A mutant	4.565E-02	0.442	49	27	326	326	14	256	287	334	0.920	0.847
LOKIASV2_1503_ESMFold_hypothetical_protein	6gub-assembly2.cif.gz_C	6gub-assembly2.cif.gz_C CDK2/CyclinA in complex with Flavopiridol	5.359E-02	0.442	49	28	316	326	9	279	292	355	0.887	0.928
LOKIASV2_1503_ESMFold_hypothetical_protein	5j5t-assembly1.cif.gz_A-2	5j5t-assembly1.cif.gz_A-2 GLK co-crystal structure with aminopyrrolopyrimidine inhibitor	1.941E-02	0.442	49	26	317	326	4	272	298	340	0.896	0.903
LOKIASV2_1503_ESMFold_hypothetical_protein	6rln-assembly1.cif.gz_A	6rln-assembly1.cif.gz_A Crystal structure of RIP1 kinase in complex with GSK3145095	4.327E-02	0.411	48	28	326	326	9	248	266	340	0.917	0.902
LOKIASV2_1503_ESMFold_hypothetical_protein	7lvh-assembly2.cif.gz_B	7lvh-assembly2.cif.gz_B CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 ISOFORM 1 COMPLEXED WITH LIGAND N-[3-METHOXY-4-(1,3-OXAZOL-5-YL)PHENYL]-3-(PROPAN-2-YL)PIPERIDINE-2-CARBOXAMIDE	1.195E-01	0.411	48	28	326	326	16	254	281	337	0.917	0.851
LOKIASV2_1503_ESMFold_hypothetical_protein	6yg6-assembly1.cif.gz_A	6yg6-assembly1.cif.gz_A Crystal structure of MKK7 (MAP2K7) covalently bound with type-II inhibitor TL10-105	7.386E-02	0.411	48	26	324	326	17	273	284	353	0.917	0.905
LOKIASV2_1503_ESMFold_hypothetical_protein	2wip-assembly1.cif.gz_A	2wip-assembly1.cif.gz_A STRUCTURE OF CDK2-CYCLIN A COMPLEXED WITH 8-ANILINO-1-METHYL-4,5-DIHYDRO- 1H-PYRAZOLO[4,3-H] QUINAZOLINE-3-CARBOXYLIC ACID	1.480E-01	0.411	48	19	326	326	2	274	297	368	0.945	0.919
LOKIASV2_1503_ESMFold_hypothetical_protein	3my1-assembly1.cif.gz_A	3my1-assembly1.cif.gz_A Structure of CDK9/cyclinT1 in complex with DRB	5.080E-02	0.411	48	27	311	326	14	304	315	376	0.874	0.924
LOKIASV2_1503_ESMFold_hypothetical_protein	6z0f-assembly1.cif.gz_A	6z0f-assembly1.cif.gz_A Crystal structure of the membrane pseudokinase YukC/EssB from Bacillus subtilis T7SS	3.494E-02	0.411	48	12	324	326	3	204	384	331	0.960	0.526
LOKIASV2_1503_ESMFold_hypothetical_protein	8dgs-assembly1.cif.gz_A	8dgs-assembly1.cif.gz_A Cryo-EM structure of a RAS/RAF complex (state 1)	2.822E-02	0.411	48	27	326	326	146	394	427	345	0.920	0.583
LOKIASV2_1503_ESMFold_hypothetical_protein	4oli-assembly1.cif.gz_A	4oli-assembly1.cif.gz_A The pseudokinase/kinase protein from JAK-family member TYK2	2.535E-02	0.411	48	26	326	326	10	250	539	342	0.923	0.447
LOKIASV2_1503_ESMFold_hypothetical_protein	7qfm-assembly1.cif.gz_A	7qfm-assembly1.cif.gz_A Pim1 in complex with (E)-4-((2-oxoindolin-3-ylidene)methyl)benzoic acid and Pimtide	1.833E-01	0.382	47	26	319	326	7	271	271	351	0.902	0.978
LOKIASV2_1503_ESMFold_hypothetical_protein	5n4x-assembly1.cif.gz_A	5n4x-assembly1.cif.gz_A Crystal structure of human Pim-1 kinase in complex with a consensuspeptide and fragment like molekule 4,5-dibromothiophene-2-carbohydrazide	1.561E-01	0.382	47	26	311	326	7	258	272	336	0.877	0.926
LOKIASV2_1503_ESMFold_hypothetical_protein	3ig7-assembly1.cif.gz_A	3ig7-assembly1.cif.gz_A Novel CDK-5 inhibitors - crystal structure of inhibitor EFP with CDK-2	3.312E-02	0.382	47	28	316	326	8	263	278	327	0.887	0.921
LOKIASV2_1503_ESMFold_hypothetical_protein	7qhl-assembly2.cif.gz_C	7qhl-assembly2.cif.gz_C Crystal structure of Cyclin-dependent kinase 2/cyclin A in complex with 3,5,7-Substituted pyrazolo[4,3-d]pyrimidine inhibitor 24	1.330E-01	0.382	47	28	326	326	3	268	287	360	0.917	0.927
LOKIASV2_1503_ESMFold_hypothetical_protein	1h27-assembly2.cif.gz_C	1h27-assembly2.cif.gz_C CDK2/CyclinA in complex with an 11-residue recruitment peptide from p27	1.261E-01	0.382	47	28	326	326	9	271	292	358	0.917	0.901
LOKIASV2_1503_ESMFold_hypothetical_protein	2wtk-assembly2.cif.gz_B	2wtk-assembly2.cif.gz_B Structure of the heterotrimeric LKB1-STRADalpha-MO25alpha complex	5.653E-02	0.382	47	27	317	326	12	278	311	343	0.893	0.859
LOKIASV2_1503_ESMFold_hypothetical_protein	5hnb-assembly1.cif.gz_A	5hnb-assembly1.cif.gz_A CDK8-CYCC IN COMPLEX WITH [6-Hydroxy-3-(3-methyl-benzyl)-1H-indazol-5-yl]-((S)-3-hydroxy-pyrrolidin-1-yl)-methanone	1.195E-01	0.382	47	10	311	326	2	319	342	395	0.926	0.930
LOKIASV2_1503_ESMFold_hypothetical_protein	6r5f-assembly2.cif.gz_B	6r5f-assembly2.cif.gz_B Crystal structure of RIP1 kinase in complex with DHP77	1.737E-01	0.353	46	36	326	326	12	238	256	330	0.893	0.887
LOKIASV2_1503_ESMFold_hypothetical_protein	7l26-assembly4.cif.gz_D	7l26-assembly4.cif.gz_D HPK1 IN COMPLEX WITH COMPOUND 38	1.133E-01	0.353	46	27	294	326	10	272	275	350	0.822	0.956
LOKIASV2_1503_ESMFold_hypothetical_protein	4nj3-assembly1.cif.gz_A	4nj3-assembly1.cif.gz_A Modulating the interaction between CDK2 and Cyclin A with a Quinoline-based inhibitor	3.889E-02	0.353	46	28	316	326	8	263	278	342	0.887	0.921
LOKIASV2_1503_ESMFold_hypothetical_protein	2iw6-assembly2.cif.gz_C	2iw6-assembly2.cif.gz_C STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR	1.195E-01	0.353	46	28	311	326	9	288	296	368	0.871	0.946
LOKIASV2_1503_ESMFold_hypothetical_protein	4eom-assembly1.cif.gz_A	4eom-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 H84S, Q85M, Q131E - human cyclin A3 complex with ATP	7.386E-02	0.353	46	26	325	326	5	263	297	347	0.920	0.872
LOKIASV2_1503_ESMFold_hypothetical_protein	3og7-assembly1.cif.gz_A	3og7-assembly1.cif.gz_A B-Raf Kinase V600E oncogenic mutant in complex with PLX4032	3.300E-01	0.326	45	28	318	326	13	245	247	328	0.893	0.943
LOKIASV2_1503_ESMFold_hypothetical_protein	7r9l-assembly1.cif.gz_A-2	7r9l-assembly1.cif.gz_A-2 Crystal structure of HPK1 in complex with compound 2	1.561E-01	0.326	45	27	326	326	11	251	282	337	0.920	0.855
LOKIASV2_1503_ESMFold_hypothetical_protein	8bzo-assembly1.cif.gz_A	8bzo-assembly1.cif.gz_A Cryo-EM structure of CDK2-CyclinA in complex with p27 from the SCFSKP2 E3 ligase Complex	1.074E-01	0.326	45	27	164	326	5	144	284	162	0.423	0.493
LOKIASV2_1503_ESMFold_hypothetical_protein	4lgd-assembly6.cif.gz_C	4lgd-assembly6.cif.gz_C Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5	2.160E-02	0.326	45	10	325	326	6	282	349	368	0.969	0.794
LOKIASV2_1503_ESMFold_hypothetical_protein	4d28-assembly1.cif.gz_A	4d28-assembly1.cif.gz_A Crystal structure of the kinase domain of CIPK24/SOS2	1.833E-01	0.301	44	27	326	326	4	238	274	337	0.920	0.858
LOKIASV2_1503_ESMFold_hypothetical_protein	2bcj-assembly1.cif.gz_A	2bcj-assembly1.cif.gz_A Crystal Structure of G Protein-Coupled Receptor Kinase 2 in Complex with Galpha-q and Gbetagamma Subunits	2.270E-01	0.254	42	28	318	326	168	435	624	344	0.893	0.429
LOKIASV2_1503_ESMFold_hypothetical_protein	8afr-assembly1.cif.gz_A	8afr-assembly1.cif.gz_A Pim1 in complex with 4-((6-hydroxybenzofuran-3-yl)methyl)benzoic acid and Pimtide	4.086E-01	0.233	41	36	311	326	14	250	264	323	0.847	0.898
LOKIASV2_1503_ESMFold_hypothetical_protein	8bya-assembly1.cif.gz_A	8bya-assembly1.cif.gz_A Cryo-EM structure of SKP1-SKP2-CKS1-CDK2-CyclinA-p27KIP1 Complex	5.060E-01	0.233	41	27	238	326	3	132	277	216	0.650	0.469
LOKIASV2_1503_ESMFold_hypothetical_protein	5n5l-assembly1.cif.gz_A	5n5l-assembly1.cif.gz_A Crystal structure of human Pim-1 kinase in complex with a consensuspeptide and [2-oxo-2-(1H-pyrrol-2-yl)ethyl] 5-bromo-1H-indole-3-carboxylate	4.311E-01	0.214	40	26	319	326	7	272	272	353	0.902	0.978
LOKIASV2_1503_ESMFold_hypothetical_protein	3ujg-assembly1.cif.gz_A	3ujg-assembly1.cif.gz_A Crystal structure of SnRK2.6 in complex with HAB1	4.327E-02	0.214	40	28	294	326	6	288	290	328	0.819	0.976
LOKIASV2_1503_ESMFold_hypothetical_protein	3c4c-assembly2.cif.gz_B	3c4c-assembly2.cif.gz_B B-Raf Kinase in Complex with PLX4720	1.833E-01	0.196	39	25	319	326	6	233	257	321	0.905	0.887
LOKIASV2_1503_ESMFold_hypothetical_protein	7ukz-assembly4.cif.gz_D	7ukz-assembly4.cif.gz_D CDK11 in complex with small molecule inhibitor OTS964	4.797E-01	0.196	39	26	286	326	1	207	294	298	0.801	0.704
LOKIASV2_1503_ESMFold_hypothetical_protein	6hv0-assembly1.cif.gz_A	6hv0-assembly1.cif.gz_A IRE1 kinase/RNase in complex with imidazo[1,2-b]pyridazin-8-amine compound 33	9.147E-02	0.196	39	28	310	326	14	248	377	328	0.868	0.623
LOKIASV2_1503_ESMFold_hypothetical_protein	6sg4-assembly1.cif.gz_C	6sg4-assembly1.cif.gz_C Structure of CDK2/cyclin A M246Q, S247EN	7.357E-01	0.150	36	45	311	326	3	253	261	342	0.819	0.962
LOKIASV2_1503_ESMFold_hypothetical_protein	6ath-assembly1.cif.gz_A	6ath-assembly1.cif.gz_A Cdk2/cyclin A/p27-KID-deltaC	5.941E-01	0.150	36	42	311	326	10	267	278	345	0.828	0.928
LOKIASV2_1503_ESMFold_hypothetical_protein	5yks-assembly1.cif.gz_B	5yks-assembly1.cif.gz_B Crystal structure of sucrose nonfermenting-related kinase (SNRK)	5.941E-01	0.138	35	16	311	326	2	253	325	342	0.908	0.775
LOKIASV2_1503_ESMFold_hypothetical_protein	6sg4-assembly1.cif.gz_A	6sg4-assembly1.cif.gz_A Structure of CDK2/cyclin A M246Q, S247EN	1.474E+00	0.045	23	45	311	326	3	255	262	323	0.819	0.966
